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 ABSTRACT 
The olfactory neuroepithelium is the only part of the central nervous system that is 
exposed directly to the external environment. Therefore, it is the only non-invasive drug 
delivery route to the brain. Surface modification of PS nanoparticles with chitosan  
(C-PS), polysorbate 80 (P80-PS) and polysorbate 80+FCS (P80-FCS-PS) changed the 
toxicity and distribution of these nanoparticles in olfactory mucosae. In addition, a 
reduction in nanoparticle diameter from 200nm to 20nm increased nanoparticle mucosal 
penetration and possibly also their cellular toxicity. 
 
In vitro vertical Franz diffusion chamber and in vivo mouse models were adapted to 
investigate the transport of nanoparticles via the olfactory system. For the in vitro 
model, preliminary studies found that olfactory epithelium lined the caudal portion of 
the dorsal nasal turbinate in the porcine nasal cavity. To ensure the scientific validity of 
the diffusion chamber studies, it was necessary to prove that the experimental 
procedures themselves (without the addition of nanoparticles) had no effect on the 
mounted tissue. Therefore, viability and cellular morphology of the dissected olfactory 
epithelia were assessed prior to application of nanoparticles to tissues. Alamar Blue™ 
viability and histological findings showed that the diffusion chamber experiment did not 
affect the olfactory tissue when compared to samples that were not mounted on the 
apparatus. Citrate buffer (pH6.0) had significantly reduced the viability (PD, Isc and 
Alamar Blue™) of the porcine olfactory epithelium compared to SNS buffer (pH7.4) 
but it did not kill it. Citrate buffer may have depleted the mucosal pH gradient in the 
epithelium. Overall both SNS buffered and citrate buffered porcine olfactory epithelia 
were suitable for nanoparticle transport studies in the vertical Franz diffusion cell. 
 The in vitro and in vivo biological models showed surface modification had changed the 
distribution of nanoparticles within the epithelia. There was good agreement between 
particle losses from donor chamber, fluorescence microscopy images and stereology 
results that C-PS particles adhered to extracellular mucus to a greater extent compared 
to PS and P80-FCS-PS. P80-PS nanoparticles were taken into the nasal epithelial cells 
to a greater extent than C-PS. Nanoparticles were not transported to the receiver 
chamber in vitro or the olfactory bulbs in vivo. The size of the nanoparticles was also 
important. Fluorescence microscopy and stereology showed that greater numbers of 
100nm PS and 100nm P80-FCS-PS were taken up into mouse olfactory epithelial cells 
compared to 200nm diameter equivalents. Larger particles may not have penetrated 
mucus as effectively as smaller ones. 
 
Bright field microscopy images of olfactory epithelia dismounted from the diffusion 
chamber apparatus after transport study with C-PS nanoparticles showed that these 
particles caused the greatest amount of cellular damage compared to PS, P80-PS and 
P80-FCS-PS systems. Greater damage was observed for progressively smaller particles. 
For example, 20nm C-PS may have accessed subcellular organelles such as 
mitochondria to cause cell death by oxidative stress. However, similar findings in the 
mouse model were not observed. It was hypothesised that, unlike the in vitro model, the 
mouse model may have been able to maintain a pH gradient across the mucous layer by 
neutralising the acidity from the citrate buffer using blood borne HCO3- ions. This 
would protect the epithelial cells by causing C-PS to aggregate in the mucus thereby 
preventing them from accessing the epithelial cells. 
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1. INTRODUCTION AND OVERVIEW 
 
1.1 INTRODUCTION 
Diseases of the Central Nervous System (CNS) that require drug treatments are 
numerous; schizophrenia, meningitis, migraine, obesity, Parkinson’s disease and 
Alzheimer’s disease and are all such examples. Drug delivery to the brain, however, 
remains problematic because of poor bioavailability from the blood due to the 
impervious nature of the endothelial membrane separating the systemic circulation and 
central interstitial fluid, termed the Blood Brain Barrier (BBB) (Pardridge 1999). This is 
a major impeding factor to progress in the field. Hence, many potent therapeutic agents 
may have been abandoned because sufficient drug levels in the brain can not be 
achieved via the blood. 
 
A well described strategy to promote BBB penetration is to derivatise small molecular 
weight drugs into pro-drug analogues which are more lipophilic and so allow passive 
diffusion of the pro-drugs across the BBB. These are later converted by enzymes to the 
native form (Krishnamoorthy & Mitra 1998). This approach however creates a new 
chemical entity which itself requires additional safety assessment for regulatory 
approval; therefore it can be an undesirable strategy. In any case, macromolecular drugs 
such as peptides and proteins, termed ‘biologics,’ are too large and too hydrophilic to 
penetrate the BBB from the systemic circulation and are rapidly cleared by 
gastrointestinal enzymes (if taken orally) or the liver cytochromes. In addition, non-
invasive therapy is also desirable for patients particularly for diseases that require 
chronic dosing such as those related to dementia. Therefore, it is beneficial to develop a 
non-invasive technique that circumvents the need to overcome the BBB. 
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In recent years it has been shown in the literature from animal and human investigations 
that transport of exogenous materials directly from nose-to-brain is a potential route for 
by-passing the BBB (Illum 2000). This route, termed direct nose-to-brain (N-B) drug 
delivery, involves the olfactory or trigeminal nerve systems which initiate in the brain 
and terminate at the olfactory neuroepithelium or respiratory epithelium (respectively) 
in the nasal cavity. It is the only externally exposed portion of the CNS and therefore 
represents the most direct method of non-invasive entry into the brain. The system is not 
currently used therapeutically and no product is licensed specifically via this route. 
 
Moreover, the strategy of applying drugs that are encapsulated into particulate vectors 
(such as synthetic nanoparticles) to the olfactory epithelium could improve non-invasive 
and direct CNS delivery of drugs - including biologics. If drugs could reach the CNS by 
this route then it would not only regenerate interest in previously abandoned drug 
compounds but also enable an entirely novel approach to CNS drug delivery. However, 
before it is possible to contemplate aspects of N-B drug delivery one must have a 
reasonable understanding of nasal anatomy and physiology relating to the field. 
1.2 NASAL ANATOMY AND PHYSIOLOGY 
This section describes the rationale for nasal drug delivery in general and the nasal 
anatomy and physiology relating to N-B drug delivery. A more detailed discussion of 
the nasal physiology and anatomy can be found elsewhere (De Lorenzo 1970; Mygind 
1979; Mygind & Dahl 1998; Lledo et al 2005). 
 
Currently, the nasal route is exploited to deliver drugs either locally (e.g. decongestants) 
or systemically (e.g. the ‘triptans’ for migraine). The nasal route offers many benefits 
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over traditional routes: (i) the process is non-invasive and rapid; (ii) the rich vasculature 
underlying the nasal mucosa can be used to greatly enhance the potential for systemic 
absorption; (iii) the enzymatic degradation of peptides is reduced compared to oral 
delivery; (iv) avoidance of first-pass metabolism has the potential to considerably 
improve bioavailability; and (v) it may improve bioavailability where symptom related 
factors reduce systemic uptake (e.g. oral anti-emetics). 
 
The disadvantages of the nasal route are that: (i) the nasal mucosa usually favours the 
passive diffusion of a combination of low molecular weight drugs (Sakane et al 1995), 
lipophilic (Sakane et al 1991) and unionized molecules (Sakane et al 1994), (ii) the 
nasal mucosa retains some enzymatic activity compared to other mucosae which can 
degrade the active compounds however, the capacity for degradation is less than for 
other absorptive tissues (Graff & Pollack 2003); (iii) nasal congestion due to allergy or 
minor infection could effect the bioavailabilty of the product considerably (Mygind & 
Dahl 1998); and (iv) local irritation (Charlton et al 2007). 
 
With specific reference to N-B delivery, drawbacks compared to systemic delivery 
include: (i) toxicity to the olfactory and trigeminal systems particularly since toxicity in 
chronic dosing to these areas is yet to be evaluated; (v) access to and targeting of the 
olfactory mucosa may be difficult considering its relatively inaccessible location at the 
roof of the nasal cavity in man since it lies away from the usual route taken by inhaled 
air (Gizurarson 1990; Ugwoke et al 2001). 
1.2.1 The External Nose and the Nasal Cavity 
The main functions of the nose are the sense of smell, the regulation of humidity and 
temperature of inhaled air, and the removal of large particulates from the inhaled air. In 
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humans, the total surface area and total volume of both nasal cavities was derived from 
computed tomography (CT) scans as 150.4cm2 (made possible by three protusions or 
‘turbinates’ within the cavity) and 13.0ml, respectively (Menache et al 1997). 
 
The filtering of particulates from the inhaled air starts where the nose opens to the 
external environment (nasal vestibule). The nasal hairs (vibrissae) filter large air-borne 
particles. Approximately 1.5 cm from the bottom of the nasal vestibule is the nasal 
valve (or internal ostium). This is the narrowest portion of the upper respiratory tract 
and thus accounts for the 50% of the total airway resistance from nostril to alveoli 
(Mygind & Dahl 1998). 
 
During rest the air is drawn into the nasal cavity in a laminar fashion at low flow rates. 
It is then directed into the medial and inferior meatuses (Figure 1.1). The medial meatus 
connects to the maxillary sinus through a 2-5mm opening (ostium). The maxillary sinus 
helps to warm and humidify inhaled air. After passing through the main nasal passage 
(cross-section B Figure 1.1), the inspired air then passes through the nasopharynx 
(cross-section C Figure 1.1) and onwards to the bronchi and lungs. 
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Figure 1.1 Schematic diagram showing the gross anatomy (in sagittal [left] and frontal [right] 
planes) of the human nasal cavities. IT, MT, and ST refer to inferior, middle, and superior 
turbinates. IM, MM, and SM refer to inferior, middle, and superior meatuses. MS refers to the 
maxillary sinus. Taken from (Croce et al 2006). 
 
The olfactory epithelium is located high in the nasal cavity in man (Figure 1.1). It partly 
overlies the cribriform plate, a bony structure that contains many pores that allow the 
passage of neuronal bundles from the olfactory epithelium to pass into the CNS (Figure 
1.6). Olfactory epithelium may also lie partly on the nasal septum and on the superior 
turbinate. It is above the normal path of the airflow which means that odorant molecules 
normally reach the sensitive receptors by diffusion. The act of sniffing enhances the 
diffusional process by increasing the airflow rate and changing it from continuous to 
pulsatile in nature. This behaviour increases the turbulence within the nasal cavity and 
therefore allows greater interaction of the inspired air with the olfactory region at the 
roof of the nasal cavity.  
 
 17 
Figure 1.2 shows a CT scan image (Figure 1.2) of air passing through a plastinised 
model of the human nasal cavity (Croce et al 2006). Vortices appear at high airflow 
(231ml/s) in the nasal cavity in the olfactory region and at the head of the inferior 
turbinate. The CT scan shows that the vortex in the olfactory region had a low velocity 
magnitude (0.4m/s). The low velocity may aid odorants to interact with the olfactory 
neuroepithelium by allowing sufficient residence time for the interaction to take place. 
 
 
Figure 1.2 CT scan of high airflow through a plastinated model of the human nasal cavity. 
NV=Nasal Vestibule. VA= Vortex Area. Taken from (Croce et al 2006). 
 
However, the laminar airflow used in this experiment did not simulate the pulsatile 
nature of sniffing. By pulsating the airflow, future studies may provide a clearer 
 18 
aerodynamic understanding within the nasal cavity during the act of sniffing and 
therefore its significance to olfaction. 
1.2.2 The Structure of Nasal Epithelia 
There are two physiologically important epithelia in the nasal cavity relating to drug 
delivery, ‘respiratory’ and ‘olfactory’. From a drug delivery perspective the respiratory 
epithelium, which has a rich submucosal blood supply, is particularly important for 
systemic drug absorption. Certain regions of the respiratory epithelium also contain 
microfold (M) cells whose function it is to present antigens found in the mucus to 
underlying nasaopharynx-associated lymphoid tissue (NALT) structure in the lamina 
propria. This initiates an immunological cascade involving T cells and B cells that 
ultimately ends in both systemic and local immune responses (e.g. mucosal IgA 
antibody secretion). This immunological cascade may be useful for the development of 
nasal vaccines. In contrast, the olfactory epithelium (which has a surface area of 3% 
(~4.5cm2) of the total nasal epithelium and is placed in the roof of the nasal cavity in 
man (Morrison & Costanzo 1990) ) contains olfactory neurones that ultimately reach 
the brain via a number of connections (Mygind 1979; Mygind & Dahl 1998).  
 
There are three structural morphologies of epithelia in the human nasal cavity: (i) 
keratinised stratified squamous found in the nasal vestibule; (ii) pseudostratified 
columnar located caudally (distal to the nasal vestibule); or (iii) stratified cuboidal 
situated between the previous two types (Mygind 1979; Mygind & Dahl 1998). 
 
The nomenclature is described in terms of the shape of the individual cells and the 
overall structure of the epithelium. Squamous cells are flat and have an irregular shape 
(Figure 1.3). They may produce keratin which is a tough insoluble protein that helps to 
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protect the underlying tissue from mechanical damage and/or dedydration. Stratified 
describes cells that appear in layers of which the superficial layers have lost contact 
with the basement membrane. (The basement membrane, or basal lamina, is an 
extracellular condensation of mucopolysaccharide and proteins that consists of a dense 
filamentous sheet measuring 50-100nm in thickness). 
 
Pseudostratified columnar cells form the respiratory epithelium. Columnar cells are tall 
and rectangular such that the height exceeds the width of the cell (Figure 1.3). It is 
thought that the shape of the columnar cell helps to maintain its ‘polarised’ function 
(Wright & Alison 1984). For example, columnar cells contain a higher density of 
mitochondria at the apical region of the cell presumably to facilitate the functions of 
active transport and/or cilia motility. Nasal pseudostratified epithelia appear to form 
different cell layers above the basement membrane but careful examination reveals that 
both basal cells and columnar cells maintain their attachment to it. The olfactory 
epithelium is a modified pseudostratified columnar epithelium as described in detail 
later (1.2.4 Olfactory Epithelium and Neuronal Supply). 
 
Cuboidal cells are so called since the height of each component cell is similar to its 
width. Cuboidal cells have a stratified layer organisation (Figure 1.3). 
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(a) Stratified squamous epithelium – cells 
are flat with irregular shapes 
 
 
(b) Pseudostratified columnar epithelium – 
columnar cells are tall and narrow with a 
regular shape. Basal cells give the 
epithelium a stratified appearance; 
however, all cells are attached to the 
basement membrane so the epithelium is 
described as ‘pseudostratified.’ 
 
 
(c) Stratified cuboidal epithelium – a 
layered cellular organisation whereby the 
height of each component cell is similar to 
its width 
Figure 1.3 Schematic representations of different epithelia found in the human nasal cavity 
(illustrations adapted from (Freeman & Bracegirdle 1976) ) 
 
 
In some mammals, including humans, there are also transitional areas at the boundaries 
between different morphological regions where these distinctions are gradually blurred. 
1.2.3 Respiratory Epithelium and Mucocillary Clearance 
The respiratory epithelium is composed of four types of cells, namely, non-ciliated and 
ciliated columnar cells, basal cells and goblet cells (Figure 1.4). All columnar cells 
express around 300 microvilli per cell that increase the surface area at the apical surface 
(Ugwoke et al 2001). These features probably facilitate active transport processes such 
as the exchange of water and ions between cells and motility of cilia (where applicable). 
They may also serve to prevent drying of the mucosa by trapping moisture. 
Columnar cell Basal cell Basement membrane 
Basement membrane 
Basement membrane 
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The ciliated and non-ciliated columnar cells contain a high density of mitochondria 
particularly near the apical surface (Matulionis & Parks 1973). This implies that these 
cells are heavily involved in active transport processes in this region. Columnar cells 
may be responsible for the transport of drug from the environment into the underlying 
blood supply either actively (for hydrophilic molecules) and/or passively (for lipophilc 
molecules). They are anchored to the neighbouring cells apically by junctional 
complexes (1.2.5 Junctional Complexes). 
 
 
 
 
Figure 1.4 Diagram of the four cell types in the respiratory epithelium (from the left) non-ciliated 
columnar cell (nCC), goblet cell (GC), basal cell (BC) and ciliated columnar cell (cCC). Adapter 
from (Mygind & Dahl 1998). 
 
Ciliated columnar cells also contain a mitochondria-rich apical region and these cells 
represent 15-20% of the respiratory epithelium (Matulionis & Parks 1973). Each 
ciliated cell contains around 100 cilia (Ugwoke et al 2001). They use energy from the 
mitochondria to facilitate the beating of cilia in an innate and synchronised fashion at a 
Cilium 
Zonula Occludens (Tight Junction) 
and Zonula Adherens 
Microvillus 
Apical Direction 
Mitochondrion 
Basement Membrane 
Desmosome (Macular Adherens) 
Basolateral Direction 
BC 
nCC GC cCC 
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frequency of 10-20Hz so as to clear the covering mucus layer at a rate of 6 mm/min 
towards the nasopharynx (Ugwoke et al 2001). 
 
Mucus (or nasal secretion) is a complex mixture of materials. It is approximately 95% 
water, 2% mucin, 1% salts, 1% of other proteins such as albumin, immunoglobulins, 
lysozymes and lactoferrin, and <1% lipids (Kaliner et al 1984).  
 
Mucus exists in two layers in order to facilitate mucociliary clearance; hence, a mucus 
‘blanket’ (Figure 1.5c; ‘gel layer’, 2-4µm thickness) floats on a serous fluid (Figure 1.5e 
‘sol layer’, 3-5µm thickness). The viscous gel layer is moved along by the hook shaped 
cilia termini during the energy-dependent ‘effective stroke’ phase of the ciliary motion 
(Figure 1.5a). Cilia are up to 7µm in length when fully extended but can fold to half this 
length during the recovery stroke. During the ‘recovery stroke’ the hook terminus 
detaches from the gel layer and moves in the opposite direction to the gel layer 
movement (Figure 1.5b). The cilia are immersed only in the sol layer during the 
recovery stroke and thus the gel layer moves only in one direction (Mygind 1979; 
Lenaerts & Gurny 1990).  
 
 
Figure 1.5 The relationship between 
ciliary motion and mucus layer 
composition that allows mucociliary 
clearance. (a) effective stroke, (b) 
recovery stroke, (c) gel layer (d) 
direction of gel layer movement, (e) 
sol layer. Adapted from (Proetz 
1953). 
 
e 
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In addition, it is well known that this mucocilary clearance rate is altered by the action 
of anaesthetics and this may complicate interpretation of in vivo experimental data since 
anaesthetics are usually required during in vivo studies (Van Der Baan 2000). 
 
The third type of cell contained in the respiratory epithelium is the basal cell. These are 
the progenitors of the other cell types. They also provide mechanical stability to the 
epithelium since they are anchored to adjacent cells and the basement membrane and by 
desmosomes and hemidesmosomes, respectively (Mygind & Dahl 1998).  
 
Finally, Goblet cells produce mucus and so the are densely packed with golgi apparatus 
which reflects their high secretory capacity. Goblet cells, however, may contribute less 
than the exocrine glands (Bowman’s Glands) to the main production of nasal secretions 
over the olfactory epithelium (Getchell & Getchell 1992).  
1.2.4 Olfactory Epithelium and Neuronal Supply 
The olfactory epithelial layer predominantly contains three cell types; the olfactory 
cells, supporting (or sustentacular) cells and basal cells. Basal cells are progenitor cells 
(of supporting cells) that also provide mechanical support as described for the 
respiratory epithelium. Supporting cells are elongated non-ciliated columnar cells that 
contain microvilli. They provide mechanical support to the olfactory cell by 
surrounding them and forming junctional complexes with them (1.2.5 Junctional 
Complexes). Also, they may help to maintain a suitable extracellular potassium 
environment for the neurones to allow polarisation, priming them, ready for an action 
potential.  
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The third cell type is the olfactory axon. The axons are unmyelinated and interspaced 
between the supporting cells (Figure 1.6). They originate at the olfactory bulb in the 
CNS and terminate at the apical surface of the olfactory epithelium. 
 
 
Figure 1.6 Diagram of the olfactory area showing the olfactory epithelium, 
bulb and tract. From (Adams et al 1989) 
 
The olfactory knob (or vesicle) protrudes out from and above the apical surface of the 
olfactory epithelium (Figure 1.7). Approximately 10-23 cilia project from the basal 
bodies of the knob, each of length up to 200µm. The cilia contain chemical detectors 
that, once activated by odorants, initiate depolarisation of the receptor cell by either 
direct ion-gated channels or cAMP operated ion-channels (Gartner & Hiatt 2000). The 
cilia entangle with the thick brush-border of microvilli of the supporting cells at the 
air/mucus/tissue interface (Figure 1.7). The cilia are non-motile in the olfactory region 
(in contrast to respiratory tissue) since they lack the dynein arms which contain the 
Mg2+-ATPase that generates the force for cilary motility (Moran et al 1982). 
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Figure 1.7 Electron microscope images of cat 
olfactory knob. (1) Neighbouring supporting 
cell; (2) tight junction; (3) mitochondrion in 
olfactory knob; (4) basal bodies; (5) olfactory 
cilia; (6) microvilli; (7) mitochondrion in 
supporting cell; (8) microtubules. From 
(Rhodin 1974). 
 
 
The lamina propria of the olfactory epithelium, which is located beneath the epithelial 
layer(s), contains a blood supply, mucus secreting acinar glands (Bowman’s glands), 
nasal lymphatics, and a neuronal supply that consists of olfactory axon bundles, 
autonomic nerve fibres and maxillary branch of the trigeminal nerve (Tucker 1971; 
Mygind 1979; Brand 2006; Brodbelt & Stoodley 2007). Bowman’s glands are under the 
control of the parasympathetic nervous system. These acinar-type glands produce nasal 
secretions in the lamina propria and secrete them through a narrow tube-like opening 
into the luminal space. 
 
Also in the lamina propria the olfactory neurones taper together and are ensheathed by 
glial cells (or Schwann cells). These processes are called filia olfactoria. De Lorenzo 
(1962) has described the fila olfactoria in detail. Fila olfactoria are unique features in 
the mammalian body in that around twenty axons are partitioned by the Schwann cell 
into fascicles. Five fascicles are shown in Figure 1.8. In this way a single Schwann cell 
0.1µm 
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may ensheathe around a hundred or so axons. In contrast, single non-olfactory neurones 
are usually ensheathed by a one Schwann cell. This feature allows 10-15nm sized 
spaces between axons that act as ionic reservoirs for action potential propagation. 
Hence, perineuronal transport of molecules to the olfactory bulbs is limited by the size 
of these spaces. Mesaxons are pores in the filia olfactoria structure that allow passage of 
extracellular fluid into the neuronal bundle structure.  
 
The average diameter, by electron microscopy, of olfactory axons in 2 month old rabbits 
is ~200nm, however, many of the axons have diameters of <100nm (De Lorenzo 1960). 
Theoretically therefore transcellular transport of up to 200nm diameter particles is 
possible in these animals. Other species show similar olfactory axonal diameters, for 
example, the African Clawed frog, various bird species and humans have diameters of 
198±93nm, 210-260nm and 100-700nm, respectively (Burd 1991; Morrison & Costanzo 
1992; Matsuzaki 1995).  
 
 
Figure 1.8 Schematic representation of 
fila olfactoria. The arrangement of 
neurones is unusual in that many (~20) 
neurones are isolated into fascicles (F). 
Here five such fascicles are ensheathed 
by a single Scwann Cell (SwC). In 
addition, the cavities in the structure 
(C) provide reservoirs for ions. This 
enables ion exchange between the 
axoplasm and the extracellular fluid. 
Mesaxons are pores in the structure 
that allow continuity between the 
extracellular fluid and the filia 
olfactoria. Adapted from De Lorenzo 
(De Lorenzo 1962). 
 
F 
SwC 
C 
C 
C 
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The Schwann-sheathed axonal bundles then pass through the lamina propria and into 
the porous structure of the cribriform plate. They then synapse on a mitral cell or tufted 
cell in the glomeruli of the olfactory bulb. Around 1500 sensory neurones synapse on 
one mitral cell. The mitral and tufted cells are branched; they project one dendrite to 
each glomerulus. These neurones then pass through to the olfactory tubercle. From 
there, the third-order neuronal projections pass to the amygdala, prepyriform cortex, the 
anterior olfactory nucleus and the entorhinal cortex as well as the hippocampus, 
hypothalamus and thalamus (Lledo et al 2005). 
1.2.5 Junctional Complexes 
Junctional complexes are the cell-to-cell contact areas found between both respiratory 
and olfactory epithelial cells in the nasal cavity. Some consist of protein anchors that 
hold two adjacent cells closely together to maintain cell contiguity and strengthen the 
epithelial sheet (Shin et al 2006). There are three different types of these complexes 
(Figure 1.4); macular adherens (or desmosomes), zonula adherens and zonula 
occludens (tight junctions [Figure 1.7]). Zonula occludens are located closest to the 
luminal space. Zonula adherens are located close to the zonula occludens and macular 
adherens are situated basolaterally in relation to other two complexes. Thus, the 
transport of drugs between cells is largely determined by the integrity of these 
complexes for in tact epithelia. 
 
Macular adherens are composed of dense attachment plaques between cells. Cells 
attach to these extracellular plaques by anchoring them to tonofilaments that loop out 
and back into the cell. Macular adherens are particularly well developed between 
stratified squamous epithelium. They are clearly observed as thin strands between cells 
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under the light microscope. Unlike the macular adherens, the zonula adherens do not 
possess a well-developed attachment plaque. They associate with the apical terminal 
web a meshwork of proteins found in the cytoplasm of cuboidal and columnar cells. 
Zonula occludens press tightly against each other (by contact of adjacent cell 
membranes) to seal the intercellular space between cells from the lumen. The pore size 
between the cells is largely determined by the claudin proteins in the Zonula occludens 
(Gumbiner 1987; Van Itallie & Anderson 2006). 
 
The structure of junctional complexes is similar throughout the body since junctional 
complexes share similar protein compositions. For example, tight junctions are mainly 
composed of three transmembrane proteins; namely, claudins, occludins and junctional 
adhesion molecules. Therefore it can be assumed that variations in tight junction 
composition between cells in the olfactory and respiratory epithelia have little 
importance for paracellular transport of nanoparticles (Shin et al 2006). 
1.2.6 Interspecies Variability of Nasal Anatomy 
The histological features of the olfactory epithelium are similar between most 
mammals. The epithelium has been consistently observed to have a pseudostratified 
columnar morphology interspaced with olfactory cells (as described before) amongst 
many species in the class (e.g. humans (Morrison & Costanzo 1990; Moran et al 1992), 
pig (Booth et al 1981), mouse (Bannister & Dodson 1992), rat (Miller et al 1995), koala 
(Kratzing 1984), rabbit (De Lorenzo 1962) ). In addition, the sialylated and sulphated 
acid mucin components of mucus has been shown to be similar in pigs and humans 
(Larochelle & Martineaudoize 1991). Thus, the similarities may go beyond physical 
appearance alone. 
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Nevertheless, some variation does exist. For example, rabbits and dogs have branching 
conchae instead of scrolls that are found in pigs and rodents (Gizurarson 1990). Such 
anatomical differences may restrict the access of formulations to the olfactory regions of 
rabbits and dogs compared to pigs and rodents depending on the exact location of the 
olfactory epithelium in each of these species. 
 
Also, the surface area of olfactory epithelium in the human nasal cavity is up to 3% 
(Morrison & Costanzo 1990) of the total nasal epithelium; whereas in mouse it is 56% 
(Adams 1972). Therefore proportionally more drug molecules may be transported to the 
mouse brain via the olfactory route compared to humans. In addition, clearance half-life 
of mucus from the nasal cavity is 1 min in mice compared to 15 minutes in humans 
(Gizurarson 1990). Hence, higher concentrations of drug may appear in the CSF of mice 
than humans. Finally, the human brain (1500g) is larger than that of rat (2g) this makes 
penetration of drug molecules deep into the brain parenchyma more difficult in humans 
(Nieuwenhuys et al 1998).  
 
Similar differences may exist between human and porcine nasal cavities; however, there 
is relative less information about nasal mucus clearance rates and percentage olfactory 
epithelium coverage in domestic pigs. Nevertheless, conclusions regarding the impact 
of the olfactory transfer of drugs in humans from other animals are difficult to make 
particularly since there is a lack of studies in man.  
 
Species variation between rats and mice has been seen for direct N-B delivery of 
morphine solution (Westin et al 2005). [3H]-morphine levels were found, by 
autoradiography and liquid scintillation analysis, to peak in the right olfactory bulb in 
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male Sprague-Dawley rats within 15 minutes of i.n. administration; however, it was 60 
minutes in Balb/c mice. 
 
In addition, morphine is metabolised in the periphery to pharmacologically active 
morphine-6-glucoronide and inactive morphine-3-glucoronide in humans (Westerling et 
al 1995) while only the inactive metabolite is formed in mice and rats (Kuo et al 1991). 
High levels of drug metabolising enzymes exist in the olfactory epithelium (Lazard et al 
1991) which could produce similar variations in drug metabolism at the level of the 
nasal mucosa. This would also be relevant if a nanoparticle formulation was used to 
release drug at the olfactory mucosa. 
 
Hence, these findings demonstrate that it may be difficult to extrapolate conclusions 
made from direct N-B drug delivery studies between mammalian species.  
1.3 CELLULAR MECHANISMS FOR TRANSMUCOSAL DRUG DELIVERY 
Two broad mechanisms of drug transport through the epithelial cell layer have been 
identified, namely, paracellular (between epithelial cells) or transcellular (apical to 
basolateral transport through epithelial cell). 
 
The paracellular route comprises of a hydrophilic channel that allows only the smallest 
of drug molecules to pass through it due to the restrictive nature of the junctional 
complexes that link the epithelial cells. In nasal epithelia the largest molecular size for 
paracellular drug transport has been estimated as 1000Da (McMartin et al 1987). Hence, 
dopamine (Dahlin et al 2000; Dahlin et al 2001) and morphine (Westin et al 2005) are 
both believed to pass paracellular (as well as trancellularly) between olfactory epithelial 
cells. However, tight junctions are generally impermeable to molecules with a 
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hydrodynamic radius greater than 4-8Å (depending on the ‘leakiness’ of the epithelium) 
which restricts the movement of molecules larger than this to pass between 
neighbouring cells (McMartin et al 1987). Hence, nanoparticles are too large for this 
route to be of use. Therefore, since the main focus of this review is to evaluate the 
particulate delivery of drugs directly from nose-to-brain, the rest of this section will 
concentrate on the transcellular route. 
 
The transcellular route is less well characterised than the paracellular route (Miaczynska 
& Stenmark 2008). However, novel spectroscopy and microscopy techniques such as 
electron energy loss spectroscopy and energy filtering transmission electron microscopy 
are providing new insights into this complex process (Rothen-Rutishauser et al 2006). 
Lipophilic, small molecular weight drugs are able to passively transport through the cell 
membrane and this is discussed later (1.6 The Transport of Drug Solutions Direct from 
Nose-to-Brain). The aim of this section, however, is to describe the different endocytic 
routes of transcellular uptake of drugs and nanoparticles by cells, and speculate how 
they may influence direct N-B drug delivery. 
 
Endocytosis has been categorised by a number of different molecular mechanisms 
including macropinocytosis, clathrin-mediated, clathrin-independent, caveolin-
mediated, caveolin-independent and phagocytosis (Conner & Schmid 2003) (Figure 
1.9). Macropinocytosis is an endocytic mechanism where the action of actin filaments 
gives rise to curved ‘ruffles’ on the cell surface. Sealing of the aperture into discrete 
vacuoles forms the macropinosome (0.5-5µm diameter) which efficiently takes up 
extracellular fluid into the cell (Xiang et al 2006). Considerable volumes of dissolved 
molecules and particles can be taken up in this way. Macropinocytosis is generally 
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thought of as a constitutive process by which the cell can sample the extracellular 
environment and is not believed to be initiated by receptor activation at the cell surface 
(Xiang et al 2006).  
 
Receptor-meditated endocytosis is a term used to describe a group of endocytic 
mechanisms where the ‘cargo’ is thought to stimulate the endocytic event by 
complementing a receptor on the cell membrane. Receptor-mediated endocytosis can 
involve either clathrin-dependent or independent mechanisms. The clathrin protein is 
endogenously expressed within mammalian cells in the form of a heavy chain and a 
light chain. The fusion of these chains results in the formation of a triskelion structure, a 
3D array of which produces a clathrin coat (Edeling et al 2006). Recruitment of the coat 
to the cytosolic cell membrane gives rise to regions called ‘coated pits’ during the initial 
stages of receptor-mediated endocytosis. Invagination of the pit results in a clathrin-
coated vesicle that is taken into the cytosol. These vesicles can take various shapes and 
sizes but are generally believed to be <150nm (Xiang et al 2006). Clathrin-dependent 
endocytosis is currently the best characterised endocytic mechanism; however, there is 
still debate over exactly how the cargo initiates the event (Sorkin 2004).  
 
Clathrin-independent endocytosis may involve cholesterol-enriched microdomains in 
cell membranes called ‘lipid-rafts’. Caveolae-mediated endocytosis is dependent on 
lipid rafts for its function. Caveolae are flask-shaped structures (50-80nm) that are rich 
in proteins and lipids such as cholesterol and sphingolipids and may be involved in 
signal transduction (Anderson 1998). Caveolae-independent lipid raft-dependent 
endocytosis also exists and has recently been identified to involve microdomains (40-
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50nm) that contain a protein called flotillin (Frick et al 2007). But this mechanism is not 
yet fully understood.  
 
A form of clathrin-independent endocytosis that does not involve the formation of lipid 
rafts is phagocytosis. This is a receptor-mediated uptake of exogenous materials by 
specialised phagocytic cells such as macrophage. This route of uptake leads to 
internalisation of relatively large (>1µm) patches of membrane (Mayor & Pagano 2007) 
and engulfment of the exogenous material into lysosomes either for destruction or 
antigen presentation. Hence, phagocytic cells act to destroy materials that may be 
harmful to other cells and also alert immune system cells to their prescence. 
 
Phagocytic cells make up a minority of the total cell population in the nasal cavity and 
therefore are not thought to contribute to cellular uptake in therapeutic concentrations 
(Mygind & Dahl 1998). Furthermore, processing of drugs by the lytic enzymes and 
acidic pH conditions present in the lysosome may reduce drug potency. Consequently, 
other forms of endocytosis (macropinocytosis and clathrin-mediated endocytosis) 
represent more promising trancellular routes of drug uptake into cells that may allow 
therapeutic levels of drug to enter the body without substantial damage to the drug 
molecule. 
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Figure 1.9 Cellular endocytic pathways (adapted from (Xiang et al 2006) ) 
 
Overall, in many cases, it is not yet fully understood how substrates such as 
nanoparticles initiate the process of cellular internalisation. Moreover, some 
commentators have even questioned the existence of a ‘cargo specific’ mechanism of 
uptake (Sorkin 2004).  
 
However, the lack of clear understanding of endocytic mechanisms should not dampen 
optimism. Knowledge from novel microscopic and spectroscopic techniques continually 
adds to the understanding of endocytosis (Gaidarov et al 1999). Phagocytosis may lead 
to damage of the drug molecule, however, other lipid raft-dependent mechanisms 
(which include caveolae or flotillins) form vesicles that could deliver very small 
nanoparticles (40-80nm diameter) into the cells. Moreover, clathrin-mediated and 
macropinocytosis vesicles are larger (<150nm and 0.5-5µm, respectively) and allow 
40-50nm 
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passage of nanoparticles into cells in greater quantities which could be of therapeutic 
benefit. A better understanding of how these later two processes initiate could lead to 
the development of nanoparticles that can target these routes of uptake. 
 
With respect to nose-to-brain drug delivery of nanoparticles it is clear that the delivery 
of different nano-sized particles may lead to uptake of the drug carriers into different 
endocytic pathways. The fate of the nanoparticles is dependent on one or more of these 
individual systems. Hence, altering nanoparticle size and composition could be useful 
approaches to improving their cellular uptake into olfactory epithelial cells. 
 
1.4 EARLY NOSE-TO-BRAIN THERAPEUTICS 
Intranasal administration of medicines and recreational therapeutics has been used 
throughout humanity. For example, ancient Tibetans used extracts of sandalwood and 
aloewood given nasally as anti-emetics (Rinpoche & Kunzang 1973). Today, cocaine, a 
highly addictive central nervous system stimulant extracted from the leaves of the coca 
plant (Erythroxylon coca) is administered intranasally for recreational use (Madge 
2001). However, a fuller understanding of the transport pathways of drugs directly from  
N-B has only become available in recent times. 
1.5 VIRAL PARTICLES AND ENVIRONMENTAL POLLUTANTS IN THE 
OLFACTORY SYSTEM 
Workers in the heavy metals industry have shown symptoms of clinical pathologies that 
are associated with poisoning of the brain (Sunderman 2001). For example, workers 
with chronic exposure to methylmercury can show symptoms of impaired visual, 
auditory and/or gustatory sensations. 
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Moreover, when instilling solutions of heavy metal toxicants (e.g. mercury, zinc and 
cobalt) to the occluded nasal cavities of rats, the metal ions appeared in distal tissues 
such as the olfactory tract, bulb and cortex (Henriksson 1998; Persson et al 2003b; 
Persson et al 2003a). It is thought that they traversed the olfactory epithelium from 
where they navigated to the brain. 
 
This interpretation concurs with that for viral particles whereby herpes simplex virus 
and mouse hepatitis virus are found in mice olfactory bulbs after intranasal inoculation 
(Barnett et al 1993). 
 
These observations lead to the suggestion that an ‘olfactory’ pathway exists that can 
completely bypass the somewhat impenetrable BBB. 
1.6 THE TRANSPORT OF DRUG SOLUTIONS DIRECT FROM NOSE-TO-
BRAIN 
Investigations of the transport pathways of drugs from the nasal cavity to the CNS have 
been a result of the observations made from traditional medicines, viral particles and 
heavy metal poisonings of the brain. The following summary highlights key 
experiments that have progressed the understanding of N-B drug delivery of solutions to 
date. Analyses of similar findings have previously been reviewed elsewhere (Illum 
2000, 2004; Merkus & van den Berg 2007). 
 
Physicochemical properties (logDC, pKa and MW) of drug molecules can affect 
intranasal absorption into the brain. For example, the CSF and plasma drug 
concentrations obtained for four sulphonamides (with molecular weights of 173.2 to 
278.3) were compared after i.v. and i.n. administration in Wister rats (Sakane et al 
1991). The CSF concentration of drug at 60 minutes after dosing was positively related 
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to its partition coefficient. Hence, i.n. drug absorption increased with increasing drug 
lipophilicity using the nasal perfusion model (Hirai et al 1981). The bioavailability of 
these drugs into the CSF was ~0.1% of the administered dose 60 minutes after dosing. 
 
The effect of drug ionisation was also studied using a similar nasal perfusion model by 
the same group (Sakane et al 1994). In order to change the degree of drug ionisation 
between samples, sulphisomidine (pKa 7.5) was nasally perfused with different buffer 
solutions over the pH range 5.5-9.4. The CSF drug concentration was found to increase 
as the concentration of the unionised drug form increased. Bioavailability of 
sulphisomidine into the CSF was low (~0.1-2% of the administered dose) which was 
similar to that for sulphonamides that were previously studied (Sakane et al 1991). 
 
To investigate the effect of molecular weight, fluorescently labelled dextrans up to 
40kDa were used in a similar experiment as above (Sakane et al 1995). The largest 
molecular weight of detectable dextrans was 20kDa, therefore, molecules larger than 
this are not likely to pass into the CSF between the olfactory epithelial cells 
(paracellularly). The absorption of dextrans into the CSF decreased with increasing size 
(from 4kDa to 20kDa). Also, the CSF bioavailability of these compounds was 2-3 
orders of magnitude lower than that for the sulphonamides (Sakane et al 1991; Sakane 
et al 1994). Therefore, drugs of molecular weight less than 4kDa are likely to absorb 
into the CSF more efficiently than larger ones. This is similar to findings by McMartin 
et al. (1987) as described earlier in this review.  
 
Hence, it is thought that the transport of drugs through these different routes could be 
manipulated by changing the physicochemical properties of the drug. Thus, increasing 
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hydrophilicity and reducing molecular weight of drugs may increase paracellular 
uptake; whereas increasing lipophilicity and reducing degree of ionisation may increase 
trancellular uptake of drugs. 
 
Unfortunately, increasing drug absorption into the CSF after i.n. administration may not 
be as simple as making physicochemical changes to the drug molecule. For example, 
one study used a series of antihistamines (hydroxyzine, chlorcyclizine, triprolidine and 
chlorpheniramine) to investigate the absorption of drugs from the nasal cavity into the 
CSF compared to plasma. Two of these drugs, hydroxyzine (MW375, 2.37 logDC) and 
chlorcyclizine (MW300, 2.91 logDC), were cationic in pH6.8 0.1M Sørensen’s 
phosphate buffer, had similar molecular weights and similar logDC values. The nasal 
cavities of male Sprague-Dawley rats were isolated in vivo and drug solutions were 
applied intranasally. CSF samples and intra-arterial samples were analysed by HPLC 
for drug levels after 3 hours. Although the physicochemical properties of the drugs were 
similar, four times more hydroxyzine was found in the CSF compared to plasma; 
whereas, chlorcyclizine was not detectable in the CSF after i.n. administration (Chou & 
Donovan 1997). The different antihistamines may have been metabolised or effluxed by 
the nasal epithelium at different rates. Therefore, transport of drug directly into the CSF 
is determined by a combination of molecular and biological properties of the drug 
which are difficult to predict. 
 
Nevertheless, an in vitro diffusion chamber experiment such as the one described in 
Chapter 2 can be used to investigate paracellular/transcellular drug transport routes 
through epithelia. Indeed, Jansson (2004) found that 1mg/ml [3H]-dopamine was 
transported across the porcine olfactory mucosa both transcellularly (because this route 
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was saturated by the addition of 4mg/ml [3H]-dopamine) and paracellularly (because 
permeability of [3H]-dopamine to the epithelium was negatively correlated with the 
‘leakiness’ of the epithelium as measured by the electrical resistance across the 
epithelium). This conclusion was strengthened by earlier (in vivo) observations made by 
Dahlin et al. (2000) (described later). 
 
The in vitro diffusion chamber method can also be used to evaluate the effect of drug 
formulations on the morphological appearance of the epithelium after exposure of the 
formulation to the mucosal surface. For example, porcine nasal respiratory epithelium 
was exposed to varying concentrations of a non-ionic surfactant (polyethyleneoxide-8-
lauryl ether) for 150 minutes at 37°C in Krebs Ringer Bicarbonate buffer solution 
(pH7.4) (Ekelund et al 2005). Transepithelial electrical resistance (Rm) was measured to 
determine the damage induced by the different concentrations of surfactant. Reductions 
in Rm were found as surfactant concentrations increased above 0.2mM. This correlated 
well with the assessment of damage to the epithelial cells after histological examination 
of the dismounted nasal mucosae (i.e. more cellular damage was found as Rm 
decreased). 
 
Other drugs have also been shown to be transported directly to the brain after intranasal 
administration. [3H]-morphine was found in the CSF surrounding the olfactory bulbs by 
autoradiography in male Sprague-Dawley rats within 5 minutes of i.n. administration 
(Westin et al 2005). After 60 minutes the morphine was found in the olfactory bulb 
ipsilaterally to the side of the nasal cavity that was administered with the dose. A 
gradient of radioactivity was observed in the brain at this time point where higher levels 
of morphine were found closer to the cribiform plate. This showed that the radioactivity 
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originated from the nasally cavity. The radioactivity in the olfactory bulb was cleared 
240 minutes after dosing. However, no significant penetration of the radioactivity was 
detected in deeper brain regions. 
 
A similar study using 5µCi [3H]-dopamine in female NMRI mice showed that 
significantly more radioactivity was found in the olfactory bulb that was ipsilateral to 
the dosing side of the nasal cavity (Dahlin et al 2000). Two radioactivity peaks were 
observed in the olfactory bulbs; first at 30 minutes (the earliest sampling time point) and 
later at 4 hours. This indicated that the drug was passing through two alternative 
pathways. The earlier appearance of radioactivity was attributed to paracellular passage 
of drug between olfactory axons whereas the later peak was attributed to transcellular 
passage of drug through the axons. This was later confirmed by Jansson’s (2004) in 
vitro method as described previously. However, in this experiment only 0.12% of the 
administered dose was detected in the olfactory bulbs 4 hours after dosing which was 
similar to that found by Sakane et al. for sulphonamides (1991a, 1991b). 
 
Dahlin et al. (2001) conducted a similar experiment as described above but this time 
50µCi [3H]-dopamine was placed into the nasal cavity in order to investigate whether a 
higher radioactivity dose could enable detection of radioactivity in deeper brain regions 
after i.n. dosing. Indeed a significantly greater amount of radioactivity was detected 
after 30 minutes in the cerebellum and cerebrum of the mice after i.n. dosing compared 
to intravenously dosed animals (Dahlin et al 2001). However, despite this, 
bioavailability remained low since 0.1% of the nasally administered dose was detected 
by HPLC in the CSF 30 minutes after dosing. This may have been partly due to 
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dopamine metabolism to dihydroxyphenylacetic acid (DOPAC) that was shown to have 
occurred by TLC either during the transfer to or in the CSF. 
 
Macromolecular transport has also been shown from N-B (Frey et al 1997; Dufes et al 
2003). One detailed study followed the transport of [125I]-IGF-I, a 7.65kDa protein 
neurotrophic factor, after i.n. or i.v. administration in Sprague-Dawley rats both in the 
olfactory system and trigeminal nerve (Thorne et al 2004). In this study, the animals 
were killed and transcardially perfused 29-30minutes after dosing with 1.25% 
glutaraldehyde/1% paraformaldehyde in 0.1M Sørenson’s phosphate buffer. The key 
findings from this study were: (i) a 100-fold greater [125I]-IGF-I concentration was 
found in most CNS areas after i.n. administration compared to i.v.; (ii) CNS levels 
peaked earlier after i.n. compared to i.v.; and (iii) highest concentrations appeared in 
rostral brain areas (olfactory bulb, motor cortex, anterior olfactory nucleus), caudal 
brain areas (medulla, cervical spinal cord) and in the trigeminal nerve. These 
observations were all consistent with the existence of a N-B pathway that involved both 
the olfactory system and the trigeminal nerve. 
 
Nevertheless, despite these observations, there was no [125I]-IGF-I found in the CSF. 
The authors’ speculated that this could be a result of a direct connection between the 
brain interstitial fluid and the nasal lymphatic system that avoided the involvement of 
the CSF. 
 
An alternative explanation, however, is that the supporting cells (or sustantacular cells) 
in the olfactory mucosa may play a role in the N-B uptake of [125I]-IGF-I by 
transcellular uptake of the peptide and subsequent transport into the lamina propria 
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where it can access both the lymphatic system and the trigeminal nerves. This would 
account for both the lack of [125I]-IGF-I in the CSF (because the 7.65kDa molecule was 
too large to be paracellularly transported) and the appearance of [125I]-IGF-I in the 
olfactory system (by transcellular transport into the olfactory axons), trigeminal nerve 
(by uptake in the lamina propria after transcellular transport through the supporting 
cells) and the lymphatic system (by uptake into the nasal lymph vessels in the lamina 
propria). 
 
To strengthen this hypothesis, Jansson found by fluorescence microscopy that FITC-
labelled dextran (3kDa) was transported transcellularly in male Sprague-Dawley rats in 
both olfactory neurones and supporting cells after i.n. administration (Jansson 2004). 
However, the supporting cells only transported the dextran into certain parts of the 
olfactory epithelia. The reason for the uneven regional distribution of dextran amongst 
supporting cells was unclear. However, this does allow an important distinction to be 
made i.e that dextran appeared in the lamina propria only when it was transcellularly 
transported by supporting cells. If true, then transport of the 3kDa dextran to the lamina 
propria (and further to the lymphatics and trigeminal nerve) is regulated by uptake into 
the supporting cells. 
 
However, this hypothesis has not yet been proven experimentally in terms of the exact 
mechanism by which substances such as [125I]-IGF-I (Thorne et al 2004) or manganese 
(Fechter et al 2002) is transported by the trigeminal nerve. 
 
The experiments that have been highlighted thus far have all used animal models. 
Relatively few studies have been performed on human subjects. These human studies do 
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not report absolute measurements of drug in the CSF or brain tissues since it would be 
unethical to do so. Nevertheless, a number of studies have demonstrated the 
pharmacological effects of drugs on the brain directly from the nasal cavity. Below are 
the findings of important direct N-B studies in humans. A more detailed review of 
human direct N-B studies can be found elsewhere (Illum 2000; Stockhorst & 
Pietrowsky 2004). 
 
Pietrowsky et al. (1995) administered doses of 10µg i.n., 0.25µg i.v. or 2.5µg i.v. 
cholecystokinin (CCK) (a neurologically active peptide hormone), or (i.n./i.v.) placebo 
to groups of five human subjects. Auditory event related potentials were recorded by an 
electroencephalogram to distinguish the effects of CCK via the different drug delivery 
routes. The area under the curve of the electroencephalogram P3 complex was used to 
determine the effect of the drug on each subject. Plasma CCK levels were measured by 
an antibody assay and were equivalent for the 10µg i.n. and 0.25µg i.v. groups; but 
higher for the 2.5µg i.v. group. P3 complexes were significantly larger for 10µg i.n. 
compared to i.n. placebo (p<0.01 ANOVA) and 0.25µg CCK i.v. (p<0.05 ANOVA). 
This showed that CCK produced a significantly greater pharmacological effect via the 
i.n. compared to i.v. route. In addition, the 2.5µg i.v. dose did not produce a greater 
pharmacological effect than 0.25µg i.v. which demonstrated that the i.v. route was 
saturated at the higher dose. These findings show strong evidence for an enhanced drug 
effect directly to the brain via the nasal cavity (Pietrowsky et al 1996a). 
 
CCK was chosen as a model drug in this study since it is an endogenously expressed 
neuropeptide/neuromodulator whose release may be mimicked by i.n. administration. It 
is a hormone that, like other hormones, has the potential to complement a high density 
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of suitable receptors in the CNS. Nevertheless, the observed pharmacological effects 
may have resulted from axonal depolarisation due to receptor-ligand interaction at the 
level of the olfactory epithelium (or its accessory neuroepithelium, the vomeronasal 
organ) rather than a direct pharmacological effect in the brain parenchyma. This 
criticism may be extended to similar studies that use endogenous hormones (e.g. 
vasopressin (Pietrowsky et al 1996b) and insulin (Benedict et al 2008) ). Hence, tracing 
radiolabelled drug would provide better evidence for direct N-B transport into the 
human brain interstitium. 
 
An attempt has been made to trace radiolabelled diethylenetriamine penta-acetic acid 
(99Tc-DTPA) through the olfactory epithelium after deposition of the drug solution onto 
the neuroepithelium via vinyl tubing (Okuyama 1997). A gamma camera was used to 
conclude that radioactivity had penetrated olfactory epithelium of a 67 year old anosmic 
woman. However, this result could neither be quantified (due to the limitations of the 
gamma camera) nor was it reproducible in a 60 year old healthy man. It was thought 
that inflammation of the olfactory epithelium that caused the anosmia could also have 
increased the neuroepithelial permeability to 99Tc-DTPA. Nevertheless, this is a suitable 
method to reveal the fate of the radiolabelled drug after i.n. administration, especially, 
with the use of modern Positron Emission Tomography techniques that may accurately 
locate the radiolabelled product within the human cranium. 
 
In conclusion, the direct N-B transport of numerous small molecular weight and 
macromolecular drugs have been proven in a variety of animal models. Indeed, intact 
peptide drugs have been shown to appear in brain parenchyma areas distal to the nasal 
cavity in rats (Thorne et al 2004). However, a similar body of evidence does not exist 
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for human subjects. Attempts have been made to evaluate the direct N-B 
pharmacological effects of various endogenous hormones. However, the transport of 
these molecules into the olfactory system has not been conclusively determined since it 
could not been excluded that they did not innervate the nasal neuroepithelia by receptor-
ligand interactions (Stockhorst & Pietrowsky 2004). Future studies could combine 
behavioural investigations with radiolabelled drugs so that pharmacological effects and 
location of radioactivity may be correlated to provide stronger evidence of direct N-B 
drug delivery in humans. 
 
1.7 NOSE-TO-BRAIN TRANSPORT OF SYNTHETIC PARTICLES 
This section considers some of the key studies that have developed the understanding of 
N-B delivery of particles. To date fewer studies, than those published on N-B drug 
delivery of non-particulate drug formulations, have specifically examined the direct 
transfer of particles from the nasal cavity to the brain. Those that have mostly used basic 
particulate materials such as iron (II) oxide (Wang et al 2007), manganese oxide (Elder 
et al 2006), gold (De Lorenzo 1970), carbon-13 (Oberdorster et al 2004) and iridium-
192 (Semmler et al 2004a). These particles have demonstrated a proof of concept (with 
varying degrees of success) for direct N-B transport of particulate matter. They were 
mostly carried out in relation to an evaluation of the toxicity to the CNS of 
environmental nanoparticles. The application of these basic materials for nanoparticle 
N-B drug delivery has a narrow scope (if at all) since they have no known targeting 
ability towards the olfactory system and their translocation has resulted in brain toxicity 
in some cases. 
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For example, drug delivery studies have shown statistically greater appearance of model 
drugs such as nimodipine in the olfactory bulb (Zhang et al 2006) or enhanced 
pharmacological activity of morphine (Betbeder et al 2000) when these small molecules 
were applied intranasally in combination with nanoparticles. However, the fate of the 
nanoparticles was not investigated in these studies therefore it is not clear whether the 
effects were caused by transport of the nanoparticles into the olfactory epithelial cells. 
 
A study using Fe2O3 nanoparticles (280±80nm diameter) demonstrated the deep brain 
penetration of the metal oxide and its potential to disrupt cellular morphology in the 
hippocampus after nasal administration (Wang et al 2007). A dose of 40mg/kg was i.n. 
instilled into 4-week old male mice (20-22g). The brain samples were examined for iron 
by absorption spectroscopy 14 days after a single dose exposure. Olfactory bulbs and 
brain stems were indeed found to contain more iron than the control group which were 
exposed to an i.n. 1% sodium caroboxy methyl cellulose solution. 
 
In addition, the hippocampus of the Fe-exposed group was also histologically dissimilar 
to that of the control group. These mice contained signs of toxicity since ‘fatty 
degeneration’ features were found in the hippocampus region. It was concluded that the 
iron was responsible for the toxicity. A direct passage of iron from nose to brain was 
hypothesised as the route of uptake possibly by the trigeminal nerve since the trigeminal 
nerve has shown to connect the nasal mucosa with the hind brain regions of the rat (1.6 
The Transport of Drug Solutions Direct from Nose-to-Brain). The results showed that 
iron penetration to deep regions of the brain was possible by the intranasal route. An i.v. 
control group, however, was not included in this study therefore the observation may 
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have been due to systemic absorption of Fe from the nasal cavity and subsequent 
translocation to the deep brain regions via receptor-mediated uptake at the BBB. 
 
In another study, poorly soluble (MnO, Mn2O3) salts of manganese were inhaled 
through the nose as aerosol by rats (200-250g body mass) (Elder et al 2006). The 
nanoparticles had a diameter of 30nm. Manganese was detected, after 6 and 12 days of 
inhalation exposure (these were repeated exposures of 6 hours/day, 5 days/week), in the 
olfactory bulbs and also in deep brain structures such as the cortex and cerebellum by 
using graphite absorption spectroscopy of microdissected brain structures (olfactory 
bulbs, striatum, trigeminal ganglions, midbrain, frontal cortex, and cerebellum). The 
manganese salts used in this study were poorly soluble and therefore the manganese was 
thought to have remained in the particulate form when transported into the brain. 
Unfortunately, images of the (30nm) nanoparticles in these brain regions were not 
shown in the publication therefore strong evidence of actual uptake of the manganese 
salt in particulate form was not presented. 
 
In an important study, De Lorenzo (1970) visualised exogenous particulate matter 
(50nm colloidal gold particles) within the olfactory neurones by TEM. The gold was 
suggested to enter the receptor cells by an endocytic process into the axoplasm within 
30 minutes. They were moved along the axon possibly by a mechanism related to 
microtubules in the cytoplasm. The velocity of this movement was estimated to be 
2.5mm/hr (De Lorenzo 1970). This was inline with observations made of poliomyelitis 
virus in rhesus monkey sciatic nerve (2.4mm/hr) (Bodian & Howe 1941). Within 60 
minutes of application to the nasal cavity the gold particles were seen in the filia 
olfactoria and olfactory glomerulus having crossed the (first-order) synapse to reach the 
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mitral cells. At this point (in the olfactory bulb) the particles were mostly located within 
mitochondria; the reason for this is unclear but it is evident that translocation of 
nanoparticles into the mitochondria can lead to cellular toxicity (Li et al 2003). 
Furthermore, the particles did not appear to travel extra-axonally. 
 
In another experiment, 14 week old rats (mean body mass 284g) were twice exposed to 
(insoluble) ~36nm elemental 13C nanoparticles (150-170µg/m3) in an inhalation 
chamber for a total of 6 hours (Oberdorster et al 2004). Exposing the rats to the 
nanoparticles by inhalation chamber is thought to allow nanoparticles access to the rat 
nasal cavity since the animals are obligate nasal breathers. The results showed that there 
was a significant (p<0.05) and persistant increase of 13C of 0.35µg/g to 0.43µg/g in the 
olfactory bulbs from day 1 to day 7. Also, deeper brain penetration of these particles 
into the cerebellum and cerebrum was not conclusive since a significant increase in 
radioactivity was not consistently observed during the full duration of the experiment. 
More repeated exposures may have increased the concentration of 13C nanoparticles in 
the cerebrum and cerebellum. 
 
Low levels of 20nm iridium-192 nanoparticles (insoluble) have also been observed over 
a 6 month period in the brain after inhalation of a single dose of particles via an 
intratracheal tube (Semmler et al 2004b). A peak number of particles were found in the 
rat brains 7 days after a 60-90 minute single exposure. This rate of transfer appears to be 
much slower than the movement of 50nm gold particles from the nasal cavity to the 
olfactory bulbs in rabbits as described earlier (De Lorenzo 1970). The differences 
between the rates of transport could have been due to the different time points at which 
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samples were taken in each case. Hence, a larger peak may have been expected if a 
measurement of iridium-192 particles were made after 60 minutes post application. 
 
Enhancement of nimodipine delivery to the brain was seen when it was intranasally 
applied in methoxy-PEG-PLA (MPEG-PLA) nanoparticles (76.5nm diameter) 
compared to solution alone (Zhang et al 2004). Statistically more drug appeared in the 
CSF compared to the blood in rats. Furthermore, 1.6-3.3 times more drug was found in 
the CSF and olfactory bulb after administration of nanoparticles compared to the drug 
solution alone. The nanoparticles may have been taken into the cells and the drug 
released thereafter. However, from analysis of the available literature (Table 1.1), it is 
likely that the drug would also have been released from the nanoparticles in the mucous 
layer from where it would be absorbed paracellularly through the tight junctions 
between cells in the epithelium. The increased bioavailability conferred by 
nanoparticles may have been due to the protection of the encapsulated drug from: i) 
biological and/or chemical degradation, and/or ii) extracellular efflux by P-gp 
transporter proteins. 
 
Nasally applied morphine only increased analgesia in mice when 60nm maltodextrin 
nanoparticles (Biovectors™) were mixed with [3H]morphine compared to [3H]morphine 
solution (Betbeder et al 2000). The effect was not due to increased levels of 
[3H]morphine transported into the brain via the blood because an s.c. dose of morphine 
produced higher plasma levels but lower analgesia than the i.n. dose of 
morphine+Biovectors™. Also, i.n. morphine+Biovectors™ produced similar plasma 
levels as i.n. morphine solution which also did not explain the increased analgesia via 
the blood. Hence, another route was involved which was speculated as the direct N-B 
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pathway. The analgesic effect was reversed by naloxone, an opioid antagonist, which 
shows that the analgesia was opiod-induced. 
 
Although this evidence showed that morphine may have transferred by the direct N-B 
route, the exact mechanism of morphine uptake was uncertain. For instance, the 
nanoparticles do not interact with the morphine in vitro and the analgesic effect is not 
enhanced by sodium deoxycholate, a tight junction modifier (or permeation enhancer), 
which was expected to increase the delivery of morphine to the brain by opening tight 
junctions. 
 
An attempt has also been made to improve N-B transport of particles by conjugation of 
Wheat Germ Agglutinin (WGA) lectin to coumarin-loaded PEG-poly(lactic acid) (PEG-
PLA) nanoparticles (85-90nm diameter) (Gao et al 2006). WGA binds to N-acetyl-D-
glucosamine and sialic acid residues both of which are abundant in mucus. A 2-fold 
increase in coumarin was observed in the olfactory bulb, olfactory tract, cerebrum and 
cerebellum of rats within 15 hours of a single dose compared to unmodified 
nanoparticles without any evidence of ciliotoxicity. The enhanced uptake was, however, 
thought to be poorly selective for coumarin delivery directly to the brain since similar 
increases were also observed in the blood. This was probably due to poor selectivity of 
WGA binding to the olfactory mucosa. However, these particles were not designed to 
be selectivity transported into the olfactory mucosa.  
 
A more recent investigation by the same group does provide evidence for successful 
targeting to the olfactory epithelium, which was suggested by visualisation of 
nanoparticle uptake in the olfactory epithelium, in rats (Gao et al 2007). The PEG-PLA 
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nanoparticles (111nm diameter) were conjugated to Ulex europeus agglutinin I (UEA I), 
a lectin that binds to an olfactory rich saccharide – L-fucose. Detection of coumarin 
(which was associated with the nanoparticles) in the different brain regions was 1.7 
times increased after surface modification with the lectin compared to unmodified 
particles. In addition, fluorescence microscopy shows that the affinity was enhanced for 
UEA I-modified nanoparticles to the olfactory epithelium compared to the respiratory 
mucosa. Nevertheless, the visual evidence provided in the article showed a low 
magnification image of the nasal tissues. Higher magnification images could have 
enabled a detailed analysis of individual particles inside the olfactory epithelium as well 
as details of the morphological condition of the olfactory epithelium. This would have 
provided yet stronger evidence for the uptake of individual particles into undamaged 
olfactory neurones. 
 
Recently, the literature has shown that nanoparticles are not inherently benign towards 
biological systems (Oberdorster et al 2005; Nel et al 2006). Nanoparticles may affect 
the biological behaviour of cells, subcellular organelles and proteins, to cause injurious 
responses. The oxidative stress paradigm best describes the toxic effects of inhaled 
nanoparticles. Under normal conditions reactive oxygen species (ROS) are generated in 
mitochondria which can be easily neutralised by antioxidants such as glutathione in 
cells. Oxidative stress occurs when glutathione is depleted by the ROS. Oxidative stress 
can be triggered by the presence of nanoparticles, possibly due to their large relative 
surface area and/or their greater ability to gain access into mitochondria, which can 
disrupt cellular function (Xia et al 2006). The formation of ROS can lead to tissue 
inflammation and cellular damage and damage to DNA and enzymes. 
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In summary, there is evidence to suggest that direct N-B transport of synthetic 
nanoparticles is possible and may be even to therapeutic levels of bioavailability. 
Nevertheless, it is still unclear whether whole particles can be selectively taken into the 
olfactory epithelial cells. The clearest evidence of uptake of synthetic particles into 
olfactory neurones remains with that published by De Lorenzo (De Lorenzo 1970). 
However, intracellular axonal transport may not be necessary since an analysis of the 
available literature tentatively suggests that targeting of different brain regions may be 
possible by altering the basic properties of the drug delivery system such as nanoparticle 
size or drug physicochemical properties (Table 1.1). It has also been suggested that 
nanoparticles may cause cellular and subcellular damage to biological systems. The 
challenge now is to improve the transfer efficiency of drug loaded particles from the 
olfactory epithelium to the brain in order to safely and successfully reach therapeutically 
relevant levels in the target brain regions. 
 
Future studies could use fluorescently labelled nanoparticles composed of non-
biodegradable polymer which could determine the route of these particles from the 
olfactory epithelium to the brain and possibly their further fate through clearance. Other 
information such as the transport rate of different sized nanoparticles to the brain and 
evaluating the effect of different surface modifications (or other formulation strategies) 
would provide useful information and progress in the field. 
 
1.8 SUMMARY: DIRECT NOSE-TO-BRAIN TRANSPORT OF DRUG 
DELIVERY FORMULATIONS  
Table 1.1 summarises the properties of drug formulations, their suggested route of 
transport and possible destinations into the CNS. The conclusions are based on the 
current anatomical knowledge of the connection between the nasal cavity and the brain 
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and the available evidence from drug transport studies that are detailed in sections 1.6 
The Transport of Drug Solutions Direct from Nose-to-Brain and 1.7 Nose-to-Brain 
Transport of Synthetic Particles of this review. 
 
In general, lipid soluble drugs are more likely to take the transcellular route to the brain. 
Water soluble drugs (<1000Da) may have rapid access to CSF compared to lipohilic 
molecules since they are less likely to be taken into the neuronal and supporting cells of 
the olfactory epithelium. Nanoparticles may be taken into the neurones and supporting 
cells by a number of endocytic mechanisms. However, nanoparticles larger than 100nm 
are thought to have a restricted access to the brain via the intra-axonal route because 
their diameters increasingly exceed that of the axons in the filia olfactoria. 
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Table 1.1 The influence of drug formulation on the cellular route of uptake and final CNS destinations of drugs after intranasal administration 
Drug Formulation Transport Route Transport Pathway Possible Drug 
Destinations in CNS 
Reference 
Solution (Drug Lipophilic) Transcellular (Supporting Cells, 
Olfactory Axons) 
Olfactory, trigeminal Rostral brain, caudal 
brain 
 (Sakane et al 1991) 
Solution (Drug MW<1000Da, 
Hydrophilic) 
Transcellular (Supporting Cells, 
Olfactory Axons) by endocytosis 
(Phagocytic, Macropinocytic, 
Clathrin-mediated, Caveolae-
mediated, Caveolae-independent 
lipid raft). Paracellular. 
CSF, Olfactory, 
trigeminal 
Rostral brain, caudal 
brain. (Drug delivered 
to CSF may not 
penetrate the brain 
parenchyma before 
clearance) 
 (Dahlin et al 2000; 
Dahlin et al 2001; 
Westin et al 2005) 
Solution (Drug MW>1000Da, 
Hydrophilic) 
Olfactory Axons, Supporting Cells Olfactory, trigeminal Rostral brain, caudal 
brain 
 (Thorne et al 2004) 
Nanoparticle (>150nm) Endocytosis (Phagocytic, 
Macropinocytic) 
Olfactory, 
trigeminal* 
Rostral brain, caudal 
brain* 
 (Wang et al 2007) 
Nanoparticle (<150nm) Endocytosis (Phagocytic, 
Macropinocytic, Clathrin-
mediated) 
Olfactory, trigeminal Rostral brain, caudal 
brain 
 (Gao et al 2007) 
Nanoparticle (<80nm) Endocytosis (Phagocytic, 
Macropinocytic, Clathrin-
mediated, Caveolae-mediated) 
Olfactory, trigeminal Rostral brain, caudal 
brain 
 (De Lorenzo 1962, 
1970; Zhang et al 2006) 
Nanoparticle (<50nm) Endocytosis (Phagocytic, 
Macropinocytic, Clathrin-
mediated, Caveolae-mediated, 
Caveolae-independent lipid raft) 
Olfactory, trigeminal Rostral brain, caudal 
brain 
 (Oberdorster 2004; 
Semmler et al 2004b; 
Elder et al 2006) 
* Bioavailability theoretically limited for nanoparticles with diameter >100nm due to diameter of olfactory axons in filia olfactoria 
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1.9 NANOPARTICLE FORMULATION STRATEGIES FOR ENHANCING 
NOSE-TO-BRAIN DRUG DELIVERY 
 
Nanoparticles may offer a realistic transmucosal drug delivery strategy since they are 
able to protect the encapsulated drug from biological and/or chemical degradation, and 
extracellular transport by P-gp efflux proteins. Also, their high relative surface area 
means that these particles will release drug faster than larger particles; this would be 
desirable where acute management of pain is required. In addition, their small diameter 
may allow them to be transported transcellularly through olfactory neurones to the brain 
via the various endocytic pathways as described earlier (1.3 Cellular Mechanisms For 
Transmucosal Drug Delivery). 
 
By using nanoparticles as a platform technology it may also be possible to deliver a 
number of different drugs using similar systems. One approach would be to surface 
modify nanoparticles so that the drug delivery properties of the formulation are 
determined by the interaction of the surface coating with the biological system. To the 
author’s knowledge, however, there has currently been no published study that has 
clearly proven the pharmacological efficacy of nanoparticle formulations for direct N-B 
drug delivery. However, chitosan and polysorbate 80 are two materials that may modify 
transport of nanoparticles across the olfactory epithelium as discussed below.  
1.9.1 Chitosan 
Chitin is one of the most abundant polymers found in nature and is present in all 
crustaceans and insects - as well as some fungi, algae and yeast. Chitin is extracted from 
the shells of crabs, lobsters and shrimps once edible portions have been removed. 
Chitosan is a linear polysaccharide which is derived from naturally occurring chitin by 
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deacteylation, using enzymatic (chitindeacetylase [Figure 1.10]) or chemical methods. It 
has randomly distributed ß-(1-4)-linked D-glucosamine (deacetylated unit) and N-
acetyl-D-glucosamine (acetylated unit). The proportion of deacetylated units to 
acetylated units is reported as the degree of deacetylation (%DA). 
 
Figure 1.10 The conversion of chitin to chitosan via enzymatic deacetylation. 
 
Chitosan has a long history of use in the drug delivery field. It has been used as an 
excipient in direct compression and wet granulation, in emulsions, and in gels and its 
uses have been reviewed numerous times. Singla et al. have written one such broad 
review (Singla & Chawla 2001). 
 
Chitosan may also be a useful material for direct N-B drug delivery. It has 
mucoadhesive properties (Kawashima et al 2000) that may increase the particle 
residence time over the target olfactory epithelium. The positive charges on the 
protonated amine groups allow interaction with negatively charged sialic acid groups on 
mucin (Kawashima et al 2000). This benefits transmucosal drug delivery by allowing 
increased residence time over the target cells (possibly by altering the viscoelastic 
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properties of the mucus (Aspden et al 1997) ), and therefore permits a greater delivery 
opportunity. 
 
As a result of the general electrostatic nature of chitosan interaction with mucus it is not 
expected that chitosan formulation used for N-B drug delivery would selectively 
interact with olfactory mucosa compared to respiratory mucosa. Therefore, for optimal 
performance it would be advantageous for a drug delivery device to deposit a chitosan-
based nanoparticle formulation over the olfactory epithelium; otherwise, drug 
absorption may occur through non-olfactory regions which could lead to local or 
systemic side effects of the delivered drug. 
 
A recent study has compared the targeting ability of a 1% chitosan glutamate (MW 200-
600kDa, 75-90%DA) in saline-acetate buffer (pH4.5) in both nasal drop and nasal spray 
formulations (Charlton et al 2007). Nasal drops were administered in the supine position 
with the head tilted back so that the formulation could drain to the olfactory epithelium 
at the roof of the nasal cavity. The nasal spray was administered in the upright position. 
It was found by nasendoscopy that nasal drops delivered the chitosan formulation over 
the olfactory mucosa better than the spray formulation in human volunteers. In addition, 
the chitosan formulation increased the olfactory residence time over the olfactory 
epithelium compared to saline-acetate buffer (pH4.5) control from 1.33 minutes to 12.6 
minutes. This shows that chitosan can increase the residence time of formulations over 
the olfactory epithelium. Also, combining this with a delivery device that can target the 
olfactory epithelium could be a useful approach in the future.  
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Chitosan has also been shown to affect the permeability of epithelial membranes by its 
interaction with the junctional complexes between epithelial cells. It is thought that the 
positive charge can transiently open the tight junctions and therefore allow a 
paracellular passage of materials through the epithelial barrier. The exact mechanism of 
this is still not yet fully understood. The latest theories, however, include: (i) 
translocation of junctional proteins, ZO-1 and claudins, from the biomembrane to the 
cytosol; and (ii) functional alteration of a tight junction protein, ZO-1, by changes in 
protein kinase Cα (PKCα) activity (Smith et al 2004; Smith et al 2005). 
 
Smith et al. (2004) used western blotting and immunofluorescence to identify protein 
association patterns after application of 0.5%w/v chitosan glutamate (MW128kDa, 85 
DA%) buffered solution (Modified Eagles Medium pH6.3) to Caco-2 cells. They found 
that chitosan application could reduce the association of ZO-1 and occludins in the cell 
membrane and concurrently increase association of these proteins with the cell 
cytoskeleton. The tight junctions were opened during the application of the chitosan 
since significantly more Horse-Radish Peroxidase (40kDa) could pass through the cell 
monolayer after 60 minutes exposure (p<0.01) compared to buffer control (pH6.3). This 
was confirmed by measuring transepithelial electrical resistance (Rm). The Rm values 
were found to return to 80% of pre-treatment levels 24 hours after removal of chitosan. 
 
Smith et al. (2005) also found, using the same materials and techniques, that chitosan 
increased the presence of PKCα in the Caco-2 cell membranes. This was related to ZO-
1 depletion from cell membranes since a PKC inhibitor (Ro318220) reduced the 
chitosan-induced translocation of ZO-1 out of the cell membrane. PKC β and δ 
isozymes were excluded as the cause of the translocation by the same methods. 
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Recently, chitosan has been used as a nucleic acid delivery vehicle. Its pKa (~6.5) 
allows a positive charge at acidic pHs (Howard et al 2006). This enables electrostatic 
interaction with nucleic acids to form polyplexes. Howard et al. found that siRNA-
chitosan polyplexes could knockdown the green fluorescent protein signal (EGFP) both 
in vitro (human lung carcinoma cells) and in vivo (murine bronchiole epithelial cells) 
models. It was thought that chitosan allowed positively charged polyplexes to interact 
with negatively charged cell membranes, therefore enabling uptake into the cell. 
 
Molecular weight, %DA and salt form of chitosan can affect its ability to interact with 
mucosa in the aforementioned ways. It has been found that 0.01%w/v pH6.2 solutions 
of different chitosan salt forms could reduce Rm reading across Caco-2 monolayers to 
60% for chitosan aspartate, 53% for chitosan lactate, 43% for chitosan lactate, and 31% 
for chitosan HCl, of initial values (Opanasopit et al 2007). The same study showed that 
increasing molecular weight of the chitosan HCl could reduce Rm values across the 
Caco-2 cells compared to the initial values; 70% for 20kDa, 50% for 45kDa, 60% for 
200kDa and 40% for 460kDa. Therefore, in vitro, high molecular weight chitosan HCl 
had the greatest effect on tight junction opening. 
 
In addition, chitosan nanoparticles can be taken into A549 (human lung carcinoma) 
cells and this uptake is increased by increasing molecular weight (from 10kDa to 
98kDa) and increasing %DA (from 46% to 88%) of chitosan acetate (Huang et al 2004). 
Also, the rate of uptake was saturated at concentration of chitosan above 0.8mg/ml 
which suggested that uptake was endocytic. 
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In summary, chitosan HCl of molecular weight >98kDa and DA% >88% may improve 
the uptake of chitosan containing nanoparticles across mucosal membranes. 
Alternatively, chitosan containing nanoparticles may improve paracellular transport of 
drugs that are released from the nanoparticles in the nasal mucus by opening the tight 
junctions. Both paracellular and transcellular transport could benefit from an increased 
residence time over the olfactory mucosa. 
1.9.2 Polysorbate 80 
Polysorbate 80 belongs to a group of non-ionic detergents called ‘polysorbates’. 
Polysorbates are often used in cosmetics and food products as solubilising agents 
(Tadros 2005). They are derived from PEO sorbitan that are esterified with fatty acids. 
The numeric value after the ‘polysorbate’ refers to the fatty acid contained in each type 
of polysorbate. 
 
Hence, polysorbate 80 (MW 1310) is a derivative of PEG-ylated sorbitan (MW 1073) 
and oleic acid (MW 237) (Figure 1.11); the two moieties composing the hydrophilic tail 
and hydrophobic head, respectively. In addition, like all surfactants, polysorbate 80 
forms micelles in aqueous solution. Critical Micellar Concentration (CMC) polysorbate 
80 in HBSS buffer (pH7.4) at 25°C has been measured at 65.5µg/ml (50µM) (Nerurkar 
et al 1997). 
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Figure 1.11 The chemical structure of polysorbate 80 containing ethylene glycol moieties (green 
highlight) and oleic acid (red highlight). 
 
In biopharmaceutics, polysorbate 80 has been used in emollient eye drops (e.g. Refresh 
Endura, Allergan). It is regarded as an acceptable pharmaceutical excipient since it is 
found in the FDA GRAS list. 
 
Polysorbate 80 may also be a useful P-gp efflux inhibitor. For example, it has been 
shown that efflux by Caco-2 cells of a model peptide Acf(NMef)2NH2 was effectively 
inhibited by polysorbate 80 (Nerurkar et al 1997). Therefore this may provide a better 
chance for drugs which are normally effluxed by cells to remain in the cell or be 
transported to its target (although the mechanism is not yet fully understood). 
 
Polysorbate 80 has also been used as a surface modification material for particles. Its 
adsorption to polybutylcyanoacrylate (PBCA) particle surfaces is thought to enhance 
their uptake compared to the native form of the particle from the systemic circulation 
into the brain via the BBB (Kreuter 2001). It has been shown that polysorbate 80 
achieves this by selectively adsorbing serum proteins (ApoE in particular) in cell culture 
which allows phagocytic uptake into the brain capillary endothelial cells (Ramge et al 
2002). 
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In addition, the polysorbate 80-coated PBCA nanoparticles were overcoated with an 
analgesic hexapeptide (dalargin) and Apo E (Kreuter et al 2002). These particles were 
administered intravenously into mice. Analgesia was determined in these mice by tail 
flick test which showed that the dalargin could reach receptors in the brain in a 
pharmacologically active form. However, Apo E deficient mice (ApoEtm1Unc) did not 
show signs of analgesia. These results showed that the analgesic effect was derived 
from an Apo E receptor-mediated uptake of the hexapeptide. 
 
It is thought that non-ionic surfactants alter the pattern of protein adsorption to charged 
particle surfaces (Muller et al 1997). Foetal Calf Serum (FCS) is a complex mixture of 
plasma proteins and other biological molecules. Differential adsorption of certain 
plasma proteins from FCS, such as Apo E, is thought to promote active uptake of 
polysorbate 80 coated PBCA particles into the cells as described above. It is speculated 
that similar mechanisms may exist that could promote the uptake of polysorbate 80-
coated particles through the olfactory epithelium as well. 
 
Polysorbate 80 can also reduce the overall zeta potential of a charged particle by 
sterically hindering the approach of counterions to the particle surface. This charge 
shielding effect may promote mucosal penetration of the coated particle, and allow 
access to underlying epithelial cells by reducing electrostatic repulsion between 
negatively charged particle and mucus (Lai et al 2007). For example, covalent 
modification of carboxylated PS nanoparticles with PEG (~2kDa) (a molecule similar in 
size and chemical composition to polysorbate 80) increased the particle transport rates 
of 100nm, 200nm and 500nm nanoparticles through human cervicovaginal mucus by 
factors of 100, 200, and 1100-fold, respectively. In my opinion, the reason for the 
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improved penetration is due to the steric repulsion resulting from a loss of 
conformational entropy of the bound PEG chains upon the approach of a mucus fibres 
and the low interfacial free energy of PEG in the hydrophilic water channel. If similar 
results were found for olfactory mucosa then this could increase transport of 
nanoparticles into the olfactory epithelial cells. Moreover, the authors of the study 
speculate that particles as large as 800nm could be transported through the mucus in this 
way. 
 
Vila et al. (2004) investigated the effect of PLA (poly-lactic acid) particle size and 
particle PEG-ylation on nasal uptake into rat epithelial cells by confocal microscopy. 
First, 60µl (0.083%w/v in PBS) rhodamine-load PLA-PEG particles (186±11nm or 
1412±200nm diameter) were intranasally administered to rats (n=4) over 30 minutes 
after which the animals were killed by cervical dislocation. The nasal epithelia were 
dissected, washed and fixed in Formalin 4% for 30 minutes. Then, the whole mucosa 
was observed directly by confocal microscopy. Quantitative analysis of particles could 
not be performed, however, visibly more nanoparticles than microparticles were 
observed at a depth of 10-20µm into the surface epithelial cells. Conversely, more 
microparticles than nanoparticles were found at the mucosal surface of the epithelium 
than inside cells. This result agrees with the observation by Lai et al. (2007) who 
concluded that larger particles penetrated mucus less successfully than smaller particles 
(as discussed previously).  
 
Second, it was concluded that a PEG-coating was required to maintain the PLA 
colloidal stability at the nasal epithelium (Vila et al 2004). PLA (191±8nm diameter) or 
PEG-PLA (186±11nm) nanoparticles were administered into rat nasal cavities as 
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described before. It was found by confocal microscopy that fewer PLA-PEG 
nanoparticles aggregated at the epithelial mucosal surface compared to PLA 
nanoparticles. This allowed the smaller PEG-PLA nanoparticles to penetrate the mucus 
layer. Hence, visibly more PEG-PLA nanoparticles compared to PLA nanoparticles 
were found at a depth of 10-20µm into the epithelial cells. The author’s speculated that 
lysozymes found in the mucus layer were responsible for the formation of PLA 
aggregates. Nevertheless, this study provides evidence that PEG-coating can improve 
nanoparticle transport into nasal epithelial cells in vivo. 
1.10 PROJECT OUTLINE 
The primary aims of the project are listed below. 
(i) Design biological drug delivery models to investigate the physiological mechanisms 
that may allow the transport of nanoparticles directly from nose-to-brain 
(ii) Formulate a number of novel non-biodegradable nanoparticulate systems and 
compare their relative abilities to transport into the olfactory system. 
(iii) Monitor the affect of nanoparticle exposure to the viability and morphology of 
olfactory epithelia. 
1.11 STUDY PLAN 
Validation of the in vitro Franz diffusion cell method was performed in relation to 
viability of excised olfactory epithelium from the porcine nasal cavity. An 
electrophysiological method and a fluorometeric assay were used to determine 
metabolic activity of the dissected olfactory epithelium to ensure that the epithelium 
was alive during the experiments. The metabolic activity was statistically compared 
with samples that had been exposed to the metabolic inhibitor sodium azide. In addition, 
the physical condition of epithelia was examined after application of the samples in the 
diffusion chamber. 
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A number of fluorescently-labelled polystyrene-containing colloid formulations were 
surface modified with chitosan, polysorbate 80 or polysorbate 80+FCS. As well as the 
surface character, the nanoparticles were varied in diameter (20nm, 100nm and 200nm). 
 
The transport of these fluorescently labelled nanoparticles was studied across the nasal 
mucosa. Transport was quantitatively and qualitatively assessed by the in vitro diffusion 
chamber and in vivo mouse models. In the in vitro system, transport of nanoparticles 
across the olfactory epithelium was detected by the appearance of the nanoparticles in 
the receiver chamber with the use of fluorescence spectroscopy. The olfactory 
epithelium was dismounted after the end of the experiment to examine the condition of 
the tissue and the association of the formulations with the mucosa. In the in vivo system, 
histological sections were taken of the mice heads after intranasal application of the test 
formulations. The distribution of nanoparticles in olfactory and non-olfactory samples 
were qualitatively assessed by fluorescence microscopy and quantitatively assessed by 
stereology. 
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2. IN VITRO EXPERIMENTAL SETUP AND METHOD VALIDATION 
2.1 INTRODUCTION 
The traditional Franz diffusion cell and the Ussing chamber methods have been used for 
measuring the transport of a variety of small molecular weight drugs across epithelia by 
applying drug formulation to the mucosal side of dissected epithelium and sampling 
buffer from the basolateral side (e.g. dopamine (Jansson 2004) and chlorcyclizine 
(Kandimalla & Donovan 2005b) ). 
 
In the present studies a modified in vitro approach involving the use of porcine 
olfactory epithelium mounted vertically in a Franz diffusion chamber was used to 
evaluate the transepithelial passage of nanoparticles. Advantages of this in vitro 
approach compared to an in vivo model are that: (i) drug transport across biological 
tissues can be determined in a time-related manner (ii) it is possible to demonstrate 
viability of the epithelium during the course of a vertical Franz diffusion cell 
experiment; (iii) the condition of the tissue after dismounting can be evaluated once the 
study is complete; (iv) it is possible to control the temperature, pH, oxygenation and 
composition of the buffering solutions as well as the concentration of particles applied 
to the mucosal surface of the olfactory epithelium; and (v) the experiments can be 
conducted on olfactory epithelium without the presence of respiratory epithelium. 
 
However, it was necessary to complete a thorough method validation to ensure the 
scientific rigor of the model before commencing the nanoparticle transport studies 
(Chapter 4). Hence, it was necessary to prove that the experimental procedures had no 
effect on the tissue with respect to viability and cellular morphology. The aim of the 
work presented in this chapter is to describe the method validation of the vertical Franz 
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diffusion cell for its use with olfactory epithelium in the investigation of direct N-B 
drug delivery of nanoparticles. 
 
First an excision protocol was established in order to ensure that the epithelium to be 
mounted in the diffusion chamber mounted was indeed olfactory. Second, an 
assessment procedure of tissue viability was developed to ensure that the mounted 
tissue was alive during the experiments. Finally, the morphological appearance of the 
olfactory epithelium before and after exposure to the experimental conditions was 
assessed (in the absence of nanoparticles on the apical surface). 
 
Once this initial stage was complete, the application of nanoparticles to the olfactory 
epithelium could be reliably investigated (Chapter 4). 
2.2 MATERIALS AND METHODS 
2.2.1 Materials 
2.2.1.1 Diffusion Chamber Experiments 
Krebs Ringer Bicarbonate buffer from Sigma (Gillingham, UK), containing 1.5 mM 
NaH2PO4, 0.83 mM NaHPO4, 1.67 mM Mg2Cl2, 4.56mM KCl, 119.78 mM NaCl and 
10 mM D-glucose. NaHCO3, CaCl2, citric acid and all other chemicals were also 
obtained from Sigma (Gillingham, UK). 02(95%)/CO2(5%) gas was obtained from BOC 
Special Gases (Guilford, UK). 
2.2.1.2 Viability Assays 
Alamar Blue™ (AbD Serotec Ltd., Oxford). Bisbenzimide Hoescht No. 33258, Papain, 
dibasic sodium phosphate, cysteine HCl, EDTA, saline sodium citrate, NaCl, Trizma 
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sodium azide and all other reagents and chemicals purchased from Sigma. Calf-thymus 
DNA was purchased from R&D systems (Abingdon, UK). 
2.2.1.3 Microscopy Sample Preparation and Differential Stains 
Glutaraldehyde, sodium cacodylate, propylene oxide, Araldite CY212, Agar 100 resin, 
DDSA and Dibutyl phthalate DMP 30 were purchased from Agar Scientific (Stanstead, 
UK). Glycine (Fisher Scientific, Loughborough, UK). IMS, osmium tetroxide (Sigma-
Aldrich, Gillingham, UK). Glass knife (Thermometric Ltd, Northwich, UK). Diamond 
knife (Diatome, Biel, Switzerland).  
2.2.2 Preparation of Physiological Buffering Solutions 
Krebs Ringer Bicarbonate buffer was modified according to (Osth et al 2002a), with the 
addition of 15 mM NaHCO3 and 1.2 mM CaCl2 to make Simulated Nasal Solution 
(SNS). The osmolarity was adjusted to 300±5 mol/kg by the addition of NaCl and the 
pH was adjusted to 7.4 by adding 1M NaOH. The buffer was oxygenated using a 
mixture of 02(95%) and CO2(5%). 
 
Citrate buffer was identical to the SNS buffer but citric acid was used instead of 
NaH2PO4, NaHPO4 and NaHCO3 since these ingredients would interfere with the 
buffering ability of the citrate at pH 6.0. Isotonicity of the citrate buffer was maintained 
by the addition of NaCl as required. 
2.2.3 Dissection of Nasal Epithelia from the Pig 
The porcine tissue has been selected previously as suitable for in vitro diffusion 
chamber studies (Jansson 2004; Fransen et al 2007). The pig is a suitable model since 
(i) the olfactory epithelium is sufficiently large to obtain workable tissue pieces for 
loading into the diffusion cell apparatus, and (ii) gross morphology of the epithelium 
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and some compositional aspects of the mucus are similar between humans and pigs as 
described previously (Larochelle & Martineaudoize 1991). 
 
The objectives for this section were: (i) to develop a protocol for the excision of 
olfactory epithelium from the head of a pig; (ii) to assess the morphology of fresh tissue 
samples from various parts of the porcine nasal cavity; and (iii) to confirm the location 
of olfactory epithelium in the porcine nasal cavity by bright field microscopy and 
Transmission Electron Microscopy (TEM). 
 
For excision of porcine nasal mucosa, the tissue was isolated from 6 month old 
domesticated sows after slaughtering in the slaughterhouse (Sutton Bonnington 
Campus, University of Nottingham, UK). A health plan was in place and was agreed 
between a veterinary surgeon and the slaughterhouse personnel to ensure only healthy 
pigs were slaughtered. The animals were electrically stunned and then killed by 
exsanguination.  
 
Thereafter, the head was removed and the nasal cavity exposed. To gain access to the 
various nasal regions a ventral incision (up to and including the hard palette) was made 
directly in front of the eyes (line (c)Figure 2.1) and then again ~5 cm rostrally (line (b) 
Figure 2.1); this gave Section C (Figure 2.1). A further cut was made ~6cm rostrally 
(line (a) Figure 2.1) to yield Sections B and A (Figure 2.1). This revealed the transverse 
profiles of the various turbinate structures as shown in Figure 2.2. 
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Figure 2.1 Schematics showing 
sections of the pig head for 
retrieval of porcine nasal mucosa. 
 
Top, anatomical navigation 
terminology in relation to middle 
and bottom schema. 
 
 
Right side of sagittal section of 
mature swine skull. Sections A, B, 
C and D. Adapted from (Getty 
1975). 
 
 
Right side of sagittal section of 
mature swine skull. Epithelium 
was retrieved from six different 
areas as shown. For reference, the 
regions are shown in relation to 
the sections taken above. Adapted 
from (Getty 1975). 
Dorsal 
Caudal Rostral 
Ventral 
A B C D 
(a) (b) (c) 
4 5 6 
3 2 1 
A B C D 
(a) (b) (c) 
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Sections A, B and C were then sawn horizontally along the middle of the nasal cavity as 
shown in each Section by the straight dashed line (Figure 2.2). The required epithelium 
(labelled 1-6 in Figure 2.1) was then exposed and peeled away in the rostro-caudal 
direction from the underlying bone or cartilage with forceps and a haemostat. Region 5 
was taken from the ventral turbinate. Arrangements were made to have quick access to 
the slaughtered pig so that the dissection could be performed within the shortest 
possible time (~15 minutes post-mortem). 
 
Figure 2.2 Actual images of caudal faces of Sections A, B and C (taken at (a), (b) and (c) as per 
Figure 2.1). In addition, regions 1-6 from Figure 2.1 are cross referenced on each section. 
Section A  
Section A demonstrates the scrolls of 
the turbinates. However, the mucosa 
lining this section lay too far 
anteriorly to be of the olfactory type.  
Section B  
The epithelium of Section B between 
points (i), (ii) and (iii) was region 6. 
Epithelium taken from the ventral 
turbinate (solid line, green box) was 
region 5. Regions 2 and 3 were taken 
from the base of the nasal cavity 
(green arrow). Region 2 was directly 
rostral to region 3. 
Section C  
Section C was taken too close to the 
eyes in this animal since the 
ethamoturbinate bones are clearly 
visible and hence little olfactory 
epithelium was retrievable. 
 
Ethamoturbinate 
bones 
4 
1 
i 
ii 
iii 
5&6 
2&3 
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Each tissue sample was then processed for visualisation by microscopic techniques as 
described elsewhere (2.2.7 Preparation of Tissue Samples for Microscopy). 
2.2.4 Vertical Franz Diffusion Chamber Studies 
The olfactory epithelium (retrieved from Section B (Figure 2.2)) was easily 
distinguishable from the surrounding respiratory type by its yellowish appearance (due 
to the presence of olfactory pigment) compared to the pinkish colour of the respiratory 
mucosa. Within 20 minutes of slaughter, two pieces (2cm diameter) of olfactory 
epithelium (one from each side of the nasal cavity) were cut out with a cork borer 
(Figure 2.3). They were then transported to the laboratory on ice in 2 x 20ml vials 
containing the relevant pre-oxygenated (using O2/CO2 95:5 mix) buffer (0.5mM citrate 
buffer or SNS) to perform transport study. 
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Figure 2.3 Epithelium extracted from one half of the roof of nasal cavity (Section B Figure 2.2) 
using the aforementioned dissection method. A clear distinction can be made between the lighter 
coloured olfactory epithelium and darker respiratory epithelium due to less vascularisation and 
presence of (yellowish) olfactory pigment of olfactory epithelium. The hole in the tissue shows the 
best area to retrieve enough olfactory epithelium to load onto one diffusion cell. 
 
The tissue was removed from the cold buffer and loaded into the diffusion chamber 
apparatus using two cork-ring braces within ~1 hour of slaughter. The braces reduced 
the physical tension on the tissue during the experiment and therefore the likelihood of 
minor tears that are unobservable to the naked-eye. The epithelium was mounted 
vertically (mucosal side facing the donor chamber) as shown in Figure 2.4. 
 
Olfactory epithelium 
from nasal septum 
(pale pink) (i) 
 
Caudal edge 
Rostral edge 
Olfactory epithelium from 
caudal region of dorsal concha 
(pale pink) (iii) 
Respiratory epithelium 
(dark pink) 
Roof of nasal 
cavity (ii) 
Cork Borer 
used to cut the 
epithelium 
Olfactory 
epithelium tissue 
dissected from this 
region 
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Figure 2.4 Vertical Franz diffusion 
chamber (Crown Glass Company, CA) 
apparatus was comprised of two 
symmetrical diffusion chambers. This 
equipment was used to investigate the 
transport of nanoparticles across 
olfactory epithelium. The tissue was 
mounted vertically between the 
chambers on cork supports; magnetic 
stirrer bars maintained homogeneity and 
water jacket kept chamber temperature 
at 29±1ºC. 
 
The inner chambers were then filled with pre-oxygenated cold buffer solution to the 
collar of the sample port by syringe through these ports. The buffer was allowed to 
warm slowly by the heating effect of the insulating outer water jackets, which were 
filled using tubing connected to a water bath via a pump. The water bath was set to 
maintain the buffer temperature within the chambers at 29±1ºC. The epithelium was 
then allowed to equilibrate for 30 minutes (equilibration period) during which time 
electrophysiological measurements (2.2.1.2 Viability Assays) were taken every 5 
minutes. 
 
In the setup used here, magnetic stirrer bars maintained homogeneity of particles and 
oxygen, and the water jacket maintained chamber temperature at 29±1ºC. It has been 
suggested that a temperature setting of 37ºC may be too high since the temperature of 
the nasal mucosa is usually slightly above room temperature due to the cooling effect of 
the inspired air (Lehr 2002). Therefore, a more suitable range may be 28-30ºC; in fact, 
Clip holder 
Sampling 
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Magnetic Stirrer 
Bar 
Mounted 
tissue 
Inner 
(Sample) 
Chamber 
Water 
Jacket 
 RECEIVING       DONOR 
 CHAMBER       CHAMBER    
Oxygenation 
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time-related pattern of ciliary activity was more stable at 25ºC than 33ºC or 37ºC 
(Phillips et al 1990). In light of this, Cremaschi et al. carried out their experiments at 27 
ºC (Cremaschi et al 1996). Some experiments have also been performed at room 
temperature (Hersey & Jackson 1987). 
 
With regards to oxygenation of the buffer, it has been found that pre-sparging the buffer 
with O2/CO2 was more important than bubbling the gas during the experiment itself 
(Maitani et al 1997). The researchers used bubbling of gas as an agitator as well as for 
sparging during the diffusion chamber experiment. In the present experiments a 
combination of pre-sparging and the use of magnetic stirrer bars was selected. 
 
The experimental parameters that needed to be controlled were pH, temperature, buffer 
oxygenation and experimental runtime. pH 7.4 was selected since the majority of 
similar in vitro experiments have used phosphate-based isotonic buffering solution at 
this pH (Osth 2002). However, in Chapter 3 the buffer pH was reduced to pH6.0 with 
the use of a citrate buffer in order to permit the stability of a chitosan-based colloidal 
system. 
 
The experimental parameters used here were largely based on a studies by Osth et al. 
(2002a) and Jansson (2004), however, the following improvements were made in order 
to evaluate the physiological mechanisms responsible for any observed effects: (1) use 
of an improved viability methodology (based on Alamar Blue™); (2) use of varying 
sizes of nanoparticles placed in the donor cell with the epithelium; (3) measurement of 
donor cell particle reductions. Further improvements to the methodology involving 
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imaging of the dismounted tissue using fluorescence based microscopic techniques are 
described in Chapter 4. 
 
After a 30 minute resting period (equilibration period), 200µL aliquots (~6% of the total 
chamber volume) were collected through the sampling port from the receiving chamber 
every 10 minutes for 90 minutes. This was replaced with fresh (pre-warmed and pre-
oxygenated) buffer. Fresh pipette tips (Gilson Inc., Middleton, WI, USA) were used 
each time to prevent contamination of the inner chamber. The aliquots were pipetted 
into a 96 well plate (Co-Star, Schiphol-Rijk, The Netherlands). In addition, four evenly 
distributed electrophysiological measurements were taken at the 40, 60, 80 and 100 
minute time points after mounting the tissue to the diffusion chambers. 
 
Thereafter, electrophysiological measurements were taken again every 5 minutes for the 
last 30 minutes of the run and the transport run was terminated after a total of ~3½ 
hours post-mortem. Then, the epithelium was dismounted and used for the Alamar 
Blue™ assay and microscopy (2.2.5.2 Alamar Blue™ and 2.2.7 Preparation of Tissue 
Samples for Microscopy). 
 
To summarise, Table 2.1 is a breakdown of events for the duration of the experiment. 
Table 2.1 Summary of events during diffusion chamber studies 
Post Mortem Time 
(minutes) 
Activity 
0-60 Slaughter, dissection, transport and initiation of 
experiment 
60-90 Electrophysiological data and tissue equilibration 
90-180 Diffusion chamber study (Electrophysiological data a 100, 
120, 140 and 160 minutes)  
180-210 Electrophysiological data 
210 Tissue dismounted and cut up for Alamar Blue™ assay 
and histological analysis. 
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In addition, Alamar Blue™ assay was also performed on fresh olfactory epithelium 
samples directly upon arrival to the laboratory. 
 
2.2.5 Sample Viability Measurements 
It was necessary to ensure that the olfactory epithelium was alive during the experiment 
therefore viability measurements were performed using a standard electrophysiological 
technique for measuring viability of epithelia in diffusion chamber apparatus (2.2.5.1 
Electrophysiological Viability Measurements) and also an Alamar Blue™ test (2.2.5.2 
Alamar Blue™). Hence, the experiments had the following objectives: (i) to evaluate 
the viability of the olfactory epithelium during and after diffusion chamber studies; (ii) 
to reduce variability in Alamar Blue™ data by normalising it with DNA content; (iii) to 
compare the effect of sodium azide on olfactory epithelium Rm and viability; (iv) to 
compare the effect of both phosphate- and citrate- based buffering systems on olfactory 
epithelium Rm and viability; and (v) to establish viability acceptance criteria for further 
diffusion chamber studies. 
 
In the olfactory tissue transport studies the single most important criterion was to 
demonstrate that the excised tissue was viable and undamaged during the experiments. 
Hence, the tissue viability was measured using two methods based on different 
scientific principles; the first method was based on electrophysiology and the second 
method was based on the rate of cell enzymatic activity. 
 
To test the viability of the tissue by these methods, negative and positive controls were 
needed to be included in the experiments. Freshly dissected olfactory epithelium was 
selected as positive control since this would provide maximum values for viability. 
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Tissue that was metabolically inactivated by chemical means was chosen as the negative 
control. It was decided not to allow the tissue to die naturally (ex vivo) since increased 
enzymatic activity from bacterial growth on dead tissue would increase the viability 
signal from the Alamar Blue™ assay. 
 
Sodium azide (300mM) was chosen as the tissue inhibitor since it reversibly blocks the 
same metabolic pathway as Alamar Blue™, i.e. the mitochondrial electron transport 
chain (Seifalian et al 2001). One of the products of metabolism is ATP which (amongst 
other functions) maintains the electrochemical gradient of ions over the epithelia and 
keeps tight junctions closed. These phenomena can be detected by the 
electrophysiological method. 
2.2.5.1 Electrophysiological Viability Measurements 
From the moment of animal slaughter, the integrity of the tight junctions between the 
epithelial cells slowly diminishes and hence the passage of materials through the 
membrane becomes less comparable to the situation when the tissue was in the live 
animal. The dead tissue may pass materials paracellularly due to the opening of tight 
junctions and pores may appear due to tissue degradation after cellular death. 
 
Mannitol has been traditionally used as a paracellular marker since it is not readily 
transported across a membrane via the transcellular route (i.e. through cells).  
14C-labelled mannitol has been used to determine the ‘leakiness’ of the tight junctions 
across biological membranes in the past (Lehr 2002). Live tissue will resist the 
paracellular movement of mannitol compared to dead epithelium since dead epithelium 
has ‘leakier’ tight junctions. 
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It was decided, however, to employ the electrophysiological methods since it is simple 
and it is a standard method to measure the viability of epithelia that are mounted in 
diffusion cells. The technique can measure both passive and active ion transport 
properties of biological membranes. Passive properties can be observed as the 
‘leakiness’ of the epithelium whereas active properties include the measurement of  
Na-pump and ion channel activities. 
 
One way of measuring the active and passive transport properties of epithelia is to plot 
the potential difference across the epithelium when an external current is applied. The 
principle is based on Ohm’s Law. A straight line relationship such as that in Figure 2.5 
was observed when the potential difference was plotted against an applied current in 
these experiments. The resting membrane potential (PD) (i.e. the potential difference 
across the membrane when no current was applied) and the short circuit current (Isc) (i.e. 
the current required to extinguish the resting membrane potential) can be calculated by 
applying simple arithmetic to the plotted values. In addition, the gradient of the straight 
line is proportional to the membrane electrical resistance (Rm). These three parameters 
can be compared between epithelia to evaluate overall trends. 
 
 
 
Figure 2.5 Explanation of the 
electrophysiological parameters used to 
determine tissue damage and viability. This 
plot is based on the Ohm’s Law principle and 
is made for each time point in the experiment. 
PD (mV) is the natural potential in the resting 
state (when no external current is applied). Isc 
(µA/cm2) is the short-circuit current (the 
current that is applied across the epithelium 
necessary to extinguish the PD). The gradient 
R is proportional to the transepithelial 
electrical resistance (Rm) (R x 1000 = Rm 
(cm2)). Taken from (Osth 2002). 
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An EVOM (World Precision Instruments, Stevenage, UK) was used to determine the 
Rm (cm2), Isc(µA/cm2) and PD (mV) (see Figure 2.5 for diagrammatic explanation of 
terms) by use of the following equations: 
 
Rm = (RE - RC) πr2 
PD = (PDE - PDC) 
Isc = (0-PD) / Rm 
 
Where: 
PDE = potential difference measurement during experiment (mV) 
PDC = background potential difference measurement (mV) 
RE = resistance measurement during experiment () 
RC = background resistance measurement () 
r = radius of tissue sample under investigation (cm) 
 
Background levels were taken without the presence of epithelium between the chambers 
both before and after mounting the tissue. The arithmetical mean of these two values 
were used as the background level for each experiment. 
 
The following is an explanation of the electrophysiological basis for these parameters. 
An innate resting membrane potential (PD) is generated by the differential transport of 
ions across the epithelium. The exact nature of this differential depends on the ions 
present and the epithelium used. It can be measured experimental by manipulating the 
concentration of Na+ and K+ ions on either side of the membrane (Gizurarson et al 
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1991). Moreover, the differential transport of ions requires energy from cell metabolism 
and so it is understood that PD is proportional to epithelial viability/metabolic rate. The 
magnitude of PD depends on a combination of two factors; (a) the rate of ion-transport 
across the epithelium and (b) the ‘leakiness’ of the epithelium. 
 
(Isc is described as the externally applied current needed to extinguish the PD. Hence, 
PD and Isc are electrophysiologically linked and so the previous explanation may be 
extended to Isc as well as the given example for PD). 
 
The equilibration (or bioelectrical stabilisation) period is the time required for the 
dissected tissue to return to a steady electrophysiological state after having been placed 
onto the diffusion chamber apparatus. Since the tissue samples are transported from the 
site of removal from the pig in buffer on ice, the epithelium uses some time to 
physically warm up and restart its temporarily dormant metabolic activities. This allows 
for tight junctions to become fully integral and for active ion transport pumps to form a 
resting membrane potential across the epithelium (Lehr 2002). 
2.2.5.2 Alamar Blue™ 
The Alamar Blue™ viability assay incorporates a reduction-oxidation (REDOX) 
indicator that can be detected by fluorometric methods. It is easily interpreted, 
minimally toxic and stable. The manufacturer’s literature suggests that the reagent, 
resazurin, is taken up by cells and reduced – predominantly in the electron transport 
chain (AbD Serotec Ltd 2004). The reduction mechanism depends on the ability of the 
reagent to substitute molecular oxygen for any of the oxioreductase enzymes. In this 
way, the non-fluorescent blue substrate (resazurin) is reduced to the red-fluorescent 
product (resorufin). Resorufin has excitation and emission maxima of 560nm and 
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590nm respectively (Figure 2.6). Hence, this assay gives a measure of cell metabolic 
activity and viability. 
 
 
Figure 2.6 Biochemical basis 
of Alamar Blue™ assay. 
Taken from AbD Serotec Ltd 
2004. 
 
The Alamar Blue™ tests were performed on tissue samples that were collected directly 
after the transport study. To perform the Alamar Blue™ test a 10%v/v solution of 
Alamar Blue™ was made up from the manufacturer’s stock solution in SNS. Next, 
200µl of this working solution was placed in wells of a 96 well microtitre plate (Co-
Star, Schiphol-Rijk, Netherlands). A 3mm diameter core of sample tissue was then 
placed into a well containing the solution. The samples were kept in the dark by 
wrapping foil around the well plate to prevent photobleaching of the fluorophore and 
left for 90 minutes at 37°C 95%O2/5%CO2 (80%) for colour to develop. The experiment 
was done in triplicate for each sample. 
 
In addition, triplicate blanks were also analysed where the same procedure was 
followed, except with no tissue. This gave the background fluorescence values. 
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After incubation the microtitre plate was de-foiled and placed into a fluorometric plate 
reader (FluoroSkan Ascent, Thermo, Stone, UK) and analysed using excitation light at 
530nm and emission light at 590nm. Subsequently, the blank values were subtracted 
from the sample readings to give the final result. 
 
The tissue samples were then frozen (-20°C) and later quantified for DNA using the 
Hoechst methodology (2.2.5.3 Hoechst DNA Quantification). Thereafter, the viability 
data was normalised per mass DNA by dividing the Alamar Blue™ viability value by 
mg DNA per sample. 
2.2.5.3 Hoechst DNA Quantification 
The viability of the excised tissue may vary depending on the thickness of the 
epithelium. An attempt was made to normalise the Alamar Blue™ viability assay 
measurements by the unit mass of tissue in each sample using the Hoechst DNA 
quantification assay. It was thought that this may reduce the effect of variations in tissue 
thickness. The Hoechst assay is a method used to quantify the amount of DNA in tissue 
samples. The reagent, bisbenzamide, is a chemical that becomes fluorescently active 
(Ex/Em 365nm/480nm) when bound to adenine-thymine base pairings in DNA in 
solution. This fluorescence activity can be quantified and standardised using calibration 
plots. The method is particularly useful since, unlike protein content, the amount of 
DNA per sample is directly proportional to number of cells in the sample. 
 
DNA quantification is more accurate than other measures of tissue mass. For example, 
measurement of tissue samples dry mass would require very sensitive weight balances 
that were not available in the laboratory. Protein content measurements would also be 
less accurate than DNA measurements since protein expression, for example of mucin, 
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can vary markedly between animals due to phenotypic differences, living conditions and 
weather. 
 
Thus, variability in Alamar Blue™ measurements deriving from the variation in 
thickness of different tissue between samples should be reduced by combining the 
results of the Alamar Blue™ and the Hoechst assays. 
 
The DNA measurements were performed in the following way. Frozen cores of porcine 
nasal epithelium (that had previously been evaluated for viability by the Alamar Blue™ 
assay) were allowed to thaw to room temperature. Next, they were individually digested 
in papain solution by placing each sample in an Eppendorf Tube and adding 1ml of 
papain solution. The Eppendorf tubes were then sealed using Parafilm and incubated at 
60°C overnight in a water bath. Following this samples were filtered using 70m2 nylon 
BD Falcon™ cell strainers to remove undigested material and therefore reduce 
variability from light scatter artefacts in the fluorometer. Next, triplicate 200l aliquots 
of each sample were added to a 24-well plate followed by 0.5 ml Hoechst buffer and 
0.75 ml Hoechst working solution. The well plate was wrapped in foil and rested for 5 
minutes at room temperature to allow for the reaction between DNA and bisbenzamide. 
Finally, fluorescent readings were carried out for each sample (FL600FA, Labtech Int. 
Ltd., Ringmer, UK). Fluorescent measurements were read at excitation wavelengths 
360±12.5nm and emission wavelengths 460±20nm. 
 
A standard curve was produced using calf thymus DNA to estimate the amount of DNA 
per sample. This was recommended by Hoechst manufacturer’s literature since it is 
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cheap, easily purified and (being eukaryotic) has a low variation in adenine-thymine 
base content. 
 
To produce a standard curve, seven 700µl concentrations of DNA solution were made 
up in Eppendorf tubes using papain solution (Table 2.2). These were sealed with 
Parafilm and immersed in 60°C water overnight. Samples were then filtered using 
70m2 nylon BD Falcon™ cell strainers (BD BioSciences, Oxford, UK). This ensured 
that the calf DNA calibration samples underwent the exact same procedure as the 
epithelial samples. 
 
Next, triplicate aliquots of 200l of these varying concentrations of calf-thymus DNA 
solution (Table 2.2) were added to a 24-well plate followed by 0.5 ml Hoechst buffer 
and 0.75 ml Hoechst working solution, wrapped in foil, rested and measured for 
fluorescence as previously described.  
 
Table 2.2 DNA calibration curve solutions for Hoechst DNA quantification 
[DNA] 
mg/ml 
Vol. stock DNA 
(10µg/ml) 
 (µl) 
Vol. Papain solution 
(µl) 
Total Vol.  
(µl) 
0.00 0 700.00 700 
0.05 3.5 696.50 700 
0.10 7.0 693.00 700 
0.15 10.5 689.50 700 
0.20 14.0 686.00 700 
0.30 21.0 679.00 700 
0.40 28.0 672.00 700 
 
The composition of the buffers that were required during sample preparation for 
measuring DNA content of tissues are described in the Appendix. 
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2.2.6 Comparison of Olfactory and Respiratory Tissue Metabolism 
To gain a better understanding of the rate of metabolism of olfactory epithelium in 
comparison to other tissues, the Alamar Blue™ method was used to compare the 
viability of olfactory to respiratory epithelia directly after excision from the pig nasal 
cavity.  
 
Hence, epithelial cores were taken from the porcine nasal cavity (as described in 2.2.3 
Dissection of Nasal Epithelia from the Pig) for respiratory and olfactory epithelia from 
regions 5 and 6, respectively. The samples were transported in 0.5mM citrate buffer 
pH6.0 and the Alamar Blue™ test was performed using the methods described earlier 
(2.2.1.2 Viability Assays). 
 
Samples were taken from nine pigs on different days. Some samples were taken for 
epithelia from the same animal. The Alamar Blue™ viability scores of 3-7 tissue cores 
from one animal were averaged per pig. The mean scores were then used in an unpaired 
statistical analysis to compare the differences between mean viability scores. 
 
2.2.7 Preparation of Tissue Samples for Microscopy 
Morphological examination of the epithelia was required for two reasons; first, to 
confirm location of the olfactory epithelium; and second, to demonstrate the 
morphology of the olfactory epithelium after manipulation in the diffusion chamber 
apparatus.  
 
Tissue samples were immediately placed in 3% glutaraldehyde for primary fixation. 
They remained in the fixative for at least 48 hours to allow for crosslinkage of cysteine 
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residues in the tissue, after which the fixative was disposed into 1M glycine using a 
plastic pipette. Then fresh (aldehyde-free) 0.1M cacodylate buffer was then added to the 
sample and was allowed to rest for 5 minutes. This rinsed away any excess 
glutaraldehyde which would chemically reduce the osmium tetroxide in the proceeding 
step. 
 
The cacodylate buffer was then replaced with a 1%w/w osmium tetroxide solution for 1 
hour. This high molecular weight metal salt had a dual purpose; (i) it chemically 
crosslinked fatty acids in the epithelial samples (termed secondary fixation); and (ii) its 
high electron density was used as a contrast medium for electron microscopy. 
  
After the 1 hour osmium tetroxide treatment the osmium salt was replaced with distilled 
water for five minutes. This was repeated twice. Then, the samples were placed through 
a series of graded alcohols as follows; 2x15 minutes in each 50%, 70%, 90%, 100% 
IMS (in distilled). Next, the IMS was replaced by immersing for 2x15 minutes in 
propylene oxide (PO). The IMS dehydrated samples were not placed directly into resin 
since these reagents were immiscible. Therefore, PO was used as an intermediate 
reagent since it is miscible in both IMS and resin. 
 
The embedding resin was made up by mixing 25ml Araldite CY212 resin, 15ml Agar 
100 resin and 55ml DDSA with a wooden stick. Thereafter, 2ml Dibutyl phthalate and 
1.5ml DMP 30 were added until the colour changed from red-orange to orange. 
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Next, a short series of graded resin in PO was used to bring the sample slowly to 100% 
resin as follows; 3:1 PO:resin for 2 hours, 1:1 PO:resin overnight, 1:3 PO:resin for 3 
hours, 3x2 hours in 100% resin. 
 
Finally the samples were placed in a flatbed mould that would hold the correct 
orientation for slicing the tissue. The moulds were placed in an oven for 48 hours at 
60°C. This hardened the sample and the resin ready for cutting. An ultra-microtome was 
used to slice the samples. For light microscopy 500nm sections were cut using a glass 
knife. For TEM 70-90nm sections were cut using a diamond knife (TEM sections were 
cut by the Imaging Unit, Queens Medical Centre, University of Nottingham, 
Nottingham, UK). 
2.2.8 Staining Samples for Light Microscopy 
The samples were stained using toluidine blue to check that the gross tissue morphology 
and identify the region(s) of interest by applying the stain for a few moments then 
washing off with distilled water. If the sample was understained then the process was 
repeated until satisfactory staining was achieved. 
 
Toluidine blue is a basic dye and therefore it has a higher affinity for negatively charged 
cell constituents (such as sulphated glycosaminoglycans and phosphated nucleic acids) 
compared to positively charged ones (such as proteins under acid conditions). This leads 
to a two-tone staining pattern in which cytoplasm contrasts with nuclei. 
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2.2.9 Staining Samples for TEM 
TEM was also used to see the epithelia at high magnification. Heavy metal staining was 
employed using two complementary stains. Lead citrate (acidophilic) stains positively 
charged groups (e.g. mitochondria and cilia) in the epithelium whereas uranyl acetate 
(basophilic) stains negatively charged groups (e.g. nucleic acids). They are used in 
combination as a standard method to visualise differential staining patterns in electron 
microscopy. 
 
To prepare the samples, regions of interest were isolated, cut to ~70-90nm using a 
diamond knife and placed on a small circular copper grid (diameter ~2mm). Then a 
drop of the uranyl acetate was placed on a Petri dish. The copper sample grids were 
inverted (sample face down) and placed on top of this drop for 10 minutes. They were 
then rinsed lightly with 50% (v/v) methanol in water then again in water alone. This 
was done by holding the grid between fine curve ended forceps and using the curved 
ends of the forceps to break the force of the liquid from a bottle. This reduced the 
likelihood of sample damage from the force of the jet. This was repeated for lead citrate 
solution. The samples were rinsed with water and methanol as before and guided off the 
forceps with filter paper onto more filter paper and allowed to air dry. 
2.2.10 Statistical Analyses 
All statistical analyses were performed by SPSS software version 15.0 (Chicago, USA). 
2.2.10.1 Comparison between grouped continuous data 
Datasets were analysed for normality using the Shapiro-Wilk test. Parametric datasets 
containing only 2 groups were analysed using a (paired/unpaired) Student’s t-test; non-
parametric datasets were analysed by Mann-Whitney test unpaired data. A non-
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parametric test was used to determine significance in cases where one group was 
parametrically distributed and the other group was non-parametrically distributed. A 
one-way analysis of variables (ANOVA) with post hoc test was performed on datasets 
with more than 2 groups. Bonferroni post hoc test was performed on groups with equal 
variances and a Games-Howell post-hoc test was performed on groups with unequal 
variances. A value of p<0.05 was considered statistically significant. 
2.2.10.2 Testing for correlation between continuous datasets 
The Pearson product-moment correlation co-efficient, r, was calculated for parametric 
continuous datasets. For non-parametric continuous datasets the Spearman’s Rank (ρ) 
correlation test was performed. This test used the same algorithm as the Pearson 
product-moment correlation; however, the values were ranked in ascending order and 
the algorithm was executed on the ranked values and the ranked means. 
 
Correlation coefficients are dimensionless indices that range from -1.0 to 1.0 inclusive; 
they reflect the extent of a linear relationship between two data sets. A correlation of +1 
means a perfect positive linear relationship between variables i.e. all the points lying 
exactly on a straight line of positive slope. Conversely, a correlation of -1 means a 
perfect negative linear relationship between variables. A correlation of 0 means there is 
no linear relationship between the two variables. In analytical practice, correlation 
values greater than 0.99 are usually required and values of less than 0.90 are uncommon 
(Miller 1993). 
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2.2.10.3 Relative Standard Deviation (RSD) 
Relative Standard Deviation (%) is a measure of data variability that relates the spread 
of data in a dataset to the mean value. It is calculated as: 
n
xRSD =%  
where x  was the sample mean and n was the sample number. 
 
It is a useful measure of variability when the absolute values (e.g. standard deviation) 
for two datasets are markedly different (e.g. Alamar Blue™ viability scores and Alamar 
Blue™ viability scores after adjustment for DNA content). 
2.3  RESULTS 
In this section the results are presented in relation to the chapter objectives: (i) the 
location of the olfactory epithelium in the porcine nasal cavity was determined by 
standard histological techniques and bright field microscopy; (ii) the viability of the 
vertical Franz diffusion cell loaded olfactory epithelia were determined in different 
physiological buffers (citrate pH6.0 and SNS pH7.4) in presence and absence of 
metabolic blockade with sodium azide; (iii) the histological appearance of citrate and 
SNS buffered olfactory epithelia were evaluated after the diffusion cell studies using 
bright field microscopy; (iv) an assessment of the bioelectrical equilibration period was 
made for the porcine olfactory epithelium using the current experimental conditions; (v) 
the viability of olfactory epithelium was compared to that of respiratory nasal epithelia; 
and (vi) the effect of correcting Alamar Blue™ viability data with DNA content was 
evaluated. 
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2.3.1 Morphological Features of Porcine Nasal Epithelia 
Figure 2.7 to Figure 2.12 show the morphology under the bright field microscope of 
epithelia from Regions 1-6 of the nasal cavity (Figure 2.2). Region 1 (Figure 2.7) was 
extracted from the nasal vestibule. It showed a stratified squamous structure with a 
keratinised surface. The keratinised surface morphologically was anuclear. Its function 
is to protect the underlying cells from mechanical damage and dehydration (Figure 
2.7(a)). The underlying cells were typical of stratified squamous epithelium. They were 
round in shape and layered in no definite formation. Intercellular connections, such as 
desmosomes, are clearly visible as strands between the cells (Figure 2.7(b)). 
 
Figure 2.7 Histology of the porcine nasal vestibule.  
 
 
 
(a) Region 1: Keratinised stratified squamous epithelium (b) Region 1: Close-up of keratinised layer and 
apically located stratified squamous epithelium. * indicates luminal space. 
* 
* 
a b 
Keratinised 
layer 
Stratified 
squamous 
epithelial cells 
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Regions 2 and 4 (Figure 2.7 (a,b)) demonstrated a simple cuboidal epithelial 
morphology. These regions lie between the (rostrally-located) squamous and (caudally-
located) columnar epithelia. The cuboidal cells were non-ciliated (Figure 2.7 (c)).  
 
Figure 2.8 Histology of the porcine nasal transitional epithelium. * indicates luminal space. 
  
 
(a) Region 2: Non-ciliated cuboidal border. 
(b) Region 4: Non-ciliated cuboidal border. 
(c) Region 4: Close-up of non-ciliated cuboidal 
border. 
 
* 
* 
* 
a b 
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Regions 3 and 5 (respiratory epithelium) were pseudostratified epithelium containing 
columnar cells in the apical cell layer (Figure 2.9 (b,d)). The columnar cells were both 
ciliated and non-ciliated (Figure 2.9 (b)). They had oval-shaped nuclei that were located 
in the middle third of the cells. Basal cells were rounder and darker stained than the 
columnar cells. They were located next to the basement membrane. The underlying 
lamina propria contained many more capillaries than in Region 2 (Figure 2.9 (a,c)).  
 
Figure 2.9 Histology of the caudally-located porcine pseudostratified columnar epithelium (respiratory 
epithelium). 
  
  
(a) Region 3: (a) Columnar border with blood vessels present in the lamina propria (arrows). The lamina 
propria also contained many glands (boxed). (b) Region 3: Close up of border. Presence of (ciliated [cC] and 
non-ciliated [ncC]) columnar cells and basal cells [BC]. (c) Region 5: Pseudostratified columnar with same 
gross morphology as Region 3. Blood vessels present in the lamina propria (arrows). The lamina propria also 
contained many glands (boxed). (d) Region 5: Close up of pseudostratified columnar epithelium. * indicates 
luminal space. 
 
BC 
ncC 
 
cC 
* 
* * 
* 
a b 
c d 
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Olfactory epithelium was found in Region 6 (Figure 2.2) covering the dorsal turbinate. 
Olfactory epithelium had similar morphology to the pseudostratified columnar epithelia 
found in Regions 3 and 5. In addition to Regions 3 and 5, olfactory epithelium also 
presented olfactory neurones (Figure 2.11) in the apical layer and filia olfactoria (Figure 
2.12) in the lamina propria. These were its main distinguishing features. 
 
Figure 2.10 Region 6 (Olfactory Epithelium). Columnar border with fewer blood vessels (arrow) 
present in the lamina propria than Regions 3 and 5. * indicates luminal space. Dash lined box shows 
filia olfactoria (magnified in Figure 2.12). Solid line box magnified in Figure 2.11 
 
 
* 
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The olfactory epithelium contained ciliated pseudostratified columnar epithelium 
(Figure 2.11). Olfactory knobs are a feature of the apical terminus of the olfactory 
axons. They are highlighted by the dash lined box in Figure 2.11. Sustentacular cells 
(SC) are non-neuronal columnar cells in the olfactory epithelium. Basal cells similar to 
those found in respiratory pseudostratified columnar epithelium (Regions 3 and 5) are 
also highlighted. 
 
Figure 2.11 Region 6 (Olfactory Epithelium). Cilia are clearly visible from the sustentacular cells 
(SC). Olfactory knobs are also seen (dashed box). BC Basal cell. * indicates luminal space. 
 
 
* 
BC 
SC 
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Filia olfactory are also a key distinguishing feature of the olfactory epithelium (Figure 
2.12). Filia olfactoria are neuronal bundles, containing neural cells (dashed box), found 
in the lamina propria underlying the olfactory epithelium. They are ensheathed with 
Schwann cell processes that maintain their electrical conductivity (arrow). The filia 
olfactoria traverse the cribiform plate and terminate in olfactory bulbs in the CNS. 
 
Figure 2.12 Region 6 (Olfactory Epithelium). Filia olfactoria magnified. Individual neuronal 
processes can be identified (dashed box). Schwann cell bundle can be identified (arrow). 
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At the subcellular level, the greatest proportion of mitochondria appeared at the apical 
surface of the epithelial cells. Figure 2.13 shows an example from the olfactory 
epithelium. 
 
Figure 2.13 Mitochondria at luminal surface of pseudostratified columnar cells in olfactory 
epithelium (Region 6). * indicates luminal space. 
 
The different epithelia found in the nasal cavity of a six month old pig are summarised 
in Figure 2.14.  
 
Figure 2.14 Summary of types of 
epithelia found in the porcine nasal 
cavity Adapted from (Getty 1975). 
Epithelium was retrieved from six 
different areas as shown (labelled 
1-6). 
Green highlight – pseudostratified 
columnar epithelium (regions 3 
and 5). Respiratory epithelium. 
Blue highlight - cuboidal cells 
(Regions 2 and 4). 
Red highlight – keratinised 
stratified squamous epithelium 
(Region 1). 
Yellow highlight - Region 6. 
Olfactory epithelium.  
 
4 5 6 
3 2 1 
A B C D 
(a) (b) (c) 
* 
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2.3.2 Effect of Different Buffers and Sodium Azide on Olfactory Epithelium 
Table 2.3 summarises the post-equilibration (30-150minutes Table 2.1) Rm, PD and Isc 
data for the 0.5mM citrate and SNS buffering conditions. Data captured within 30 
minutes of tissue mounting for the electrophysiological data were assumed to be 
unrepresentative of stable bioelectrical conditions (although in reality this may not be 
true Table 2.4). The mean, standard deviation and statistical significances were 
calculated for each buffering system, with and without exposure to sodium azide, for all 
three electrophysiological measurements. 
 
The following two observations were made. First, for SNS buffer, the addition of 
sodium azide to the olfactory epithelium statistically changed Rm and PD values 
(p<0.05 ANOVA) from 58.6±12.7	cm2 and -0.8±0.2mV to 8.2±3.0	cm2 and 
0.7±0.4mV, respectively. However, similar observations could not be made for citrate 
buffer where no significant differences were observed. Isc values were not statistically 
different (p<0.05 ANOVA). 
 
Second, there was no statistical difference between the Rm value for SNS buffer 
(58.6.3±12.7	cm2) and citrate buffer (78.8±40.2	cm2) (mean±s.d.). However, there 
were statistical differences for PD (-0.8±0.2mV [SNS] compared to -0.1±0.1mV 
[citrate]) and Isc values (13.3±1.5mV [SNS] compared to 1.0±0.2mV [citrate]). This 
suggested that the citrate buffer statistically reduced the metabolic activity of the 
olfactory epithelia but the amount of tight junction opening remained unchanged. 
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Table 2.3 Post-equilibration Rm, PD and Isc data summary for porcine olfactory 
epithelia that were mounted on the vertical Franz diffusion cell and exposed to 
either SNS or Citrate buffers, with and without sodium azide. 
 Rm (cm2) PD (mV) Isc(µA/cm2) 
SNS Buffer 
 
58.6±12.7a 
 
-0.8±0.2a,b 13.3±1.5b 
SNS Buffer + 
azide 
 
8.2±3.0a 
 
0.7±0.4a 
 
 -107.0±73.0 
 
Citrate buffer 
 
78.8±40.2  -0.1±0.1b 1.0±0.2b 
Citrate buffer + 
azide 
11.5±2.7 1.5±0.9  -134.0±74.8 
a
 Statistical difference (p<0.05) between SNS buffer and SNS buffer+azide data 
b
 Statistical difference (p<0.05) between SNS buffer and citrate buffer data 
Statistical test: One way ANOVA with Games-Howell post hoc test 
(mean±s.d. deviation; n=3) 
 
Figure 2.15 shows the Alamar Blue™ viability values for: (a) freshly excised porcine 
olfactory epithelia on arrival to the laboratory, and (b) olfactory epithelia that had been 
used for experiments in the vertical Franz diffusion chambers. The graph shows values 
for samples exposed to either SNS or citrate buffers (with and without added sodium 
azide). 
 
A number of observations were made. First, sodium azide significantly reduced the 
viability of the diffusion chamber mounted epithelia exposed to SNS (10528±676 to 
3260±487, mean±s.d., P<0.01 ANOVA) but not 0.5mM citrate buffered samples 
(p>0.05, ANOVA). However, sodium azide did statistically reduce Alamar Blue™ 
viability scores for 0.5mM citrate buffered olfactory epithelia (pH6.0) when compared 
to freshly excised citrate buffered samples (p<0.05, ANOVA). It was expected that the 
sodium azide would reduce the metabolic rate of cells in the epithelium since it 
reversibly blocks the same metabolic pathway (in the mitochondrial electron transport 
 101 
chain) as that required by the conversion of the (Alamar Blue™ reagent) resazurin to 
resorufin (Seifalian et al 2001). 
 
Nonetheless, even though a high concentration of the metabolic inhibitor (300mM) was 
used it was observed that sodium azide did not completely block the metabolism of the 
cells. The apparent residual viability could be a result of background levels of REDOX 
reactions, such as those involved in anaerobic respiratory pathways, that are also able to 
convert Alamar Blue™ to its fluorescent form (Seifalian et al 2001; AbD Serotec Ltd 
2004). 
 
Second, the type of buffer system had an effect on viability for azide-free samples. 
Alamar Blue™ measured viability was significantly reduced for 0.5mM citrate buffered 
(pH6.0) olfactory epithelium (9870±570) compared to SNS buffered (pH7.4) samples 
(6690±870) (for freshly dissected tissues in the absence sodium azide) (p<0.05, 
ANOVA, n=3) (Figure 2.15). This data shows that pH had a significant effect on 
viability. 
 
Third, the diffusion chamber experiment did not have a significant effect on viability of 
the tissue. The mean viability values for freshly excised samples compared to samples 
that were subjected to the diffusion chamber experiment were not significantly different 
(p>0.05, ANOVA) for the SNS (9870±570 [freshly dissected samples] compared to 
10530±390 [diffusion chamber loaded samples]) or citrate (6690±870[freshly dissected 
samples] compared to 5760± 280 [diffusion chamber loaded samples]) buffered 
epithelia. 
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Overall, Table 2.3 and Figure 2.15 highlight three important conclusions; first, sodium 
azide significantly affected the viability of the epithelia for all SNS buffered but not all 
the citrate buffered samples. Therefore, it could not be confirmed by these methods that 
the 0.5mM citrate buffered samples (pH6.0) were alive after the diffusion cell 
experiment. Second, a change in the buffering system from SNS (pH7.4) to 0.5mM 
citrate (pH6.0) buffer significantly affected the viability of the olfactory epithelia. Third, 
the mounting of the epithelia to the diffusion chamber did not have a direct effect on the 
viability of the samples. 
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Figure 2.15 Alamar Blue™ Viability Data for porcine olfactory epithelia tested for fresh samples and samples that were dismounted from the diffusion chamber 
apparatus, with and without addition of azide (mean±standard error; n=8,3,3,1,5,3,3,2 [from left to right]). * Significant difference (p≤0.01), † Significant difference 
(p≤0.05); One way ANOVA with Bonferroni post hoc test.
† 
* 
* 
† 
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The second conclusion, made from electrophysiology and Alamar Blue™ analysis, of 
the viability effects of the buffering solution on the olfactory epithelium is supported by 
the following morphological observations made under bright field microscopy. Figure 
2.16 and Figure 2.17 demonstrate the condition of the olfactory epithelium after 
exposure to the diffusion chamber conditions (without the presence of particles) in the 
different buffering conditions. The SNS buffered epithelia appeared to have similar 
morphology to the fresh samples (see Figure 2.10 to Figure 2.12). However, there were 
minor changes to the pH6.0 citrate buffer samples such as the condition of the cilia 
which were not as prominent, subcellular components appeared less clear, and the shape 
of the olfactory knob had changed (dashed box Figure 2.17). These findings were noted 
when evaluating the effect of nanoparticles on the olfactory epithelia exposed to 0.5mM 
citrate buffer pH6.0 (Chapter 4). 
 
Nevertheless, for both conditions the gross morphologies of these tissues were similar to 
the fresh sample represented in Figure 2.11. Hence, columnar cells were intact with 
basal cells aligned above the basement membrane and cilia were visible (solid line 
boxes Figure 2.16 and Figure 2.17). Therefore, from a morphological perspective (and 
to a lesser extent from Alamar Blue™ data) the olfactory epithelia buffered with SNS or 
citrate systems were deemed suitable for use with the diffusion chamber apparatus. 
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Figure 2.16 Morphology of olfactory porcine olfactory epithelium after dismounting the tissue from 
the diffusion chamber apparatus. The tissue was exposed to SNS buffer pH7.4 for 150 minutes. 
Cilia highlighted in solid lined box. BC Basal Cell. SC Sustentacular cell. * indicates luminal space. 
 
* 
BC 
SC 
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Figure 2.17 Morphology of olfactory porcine olfactory epithelium after 150 minutes exposure to 
citrate buffer pH6.0 in the diffusion chamber apparatus. Olfactory knob highlighted in dashed box. 
Vesicles appeared in the diffusion chamber exposed samples (solid and dashed boxes). BC Basal 
Cell. SC Sustentacular cell. * indicates luminal space. 
 
2.3.3 Assessment of Equilibration Period 
The stability of the electrophysiological readings were tested by comparing the mean 
values of Rm, PD and Isc between 0-30 minutes and 120-150 minutes after mounting of 
the olfactory epithelium onto the diffusion chamber apparatus. Both the affects of 
sodium azide and buffer type were considered (Table 2.4). 
 
For azide-free samples, PD and Isc values remained reasonably constant over the time 
period measured for both buffering conditions. For citrate buffer, there was no statistical 
change for Rm between the two time periods. For SNS buffer, however, Rm significantly 
increased with time (p<0.05 paired t-test) from approximately 40 to 65cm2 (Table 
2.4). 
* 
BC 
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For azide-exposed samples corresponding Rm, PD and Isc values remained constant for 
all buffering conditions . The results are summarised in Table 2.4. 
 
Table 2.4 Summary of electrophysiological measurements (mean±s.d).  
 Rm (	cm2) PD (mV) Isc(µA/cm2) 
SNS 
(0-30min) 
41.0±12.6* -0.2±0.6 2.2±14.9 
SNS 
(120-150min) 
65.4±12.5* -0.9±0.2 14.5±2.5 
SNS+Azide 
(0-30min) 
8.5±2.3 -0.3±0.6 47.5±84.1 
SNS+Azide 
(120-150min) 
7.6±3.4 0.7±0.4 -125.4±88.5 
Citrate 
(0-30min) 
62.6±26.8 0.4±0.1 -7.7±4.6 
Citrate 
(120-150min) 
80.5±43.9 -0.1±0.1 
 
0.2±0.9 
 
Citrate+Azide 
(0-30min) 
9.5±4.5 1.6±1.1 -162.3±105.5 
Citrate+Azide 
(120-150min) 
12.2±1.7 1.7±1.1 -137.9±83.1 
Both azide-free and azide-containing SNS and citrate buffered olfactory epithelia were tested for 
significant changes between two time periods: 0-30minutes and 120-150minutes. Statistical tests 
were performed between the two corresponding time periods to check for changes during the 
experiments. (n=3). * Significant difference (paired t-test) (p<0.05). 
 
In summary, Rm for SNS buffer was the only parameter that changed during the 
experiments (Table 2.4). Otherwise Rm, PD and Isc did not significantly change during 
the course of the measurements. Therefore, the epithelia which were mounted in the 
vertical Franz diffusion cell were considered to be bioelectrically stable during the 
course of the experiments. Hence, the 30 minute equilibration period was considered 
suitable for this system. 
2.3.4 Comparison of Olfactory and Respiratory Tissue Metabolism 
Table 2.5 summarises the Alamar Blue™ assay results for olfactory and respiratory 
epithelia; 6890±1602 and 8887±1752, respectively. Respiratory epithelium was more 
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metabolically active than olfactory epithelium (p<0.05; unpaired t-test; n=7). The 
variability was proportionally high with respect to the mean; RSD 23% and 20% for 
olfactory and respiratory epithelia, respectively. Therefore, a larger sample number is 
likely to improve the significance level. 
 
Table 2.5 Comparison of metabolic rate between olfactory and 
respiratory nasal epithelia. 
Date Olfactory  
RFU (Mean±s.d.) 
Respiratory 
RFU (Mean±s.d.) 
21/11/2006 7040±885 (n=6) 9363±2236 (n=6) 
23/11/2006 8018±2077 (n=6)  
28/11/2006 7496±1450 (n=3) 7003±924 (n=6) 
30/11/2006 8801±1174 (n=4) 11286±2675 (n=7) 
05/12/2006 6098±661 (n=3) 7524±556 (n=3) 
06/12/2006 6960±258 (n=3)  
07/12/2006  9622±2504 (n=3) 
12/12/2006 3817±462 (n=3) 6910±2748 (n=3) 
13/12/2006  10497±5226 (n=6) 
 6890±1602* (n=7) 8887±1752* (n=7) 
* Statistical difference (p<0.05; unpaired t-test; n=7) 
2.3.5 Correction Effect of Alamar Blue™ Values with DNA Content 
Alamar Blue™ values (RFU) for 10 olfactory epithelia (each from a different animal) 
were corrected for their DNA content using the Hoechst DNA quantification method. A 
scatter diagram of DNA content against Alamar Blue™ values (RFU) was plotted 
(Figure 2.18). It was expected that a strong positive relationship would exist between 
the variables since it is logical that the metabolic activity of the tissue would depend on 
total amount of the tissue. 
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Figure 2.18 Scatter diagram showing the correlation between Alamar Blue™ viability 
measurements and the corresponding DNA content values. 
 
The Spearman’s Rank correlation coefficient was calculated as -0.430. There was no 
significant correlation between core size and Alamar Blue™ viability measurements 
(p>0.05; Spearman’s Rank correlation test; n=10). 
 
In addition, the variability of Alamar Blue™ data increased when the correction with 
DNA content was calculated. On average %RSD increased from 14% before correction 
to 27% after correction. It was expected that the variability would reduce, not increase, 
after the correction for amount of tissue per sample. Consequently, correction of Alamar 
Blue™ viability by DNA content was abandoned. 
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The DNA content per epithelial sample was derived using a DNA standard curve. 
Figure 2.19 shows an example of a DNA standard curve obtained using the Hoechst 
assay. The correlation is positive and linear. Four replicate plots were constructed in this 
way and all demonstrated a Pearson correlation coefficient of 0.9794 or higher. 
Therefore, all calibration plots were acceptable for analytical practice. The mean±s.d. 
Pearson correlation coefficient for these plots was 0.9887±0.008 (n=4). For good 
practice, however, a new calibration plot was constructed each time the DNA content of 
samples was measured. 
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Figure 2.19 An example of a DNA standard curve using the Hoechst DNA quantification assay. A 
positive linear correlation was observed. The Pearson correlation coefficient for this plot was 
0.9970. Individual values represent mean±standard error of mean (n=3). 
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2.4 DISCUSSION 
The aim of this first section of investigations was to describe the method validation of 
the vertical Franz diffusion cell for its use with porcine olfactory epithelium in the 
investigation of direct N-B drug delivery of nanoparticles. Hence, it was necessary to 
prove that the experimental procedures had no effect on the tissue with respect to 
viability and cellular morphology.  
 
The following objectives were defined in order to achieve this aim: first, an excision 
protocol was established to ensure that the diffusion chamber mounted epithelium was 
indeed olfactory; second, an assessment procedure of tissue viability was developed to 
ensure that the mounted tissue was alive during the experiments; and third, the 
morphological appearance of the olfactory epithelium before and after exposure to the 
experimental conditions was assessed (in absence of nanoparticles applied to the apical 
surface). In addition, the metabolic rate of olfactory and respiratory epithelia were 
compared which may help to gain a better quantitative understanding of active 
processes in the nasal epithelia and its speculative impact on drug delivery. 
2.4.1 The Histology of the Porcine Nasal Epithelium 
The morphology of the epithelium was different in various zones of the porcine nasal 
cavity. The transitory nature of the porcine epithelium (Adams 1990) is, in fact, 
common throughout the animal kingdom; goats (Kahwa & Purton 1996), rats ( (Popp & 
Martin 1984)) bonnet monkey (Harkema et al 1987) and koalas (Kratzing 1984) and 
humans (Mygind 1979) have this feature. 
 
The specific pattern of change from one epithelium type to the next was also common. 
In the work presented here, the porcine nasal epithelium changed from keratinised 
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stratified squamous at the nasal vestibule, to cuboidal and then pseudostratified 
columnar in the caudal direction. Indeed, these specific changes in epithelium types 
were remarkably similar to the Bonnet Monkey (Harkema et al 1987) which 
demonstrated that the gross morphology of the nasal epithelia are similar between 
mammalian species. 
 
Nevertheless, a few notable differences were observed between that found here and 
previously in the literature. For example, Adams (1990) did not find the keratinised 
version of the stratified squamous epithelium in the rostral portion of the nasal cavity. 
The keratinised version was, however, found in goats (Kahwa & Purton 1996). The 
physiological function of keratinised stratified squamous epithelium is thought to 
protect the underlying cells from dehydration and mechanical insults. This would seem 
logical from the position of the epithelium at the nasal vestibule. The tissue here would 
be at most risk of damage from particulates upon inhalation and loss of water externally 
upon exhalation. 
 
The epithelium changed from stratified squamous to non-ciliated cuboidal in the caudal 
direction. The physiological function of nasal cuboidal cells remains speculative. They 
may be involved in antigen presenting, osmotic balancing and/or detoxification (Adams 
1990).  
 
The epithelium finally changes again to pseudostratified columnar epithelium which 
was 30-40µm in height (Figure 2.9). Both ciliated and non-ciliated columnar cells were 
found in the current study. Previously, however, only the non-ciliated type has been 
observed in pigs (Adams 1990). It was noted that the lamina propria underlying this 
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area (Region 5 Figure 2.2) had the highest level of vascularisation. This has been 
observed previously in the literature (MartineauDoize & Caya 1996). From a drug 
delivery perspective, Region 5 is therefore a suitable epithelium for drug transport to the 
systemic circulation. Indeed, it has since been used in this capacity within our research 
group (to be published). 
 
Moreover, Adams found that epithelial characteristics of piglets were similar regardless 
of age (1-70 days old) (Adams 1990). To my knowledge, no detailed study of porcine 
nasal mucosa has been carried out on 6 month old pigs to date. Therefore, this is the 
first description of such work and extends the same conclusion over the first six months 
of a pig’s life. 
 
Olfactory epithelium was found in Region 6 covering the caudal region of the dorsal 
turbinate (Figures 2.2, 2.10 and 2.11). It was characterised by a ciliated columnar 
epithelium (40-50µm in height). It has been suggested that the columnar cells in the 
olfactory epithelium are taller (60-80m) than the respiratory type (~25m) (Jansson 
2004). However, the distinction in epithelial cell layer height in the olfactory and 
respiratory epithelia was less pronounced in the animals used in this study. 
 
Finally, olfactory tissue is characterised for having filia olfactoria in the lamina propria 
(Figure 2.12) and olfactory knobs on the apical terminus of the olfactory axons (Figure 
2.11). These features are not present in respiratory mucosa since it does not contain 
axons. Moreover, toluidine blue was a suitable choice of monochromatic stain since it 
enabled clear distinction of filia olfactoria and olfactory knobs from other 
morphological features. 
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In general, the pattern of epithelia found in the porcine nasal cavity conformed to that 
found previously in pigs (Adams 1990; MartineauDoize & Caya 1996). Modest 
variations in morphology may have resulted from sampling of the epithelia from 
slightly different locations from within the nasal cavity compared to the literature. 
However, it would be time consuming to exhaustively characterise the nasal cavity in 
this way therefore this work was not done. 
2.4.2 Tissue Viability: The Effect of pH Buffers and Sodium Azide 
The results presented here have shown that the excised tissue could be kept alive for 
approximately 4 hours after excision. During this period the epithelia were transported 
on ice for ~1 hour and mounted on the diffusion chamber apparatus for 2½ hours. Nasal 
epithelia have previously been used in similar diffusion chamber experiments in a 
number of different species. Viability can be maintained for 8 hours in sheep (Wheatley 
et al 1988), 10 hours in rabbits (Bechgaard et al 1992), 4 hours in cattle (Bechgaard et al 
1992) and 8 hours in pigs (Wadell et al 1999). Therefore, the excised tissues used here 
were within the accepted viability timeframes. 
 
The studies described in the literature were performed at 37°C unlike in the current 
work which was carried out at 29°C. Cremaschi et al. performed their diffusion 
chamber studies at 27°C in order to improve the tissue survival time (Cremaschi et al 
1996). Hence, since the present experiments were conducted at a lower temperature, it 
was anticipated that the tissues buffered at 29°C would have a longer survival time than 
that described previously. 
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Rm, PD, Isc and Alamar Blue™ assay measurements were performed in order to 
examine the viability of the epithelia in detail. Rm provides a measure of membrane 
‘leakiness.’ Rm was measured to be 58.6±12.7cm2 for SNS and 78.8±40.2cm2 for 
citrate buffers. There is a lack of electrophysiological data available in the literature for 
olfactory mucosa; therefore, these values were compared to respiratory epithelium. 
Hence, the Rm data conformed with those found previously (Table 2.6): 75.0±28.0cm2 
(porcine respiratory epithelium, 37°C (Osth et al 2002a) ), ~40cm2 (rabbit respiratory 
epithelium, 37°C (Kubo et al 1994) ), and ~70cm2 (rabbit respiratory epithelium, 37°C 
(Bechgaard et al 1992) ). Moreover, the temperature maintained during the experiment 
does not appear to affect Rm, 52.1±5.6cm2 (27°C, rabbit respiratory epithelium 
(Cremaschi et al 1991) ). 
 
Table 2.6 Literature values (mean±s.d.) for electrophysiological parameters of nasal tissues that 
were mounted to diffusion cells for different animal species and at different temperatures.  
Reference Rm (.cm2) PD (mV) Isc(µA/cm2) Comment 
 (Osth et al 
2002a) 
75.0±28.0 -4.5±3.4 
 
58.6±28.8 37°C, porcine respiratory 
epithelium 
 (Cremaschi et 
al 1991) 
52.1±5.6 -3.4±0.5a 
 
65.0±6.7 27°C, rabbit respiratory 
epithelium 
 (Kubo et al 
1994) 
~40 ~-5 a 
 
100-120 37°C, rabbit respiratory 
epithelium 
 (Bechgaard et 
al 1992) 
~70 -6.4±1.5 a 
 
92±13 37°C, rabbit respiratory 
epithelium 
a
 Quoted as positive values in literature because positive electrode was placed on the serosal side of 
the epithelium. 
 
Nasal epithelia are regarded as a ‘leaky,’ i.e. have a lower permeability than other 
biomembranes and therefore is regarded as a potential drug delivery membrane (Lehr 
2002). For example, the permeation of a paracellularly transported molecule THA (9-
amino-1,2,3,4-tetrahydroacridine) was compared across different mucosae of the 
domestic pig. The study showed that nasal epithelium had a significantly enhanced 
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THA permeation rate (p<0.05) compared to all other biomembranes tested (sublingual, 
buccal, rectal, duodenum, jejunum and ileum) (Gore et al 1998). 
 
PD, Isc and Alamar Blue™ data showed that tissue viability was statistically lowered 
when 0.5mM citrate buffered (pH6.0) olfactory epithelium samples were compared to 
SNS buffered samples (Table 2.3 and Figure 2.15). Pujara et al. studied the effects of 
buffer types on protein release from the nasal mucosa of rat intranasal perfusion studies 
using a LDH assay (Pujara et al 1995). According to these authors protein release is 
positively associated with cellular damage and therefore is indicative of tight junction 
integrity. Phosphate and adipic acid buffers (70mM) at pH 4.75 were found to 
contribute least to protein release and were not significantly different to saline perfusion 
levels (negative control). Acetate buffer (70mM) was the most damaging which (in the 
authors’ opinion) probably was due to phospholipid partitioning ability of the unionised 
(acetic acid) entity. Further, there was no apparent tissue damage resulting from 30 
minute nasal perfusion with citrate or phosphate buffers. The authors suggested that 
there was ‘an intrinsic factor unique to [each] buffer species which was responsible for 
any [minimal] damage to the nasal mucosa.’  
 
Pujara et al. (1995) also found damage to nasal epithelium from acetate buffer in the 
concentration range 70mM to 210mM. This damage was proportional to the 
concentration of acetate ions. The unionised acetic acid molecules were thought to 
interfere with the phospholipid membrane function. But no such trend or mechanism 
was detailed for citrate or phosphate buffers (Pujara et al 1995). Moreover, the 
concentrations of buffering ions used in this experiment were much higher than those 
used in the present work (SNS buffer 1.5 mM NaH2PO4, 0.83 mM NaHPO4 and 15 mM 
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NaHCO3; 0.5mM citrate buffer). Therefore, buffer concentrations used here were 
thought to have negligible effect on tight junction integrity. 
 
The similarity between Rm values for citrate (pH6.0) and SNS (phosphate-based; pH7.4) 
buffers suggested that extent of tissue damage was not correlated with pH. In support of 
this, Maitani et al. (1997) found that levels of tissue damage (expressed in terms of 
protein release) were the same between saline solutions adjusted to pH5.2 or pH7.4 after 
placing rabbit nasal tissue into a diffusion chamber apparatus. This concurred with 
results by Pujara et al. (1995) who found no differences in tissue damage over the pH 
range 3-10. 
 
In contrast, Maitani et al. (1997) in the same study found that reducing pH from 7.4 to 
5.2 significantly increased (p<0.05 Student’s t-test) movement of Lucifer Yellow (a 
hydrophilic paracellular marker) across the nasal epithelium of male Japanese White 
rabbits. The authors did not give an explanation for this. Thus, phosphate buffer (SNS 
pH7.4) may preserve tight junction integrity better than citrate buffered (pH6.0) samples 
but no such statistical differences were observed in this investigation (Table 2.3). This 
could have been due to high data variability or low sample numbers. 
 
There were differences, however, in the morphology of the samples after 150 minute 
exposure in the diffusion chambers (Figure 2.16 and Figure 2.17). The morphology of 
the cells from the citrate buffered olfactory samples was worse than that of SNS 
samples. This indicated that either the viability or the integrity of the olfactory 
epithelium was affected by the citrate buffer. 
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In support of this, significant differences were found between PD and Isc for these two 
buffering systems (p<0.05, ANOVA, Table 2.3). When these data were compared with 
the data obtained for Alamar Blue™ enzymatic assay for viability it was found that 
samples exposed to SNS buffer were more metabolically active than those exposed to 
citrate buffer. This was evident both with and without the use of the diffusion chamber 
apparatus (p<0.01, ANOVA, Figure 2.15). Therefore, although no tissue damage was 
observed by a reduction in Rm, a reduction in metabolic activity (PD, Isc and Alamar 
Blue™ values) was observed. 
 
With regards to tissue viability it can be concluded, through PD, Isc and Alamar Blue™ 
data, that metabolism was reduced by citrate (pH6.0) compared to SNS (pH7.4) buffer. 
Indeed, the cellular morphology of the SNS buffered samples (compared to citrate 
buffered ones) was more akin to the freshly excised olfactory epithelium (Figure 2.11, 
Figure 2.16 and Figure 2.17) which supports this conclusion. As discussed, this effect 
was unlikely to be a consequence of the different species of buffering ions, the 
concentration of buffering ions, or mechanical damage to the mucosa. Therefore, pH 
remained as the likely cause for this observation.  
 
The possibility that pH reduction from pH7.4 to pH6.0 may have affected nasal tissue 
viability is also implied in the literature. For example, baseline pH levels of nasal 
mucosa in eight human volunteers (four with allergic rhinitis) have been found to be 
7.04-7.70 (physiologically neutral) (Shusterman & Avila 2003). After an application of 
carbon dioxide the mucous pH transiently reduced before rising again to baseline levels. 
This would suggest that pH 7.04-7.70 is a preferable environment for the epithelial cells 
underlying the mucous layer compared to a lower pH environment. The homeostatic 
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mechanism for this was thought to involve bicarbonate ions and carbonic anhydrase 
enzyme similar to that found in the gastric mucosa (Allen & Flemstrom 2005). 
 
The exact pH environment of the nasal mucus, however, is controversial since there is 
some evidence to suggest that it is lower. Washington et al. (2000) placed a pH 
electrode (composition of electrode unspecified) 3cm posteriorly from the nasal 
vestibule on the floor of the nasal cavity. They found that the mean pH was 6.27 
(+0.13/-0.18) (n=12) (the standard deviation was not evenly spread due to conversion of 
[H+] to pH). The pH range, however, of these values varied considerably (5.20-8.00).  
 
Similarly, McShane et al. (2003) used monocrystalline antimony catheter pH electrodes 
to measure the pH of the nasal floor 4-5cm from the nasal vestibule. Healthy volunteers 
had a pH 6.7±0.13 (n=6). Overall, there is considerable inter-study variation between 
pH measurements of nasal mucosa amongst healthy human subjects. 
 
Cystic fibrosis patients, who have characteristically thicker mucus due to a reduced sol 
layer and therefore poor mucociliary clearance, had an even lower nasal pH (6.2±0.1; 
n=6) (McShane et al 2003). However, the pH difference between healthy and cystic 
fibrosis patients was not observed with gold combined pH-glass electrodes. It was not 
understood why the composition of the electrodes produced different results. 
 
In contrast, nasal mucosal pH of patients with rhinitis was 7.2-8.3 (Fabricant 1941). 
Rhinitis is characterised by an over production of serous secretions from the epithelial 
cells that form the mucosal sol layer. 
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The observations of over- and under-production of sol layer in pathological states 
suggests that a pH gradient exists between nasal gel layer (pH5.5-6.5) and sol layer 
(pH7.4) i.e. pH measurements were low (pH 6.2±0.1) when sol layer was 
underproduced (cystic fibrosis) and pH was high (pH 7.2-8.3) when sol layer was 
overproduced (rhinitis). 
 
If a mucosal pH gradient did exist then the single pH measurements described above 
would be unrepresentative of the pH conditions at the epithelial cell surface. The pH 
electrode tips used in these studies (~3mm diameter) were larger than the thickness of 
the whole mucous layer (~9µm, gel layer and sol layer combined). This could explain 
the differences in nasal pH measurements that were found between the studies described 
above. 
 
Indeed, pH gradients have been observed previously in the rat gastric mucosa model in 
vivo (Phillipson et al 2002). In this study, male Sprague-Dawley rat gastric mucosae 
were exposed to 1.2cm2 in a mucosal chamber. The pH of the sol layer (described as 
‘adherent mucus’ by the authors) at the epithelial surface was measured using fine 
microelectrodes (tip diameter 1-3µm). The mucosal surface was exposed to 0.9% NaCl 
which was maintained at 37°C. After 10 minutes the 0.9% NaCl was replaced with acid 
(HCl, pH 1). The pH of the sol layer was measured as 7.03±0.09 whilst acid secretion 
was stimulated with i.v. pentagastrin (40µg.kg-1h-1). Pentagastrin is a pentapeptide drug 
that stimulates parietal cells in the stomach mucosa to secrete HCl into the gastric 
lumen. This experiment was repeated after removal of the gel layer (described in the 
report as ‘loosely adherent mucus’). Removal of the gel layer did not to statistically 
reduce the pH in the sol layer (6.82±0.19). It was therefore concluded that the gel layer 
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was not important for the maintenance of the pH gradient. In addition, the experiment 
was also repeated with removal of gel layer and luminal exposure to 0.5mM DIDS (4,4'-
diisothiocyano-stilbene-2,2'-disulphonate), a pharmacological inhibitor of apical Cl-
/HCO3- ion channels. In these conditions, sol layer pH was reduced to 1.37±0.21; 
therefore, it was concluded that a bicarbonate buffering mechanism was required for 
maintenance of physiologically neutral sol layer pH. 
 
In a different study, the same gastric mucosa model showed that rats given i.v. HCO3- 
(5mmol.kg-1.h-1) produced a higher epithelial cell surface pH (pH ~5) compared to 
control rats (no HCO3- given, pH ~1.6) (Synnerstad et al 2001). This provided more 
evidence that HCO3- from the blood is involved in maintenance of the mucosal layer pH 
gradient. (For further reading, the nature of the gastric mucosal pH gradient can be 
found in greater detail elsewhere (Allen & Flemstrom 2005) ). 
 
In the current work, viability of excised nasal tissue was higher at pH7.4 than at pH6.0. 
Olfactory epithelia exposed to 0.5mM pH6.0 citrate buffer, which contained no HCO3- 
ions, showed reduced PD, Isc and Alamar Blue™ viability scores. Therefore, it could be 
interpreted from this data that the nasal epithelial cells may not have been able to 
maintain pH7.4 in the sol layer.  
  
Gastric mucosa acidity (~pH1) in the lumen is produced by the release of HCl from the 
parietal cells. In the nasal cavity the pH gradient is more likely to be derived from 
solubilisation of expired carbon dioxide in the nasal mucus. Carbonic acid is weaker 
than HCl therefore it is expected that a shallower pH gradient exists in the nasal cavity. 
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The effect of metabolic blocker, sodium azide, on the viability of olfactory epithelia was 
also assessed in these investigations. Sodium azide statistically reduced viability for the 
SNS buffered olfactory epithelium as measured by Rm, PD and Alamar Blue™ (but not 
Isc) scores (Rm and PD p<0.05, ANOVA, Table 2.3; Alamar Blue™ p<0.01, ANOVA, 
Figure 2.15). However, similar statistical changes were not observed for citrate buffered 
samples (p>0.05, ANOVA). A reduction in metabolism, as observed by these methods, 
was expected since sodium azide is a broad metabolic inhibitor that affects electron 
transport chain production of ATP. The lack of significance for Isc values was probably 
due to variability of data. Citrate buffered olfactory epithelium that had been mounted 
onto the diffusion chamber was not effected by sodium azide. It was suggested that the 
reduction in pH from 7.4 to 6.0 between the different buffering systems caused an 
overall reduction in cellular viability in the olfactory epithelium; thus, addition of 
metabolic blocker did not cause significant changes to the viability of the tissue. 
 
However, it could not be concluded that the olfactory epithelium was killed by the 
citrate buffer. Citrate pH6.0 buffered unmounted samples had statistically higher 
Alamar Blue™ viability scores than citrate-buffered azide-exposed olfactory epithelium 
after dismounting from the diffusion cell apparatus (p<0.05, ANOVA, Figure 2.15). 
 
2.4.3 The Bioelectrical Equilibration Period for Porcine Olfactory Epithelium 
There were no statistical changes in PD or Isc values over a 150 minute period in either 
SNS or citrate buffer (Table 2.4). In addition, Rm values remained constant for citrate 
buffered olfactory epithelia. This would suggest that equilibration occurred within 30 
minutes. Tissues were dismounted from the diffusion chamber apparatus within 4 hours 
of slaughter. Longer validation of tissue survival time was not practical due to the total 
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time taken per experiment. For these reasons an equilibration period of 30 minutes was 
chosen. 
 
Rm values increased with statistical significance for SNS buffered samples between 0-30 
minutes and 120-150 minutes (p<0.05 paired t-test). This would suggest, in fact, that 
more time was required for equilibration since Rm values had not settled to reach a 
steady state. However, no other parameter required more time to a steady state (Table 
2.4). Thus in conclusion, a 30 minute equilibration period was deemed sufficient for the 
diffusion chamber experiments.  
 
Alternatively, it could be considered that the samples might not have equilibrated within 
the 150 minutes of this experiment and that significant differences could have been 
found if longer time periods were allowed. This, however, is unlikely since equilibration 
periods of greater than 120 minutes have not been necessary previously (either at 37°C 
or 27°C [Table 2.7]). 
 
Indeed, a range of equilibration periods between 30-120 minutes and temperature 
conditions have been used in the past (Table 2.7). A 30 minute equilibration period has 
been used for porcine, bovine and rabbit nasal epithelia experiments at both 27°C and 
37°C and for respiratory or olfactory epithelia (Cremaschi et al 1996; Schmidt et al 
2000; Wadell et al 2003; Kandimalla & Donovan 2005b, a). 
 
 So, although equilibration periods up to 120 minutes have been used previously 
(Bechgaard et al 1992; Kubo et al 1994; Maitani et al 1997; Osth et al 2002a; Osth et al 
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2002b; Jansson 2004), these longer periods did not seem to be necessary and were 
impractical to undertake for the current work.  
 
Table 2.7 Equilibrium periods and experimental temperatures for diffusion chamber studies with 
various nasal epithelia.  
Equilibration Period 
(minutes) 
Experimental Conditions Reference 
 
30 Bovine respiratory 
epitheliuma (37°C) 
 (Schmidt et al 2000) a  
30 Bovine olfactory 
epitheliuma (37°C) 
 (Kandimalla & Donovan 
2005b) a 
30 Porcine respiratory 
epithelium (37°C) 
 (Wadell et al 2003) 
30 Rabbit respiratory 
epithelium (27°C) 
 (Cremaschi et al 1996) 
30-60 Bovine and porcine 
olfactory mucosa (37°C) 
 (Jansson 2004) 
60 Porcine respiratory 
epithelium (37°C) 
 (Osth 2002; Osth et al 
2002a; Osth et al 2002b) 
60 Rabbit respiratory 
epithelium (37°C) 
 (Bechgaard et al 1992; 
Maitani et al 1997) 
120 Rabbit respiratory nasal 
mucosa (37°C) 
 (Kubo et al 1994) 
a
 Electrophysiological data unavailable. 
 
2.4.4 Comparison of Olfactory and Respiratory Tissue Metabolism 
Tissue viability data was examined in terms of Rm, PD, Isc and Alamar Blue™ for 
porcine olfactory epithelium. In addition the Alamar Blue™ measurements were 
performed on freshly excised respiratory epithelia which were dissected from Region 5 
of the pig nasal cavity (Figure 2.2). 
 
Rm and PD values for porcine olfactory epithelia in SNS buffer (29°C) are reported here 
as 58.6±12.7cm2 and -0.8±0.2mV. Previously, Jansson (2004) had found similar 
figures for porcine olfactory epithelium in the same buffer at 37°C (45±9cm2 and  
-1±0.5mV [values approximated from graphical data]. This is the only example of 
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electrophysiological data for olfactory epithelium in the literature known to date. In 
addition, it is possible to speculate that the temperature difference did not have a 
considerable effect on the values. Nevertheless, passive and active transport of ions 
would presumably increase with temperature. Therefore, an explanation for the 
indifferent affect of temperature on the electrophysiology of the nasal epithelial tissues 
remains unclear. But this insensitivity of temperature on Rm has also been noted within 
the literature (Table 2.6). 
 
The PD (-0.8±0.2mV [SNS], -0.1±0.1mV [citrate buffer]) and Isc (-13.3±1.5µA/cm2 
[SNS], 1.0±0.2µA/cm2 [citrate buffer]) values, however, are low compared to those for 
nasal respiratory epithelia from various species (Table 2.6). Rabbits had a PD of ~-5mV 
(Kubo et al 1994) and -6.4±1.5mV (Bechgaard et al 1992) at 37°C. The value decreased 
to -3.4±0.5mV when the temperature was reduced to 27°C (Cremaschi et al 1991). PD 
for porcine epithelia at 37°C agreed with the rabbit species but were more variable,  
-4.5±3.4mV (Osth et al 2002a). Also, in general, lower PD values corresponded with 
higher Isc measurements (Table 2.6). 
 
Hence, Rm (which measures passive transport of ions across the epithelium) agrees with 
previous data but PD and Isc (which both measure active transport of ions across the 
epithelium) were lower. This would imply that the olfactory epithelium used in these 
studies were less metabolically active than the respiratory nasal tissues (Table 2.6). This 
can be explained by understanding the electrophysiological method used. 
 
An innate resting membrane potential (PD) is generated by the active transport of ions 
across the epithelium. The magnitude of PD depends on a combination of two factors; 
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(a) the rate of ion-transport across the epithelium and (b) the ‘leakiness’ of the 
epithelium. As rate of ion transport across the epithelium increases then the PD will also 
increase since, by definition, the imbalance of ions across the epithelium generates the 
PD. If the epithelium is very ‘leaky’ then the imbalanced ions are able to passively 
transport back down the electrochemical gradient that is formed. This is essentially a 
naturally occurring short-circuit which has the effect of nullifying the PD. Therefore, 
PD is theoretically a function of tight junction integrity (Rm) and transport rate of ions 
across the epithelium (Lehr 2002). 
 
Thus, the ‘leaky’ nature of the nasal epithelia and/or their inability to overcome the 
resultant short-circuit may have lead to the low observed PD and Isc values. Since 
olfactory and respiratory Rm values are similar, then ‘leakiness’ of these epithelia are 
also likely to be the same. Therefore, the metabolic rate is likely to be different between 
these epithelia. 
 
(Isc is described as the externally applied current needed to extinguish the PD. Hence, 
PD and Isc are physiologically linked and so the previous discussion may be extended to 
Isc as well as the given example for PD). 
 
The difference between viability scores of olfactory and respiratory epithelia was 
confirmed by assessment of the tissue viability by Alamar Blue™ assay (Table 2.5). 
Hence, olfactory and respiratory epithelia cores were extracted from pigs and assayed 
by Alamar Blue™, as described in 2.2.6 Comparison of Olfactory and Respiratory 
Tissue Metabolism. The metabolic activity of the respiratory epithelium (8887±1752 
RFU) was significantly higher than that for olfactory epithelium (6890±1602 RFU) 
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(p<0.05, unpaired t-test, n=7). It was not likely that the differences for the Alamar 
Blue™ were a result of differences between thickness of the respiratory and olfactory 
epithelia in these samples (2.4.5 Hoechst Assay). Therefore, this result strongly supports 
the conclusions obtained from the differences in electrophysiological parameters. 
 
The reason for the difference in metabolic rate between the respiratory and olfactory 
epithelium were not investigated in this study. However, physiologically specialised 
functions of the respiratory epithelium, such as antigen sampling or generating ciliary 
motion, could explain the observed difference. 
 
The difference between the metabolic activity of the olfactory and respiratory epithelia 
found in the nasal cavity of pigs is an important finding that may have wider 
implications regarding the treatment of exogenous materials (e.g. nanoparticles and drug 
molecules) by nasal epithelia. For example, it could mean that greater active transport of 
nanoparticles occurs into the respiratory epithelium compared to olfactory epithelium; 
this would increase the transport of nanoparticles across the respiratory epithelium 
compared to olfactory tissue. Alternatively, it could mean that drug molecules (or 
biodegradable nanoparticles) may be actively degraded at a slower rate at the olfactory 
epithelium and therefore this may have the potential to increase drug transport across 
this epithelium compared to respiratory tissue. The relationship between nasal epithelia 
and exogenously applied materials may also vary depending on the properties of the 
exogenous material. However, this relationship between drug transport and metabolic 
activity of the epithelium remains speculative and requires further investigation. 
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2.4.5 Hoechst Assay 
When correcting the Alamar Blue™ data for amount of tissue per sample, it was 
expected that the variability would reduce since the metabolic activity of each cell in the 
epithelium was assumed to be equivalent (2.3.5 Correction Effect of Alamar Blue™ 
Values with DNA Content); however, variability was found to increase. 
 
The reasons for this are unclear but it may be that a subset of cells (most probably 
located near the apical surface) was the most metabolically active in the epithelium and 
therefore contributed heavily to the Alamar Blue™ measurements. These cells may, for 
example, be responsible for the production of mucus or active movement of substances 
into or out of the luminal space. Thus, the overall metabolic activity of the epithelium 
may actually be determined by the activity of these cells and not the thickness of the 
membrane. This hypothesis is strengthened by the finding that there are proportionally 
more mitochondria located at the apical surface than elsewhere in the epithelium (Figure 
2.13). This mitochondrial zone has also been reported elsewhere (Matulionis & Parks 
1973). Consequently, correction of Alamar Blue™ viability by DNA content was 
abandoned. 
2.4.6 Assessment Methods for Epithelial Viability / Metabolic Rate 
The bioelectrical characterisation of membranes as described in this chapter is the best 
known (and probably only) example of a real time method to assess cellular activity in 
epithelia. Nevertheless, limitations of the method have been noted previously. For 
example, it can only measure one aspect of cellular metabolism – transport of ions 
across the epithelium. Measurement of this data is inherently variable, particularly, 
when the epithelia under investigation are ‘leaky’. Nasal epithelia are more ‘leaky’ than 
many other epithelia (2.4.2 Tissue Viability: The Effect of pH Buffers and Sodium 
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Azide); thus confidence levels of no more than 95% were achieved in this work for 
evaluating statisitcal differences for these measurements. 
 
Furthermore, it is possible that subjecting the delicate biological membranes to 
unnatural electrical currents (during closed circuit conditions) may affect its condition 
(Cremaschi et al 1991). Cremaschi used open circuit conditions (no applied current) at 
27±1°C to establish tissue viability in rabbits. The effect of externally applied currents, 
however, is likely to be negligible due to the short duration and small currents applied 
to the membranes with this procedure. 
 
Nevertheless, alternative methods have been used previously to monitor viability. These 
tests, like Alamar Blue™, use enzymatic activity as a marker for cell 
viability/cytotoxicity. For example, Trypan Blue has been widely used to detect 
damaged or dead cells. The dye is taken up by non-viable cells but excluded by live 
ones. The method is particularly important for cells suspensions where the proportion of 
viable cells can quickly and easily be counted within the population by light 
microscopy. It is, however, less practical to use with intact epithelia and there are 
concerns with its accuracy and ability to penetrate the epithelium (Jones & Senft 1985). 
 
Further, a double staining method using calcein AM ester (an acetoxymethyl ester of 
calcein) and ethidium homodimer has been utilised for viability assessment of (bovine 
olfactory) epithelium (Schmidt et al 2000; Kandimalla & Donovan 2005b, a). The first 
dye is a non-fluorescent precursor that is quickly metabolised by viable cells to green 
fluorescent calcein by esterase enzymes. The second dye enters non-viable cells and 
binds with DNA to form a red fluorescent signal. The signals can be observed by 
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fluorescent microscopes. This bimodal system is thought to be more accurate than 
Trypan Blue and viability can be assessed up to one week after original sample 
preparation. But, like Trypan Blue, it may be difficult to accurately quantify viability 
for intact epithelia due to the presence of mucus and other extracellular components of 
the tissue.  
 
The conversion of a soluble yellow tetrazolium salt (MTT) to the insoluble blue form 
MTT formazan by viable cells containing succinic dehydrogenase uses a similar 
principle. It has also been widely used for cell cultures and monolayers. It can be 
adapted for membrane layers (Imamura et al 1994). The process, however, has the 
added step of dissolving the insoluble MTT formazan in dimethyl sulfoxide which can 
increase data variability. 
 
Alternatively, lactate dehydrogenase (LDH) assay is a similar assay that is based on the 
reduction of a different tetrazolium salt (INT). INT is converted in an enzymatic 
reaction to formazan. This time formazan is a water-soluble product and exhibits an 
absorption maximum at 492 nm. Higher UV absorption relates to more LDH activity 
which is symptomatic of tissue damage or cell death. 
 
Both MTT and LDH assay, however, can only measure cell toxicity; hence, differences 
between viability of different epithelia can not be assessed. Therefore, the inherent 
differences in overall metabolic activity, which were observed for respiratory and 
olfactory tissues in the work presented here, may not be observed by MTT and LDH 
assays.  
 
 131 
In contrast to the above methods, Alamar Blue™ was quick, simple and easily 
quantifiable since both reagent and product were water soluble. Data variability was low 
compared to electrophysiological methods and statistical confidence levels of above 
99% are reported here. Also, viability differences between olfactory and respiratory 
were observed, a conclusion that could not be possible by biochemical cytotoxicity 
assays as explained previously. 
 
A combination of the electrophysiological method and Alamar Blue™ has the 
advantage of providing an overall description of viability that each individually can not. 
Hence, the assessment of viability by Alamar Blue™, particularly in combination with 
electrophysiological methods (which has not previously been described in the relevant 
literature to date) could prove to be a powerful method to assess the viability of excised 
epithelia. 
2.4.7 Viability Acceptance Criteria for Porcine Olfactory Epithelium  
Data variability for diffusion chamber studies could be due to species/population 
differences, specific site of excision, thickness of the isolated mucosa, and/or buffer 
conditions (temperature, pH, oxygenation and composition). These variables need to be 
controlled in order to identify any differences between samples. Some factors are more 
important than others, since for example, it has been shown in this study that pH (2.3.2 
Effect of Different Buffers and Sodium Azide on Olfactory Epithelium) significantly 
affected tissue viability whereas the thickness of the isolated epithelium had little effect 
(2.3.5 Correction Effect of Alamar Blue™ Values with DNA Content). 
 
Therefore, different acceptance criteria need to be assessed for each system used. 
Hence, the Rm, PD, Isc and Alamar Blue™ data that are presented in this chapter will be 
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used to statistically compare the viability of epithelia used for nanoparticle transport 
studies in Chapter 4. 
2.5 CONCLUSIONS 
A protocol for the extraction of porcine nasal epithelia was developed and the location 
of olfactory epithelium was confirmed. The olfactory region was found at the caudal 
portion of the porcine nasal cavity (Figure 2.2). A circular piece (~2cm2) of olfactory 
epithelium, which was large enough for the diffusion chamber experiments, was 
extracted from the epithelium lining the dorsal nasal turbinate. 
 
In terms of tissue viability, Alamar Blue™ viability showed that the diffusion chamber 
experiment did not have a statistical affect (p>0.05, ANOVA, Figure 2.15) on the 
metabolic activity of the olfactory tissue when compared to samples that had not been 
mounted on the apparatus. Furthermore, the histological examination of the SNS 
buffered olfactory epithelia showed that the tissues did not change considerably when 
they were dismounted from the diffusion cells compared to unmounted samples. 
 
Also, it was found that the nature of the buffering system had significant effects on the 
viability of the porcine olfactory epithelium. PD (p<0.05, ANOVA, Table 2.3), Isc 
(p<0.05, ANOVA, Table 2.3) and Alamar Blue™ (p<0.01, ANOVA, Figure 2.15) 
viabilities were significantly greater for diffusion cell mounted epithelia buffered in 
SNS compared to those buffered in 0.5 mM citrate buffer (pH6.0). After comparison 
with the literature it was concluded that pH was the major contributing factor in this 
respect. 
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Further, a metabolic blocker, sodium azide, statistically reduced viability for the SNS 
buffered olfactory epithelium as measured by Rm, PD and Alamar Blue™ (but not Isc) 
scores (Rm and PD p<0.05, ANOVA, Table 2.3; Alamar Blue™ p<0.01, ANOVA, 
Figure 2.15). However, similar statistical changes were not observed for citrate buffered 
samples (p>0.05, ANOVA). It was interpreted from this, and observations of a slight 
morphological deterioration to the citrate buffered olfactory tissues (Figure 2.17), that 
the citrate buffer may have completely reduced the viability of the olfactory epithelium. 
However, sodium azide did statistically reduce the Alamar Blue™ viability score of 
citrate buffered olfactory epithelium compared to (azide-free) unmounted tissues 
(Figure 2.15). Therefore, the citrate buffered samples were presumed to have 
statistically reduced the viability of the olfactory epithelium but not to have killed it 
completely. 
 
A novel methodology was developed to find a suitable bioelectrical equilibration period 
for the porcine olfactory epithelium. A 30 minute equilibration period was acceptable 
for both SNS and citrate buffers since, except in one instance, statistical changes were 
not observed between the initial and final Rm, PD and Isc measurements (p<0.05, paired 
Student’s t-test). A 30 minute equilibration was in agreement with previous studies of 
nasal respiratory epithelium. 
 
Alamar Blue™ viability for olfactory epithelium was statistically reduced compared to 
respiratory epithelium (p<0.05, unpaired Student’s t-test, Table 2.5). This was 
confirmed by a comparison of the electrophysiological data for olfactory epithelium 
obtained here with that for respiratory data found in the literature (2.4.4 Comparison of 
Olfactory and Respiratory Tissue Metabolism). It was hypothesised that a greater 
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metabolic rate was required by the respiratory epithelium in order to maintain 
specialised functions such as ciliary beating for mucociliary clearance. From a direct  
N-B drug delivery perspective this may be either beneficial (by allowing slower drug 
degradation in the olfactory mucosa or slower efflux of drug from apical cells) or 
detrimental (by allowing slower uptake of drug into the olfactory epithelial cells); 
however, this has yet to be substantiated experimentally. 
 
Adjustment of the Alamar Blue™ viability scores for the thickness of the epithelium 
was found to be ineffective at reducing data variability (Figure 2.18). It was thought that 
this was due to a greater metabolic activity in the apical region of the membrane. This 
hypothesis was strengthened by the observation that a greater proportion of 
mitochondria were present at the luminal surface of the olfactory epithelial cells (Figure 
2.13).  
 
In summary, the aims of this chapter were achieved sufficiently to allow both SNS 
(pH7.4) and 0.5mM citrate (pH6.0) buffered olfactory epithelia, which were dissected 
from a particular location of the porcine nasal epithelium, to be used to evaluate the 
transmucosal transport of nanoparticles in the vertical Franz diffusion cell (Chapter 4). 
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3. DEVELOPMENT OF SURFACE MODIFIED NANOPARTICLES 
3.1 INTRODUCTION 
The vertical Franz diffusion cell and mouse in vivo models (Chapter 4) were used to 
evaluate the permeation of nanoparticles across the olfactory epithelium. Polystyrene 
(PS) nanoparticles were surface modified with different materials. Therefore, changes in 
nanoparticle transport patterns across the epithelium could be directly attributable to 
different surface characteristics. 
 
A naturally occurring polysaccharide (chitosan) and a non-ionic surfactant (polysorbate 
80) were chosen for surface coating (Chapter 1). The aim of this Chapter is to explain 
the formulation development of 20nm, 100nm and 200nm diameter chitosan-coated  
(C-PS) and polysorbate 80-coated polystyrene (P80-PS) nanoparticles. Serum proteins 
from Foetal Calf Serum (FCS), which may interact with the olfactory epithelium to 
induce receptor-mediated uptake (Chapter 1), were also adsorbed onto the P80-PS 
formulations (P80-FCS-PS). The development methods of these colloidal systems are 
described here. 
 
The aim of this Chapter was met by: (i) changing the aqueous phase ionic strength and 
pH conditions to investigate the experimental conditions that were required to increase 
the adsorption of chitosan onto PS nanoparticles; (ii) determining the minimum 
concentration of bulk phase polysorbate 80 required to enable maximum adsorption of 
polysorbate 80 to the PS surface; and (iii) determining the existence of FCS serum 
protein adsorption to P80-PS nanoparticle. 
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3.2 MATERIALS AND METHODS 
3.2.1  Materials 
Carboxylate-modified polystyrene nanoparticles (FluoSpheres™) were purchased from 
Molecular Probes (Paisley, UK) with nominal sizes of 20nm, 100nm and 200nm. 
Tween™ 80 (polysorbate 80) was purchased from Sigma (Gillingham, UK). FCS was 
purchased from Sigma Aldrich (Ayrshire, UK). Chitosan (143kDa, 89% DA) was 
kindly donated by Bioneer (Hørsholm, Denmark). All other reagents were obtained as 
detailed in Chapter 2. 
3.2.2 FluoSpheres™ 
FluoSpheres™ are carboxylate-modified polystyrene (PS) nanoparticles with a narrow 
particle size distribution. They contained a fluorescent dye that is not readily released 
from the particles. 
 
The narrow particle size distribution enabled tight control of particle numbers applied to 
the tissue. Also, the effect of nanoparticle size on transport through the epithelium could 
be examined by using different sized nanoparticles. The incorporated fluorescent dye 
allowed quantification of particle transport across the olfactory membrane using 
spectroflurometry as well as visualisation of particles in cross-sections of the olfactory 
membrane using fluorescence based microscopy techniques (Chapter 4). The images 
could then be used to qualitatively assess the appearance of nanoparticles within the 
membrane. 
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3.2.3 Nanoparticle Physicochemical Characterisation 
Nanoparticle suspensions were characterised for nanoparticle diameter and zeta 
potential (ζ potential). Below is a brief introduction of the techniques and how the 
measurements were taken. It is beyond the scope of this work to give a detailed account 
of the methods. However, the reader is directed elsewhere for such discussions: 
Washington (Washington 1992) for particle sizing and Hunter (Hunter 1981) for ζ 
potential measurements. 
 
3.2.3.1 Particle size distribution 
The Dynamic Light Scattering (DLS) (Model 802, Viscotek, Worcestershire, UK) 
instrument was used to determine particle diameter. DLS measures the scattering pattern 
of polarised (laser) light and processes this through an algorithm based on the Rayleigh 
Theory. Such calculations were performed by the OMNISize 2.0 Software (Viscotek, 
Worcestershire, UK). 
 
The DLS reports particle size as moment-mean mass diameter which is given in this 
work. It is equal to the diameter of the sphere that has same mass as a given particle. It 
is an appropriate measure of particle diameter since the bare particles are already 
spherical and entirely made of polystyrene. For the coated systems, the mathematical 
algorithm assumes that there is negligible coating material on the particles in 
comparison to the mass of the particles themselves i.e. it assumes that nanoparticle are 
entirely composed of PS. This assumption is acceptable, particularly, with the larger 
particle systems where the relative proportion of PS compared to adsorbent is greater. 
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Particles size measurements were performed in the appropriate formulation buffer at 
25°C with the laser strength set to 2.5/10. The sample concentration was adjusted with 
the appropriate buffer so that instrument detected ~300kCounts/sec. According to the 
instrument manufacturer, this represented the optimum quantity of light scatter required 
for accurate measurements. An average of thirty (3 second) measurements was made for 
each sample. Particle diameter is reported as the mean±polydispersity index (PdI).  
2
2
DZ
PdI σ=  
Where: 
σ = standard deviation of particles 
ZD = mean particle diameter  
Samples with PdI<0.04 are termed monomodal. 
3.2.3.2 Measurement of ζ potential 
ζ potential readings were measured using (ZetaSizer 2000, Malvern, Malvern, UK) at 
25°C. The sample concentration was adjusted with the appropriate formulation buffer so 
that instrument detected ~300kCounts/sec. According to the instrument manufacturer, 
this represented the optimum quantity of light scatter required for accurate 
measurements. An average of five measurements was made for each sample. ζ potential 
is reported as the mean±standard deviation of these measurements. 
3.2.4 Preparation of Chitosan-coated Nanoparticles 
3.2.4.1 Varying pH conditions for adsorption (100nm C-PS) 
Chitosan was adsorbed on the 100nm PS nanoparticles at pH 3.0, 4.0 and 5.0. First, 4mg 
chitosan was dissolved in 5.0ml 0.5M HCl. Then, the pH was adjusted as required with 
(2M and 0.1M) NaOH. The 0.5mg/ml solution was finally made up to 8.0ml with water. 
This did not affect the overall pH of the solution. 100nm PS were diluted from stock 
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suspension to 0.04% w/v and pH adjusted as required. 3.5ml of the particle suspension 
was pipetted into 3.5ml chitosan solution. The mixture was then slowly stirred 
overnight in the dark. Preparation of chitosan-free control samples followed the same 
procedure but without chitosan. 
 
Excess chitosan was not removed from the bulk solution since it is required for the 
stability of the particle suspension as explained elsewhere (3.4.1.2 Effect of Excess 
Chitosan in Suspension). 
3.2.4.2 Evaluating the Effect of Adjusting Aqueous Phase Ionic Strength 
A number of alterations were made to the initial formulation conditions (3.2.4.1 
Varying pH conditions for adsorption (100nm C-PS)). First, the formulation was 
changed by adding a small concentration of citric acid (0.5mM) to both particles and 
chitosan solution in order to stabilise the pH at 4.5 by creating a pH buffer with addition 
of NaOH. Hence, it was thought that better control of pH conditions would enable more 
predictable adsorption behaviour of chitosan to PS surface and therefore allow 
reproducible C-PS ζ potential and particle size measurements. 
 
Second, the initial formulation attempt allowed overnight adsorption of chitosan to PS. 
This was changed to one hour since there is evidence to show that coating chitosan onto 
polylactic acid (PLA) 500nm diameter nanoparticles only required 10 minutes (Munier 
et al 2005). It was expected that chitosan coating to PS would behave similarly to PLA. 
 
Third, chitosan powder was initially dissolved in aqueous HCl. During the early 
formulation attempts (3.2.4.1 Varying pH conditions for adsorption (100nm C-PS)) the 
majority of counter-ions (Na+ and Cl-) were generated during the neutralisation reaction 
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between excess 0.5M HCl with (2M or 0.1M) NaOH after chitosan was dissolved. It 
was therefore proposed that a less concentrated acid (0.1M HCl) would produce less 
excess HCl and therefore fewer counterions during pH adjustment. 
 
The presence of a high concentration of counterions in solution reduces the likelihood 
of electrostatic interaction between the polycation and anionic particle surface (Bauer et 
al 1998). Counterions can therefore have the ability to interfere with the adsorption of 
chitosan to the particle surface by shielding the charges on both the particles and the 
chitosan. In fact, chitosan is not soluble at high salt concentrations (equivalent to 1M 
HCl) due to this shielding (or salting out) effect (Rinaudo et al 1999). This experiment 
was designed to reduce the total concentration of ions during the chitosan adsorption to 
PS. 
 
Hence, 3.5mg chitosan was dissolved in 5.0ml 0.1M HCl. Then, the pH was adjusted as 
required with NaOH. The 0.5mg/ml solution was finally made up to 7.0ml with water. 
100nm PS particles were diluted from stock suspension as required with 0.5mM citrate 
buffer (pH4.5). 3.5ml of the particle suspension was pipetted into 3.5ml chitosan 
solution. After one hour some of the suspension was pH readjusted to 6.0 and 
supplemented with MgCl2 0.492mM, KCl 4.56mM, CaCl2 1.2mM and D-glucose 
10mM. NaCl was also supplemented to 122mM after calculating the amount produced 
from the neutralisation of HCl with NaOH to form the final physiological buffer. 
Chitosan-free samples followed the same procedure but without chitosan. The 
suspensions were characterised by particle sizing (DLS) and measuring ζ potential. 
Samples were performed in triplicate.  
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3.2.5 Preparation of 100nm and 200nm P80-PS 
Polysorbate 80 was adsorbed onto the polystyrene particles in Simulated Nasal Solution 
(SNS) and in ratios similar to those suggested in the literature (Kronberg et al 1990; 
Tangboriboonrat et al 2003). First, a stock solution of polysorbate 80 (642g/ml) was 
diluted with SNS to the required concentration for formulation. Then the PS suspension 
(0.08%w/v [200nm] and 0.05324%w/v [100nm]) was pipetted into this solution in a 1:1 
ratio whilst agitating to allow homogenisation. The mixture was rested at room 
temperature for 30 minutes to allow adsorption of the surfactant to the polystyrene 
surface. Thereafter, particles size and ζ potential measurements were performed as 
described in Section 3.2.3 Nanoparticle Physicochemical Characterisation. The particle 
size was measured for coated, uncoated particles and for 321µg/ml polysorbate 80 
solution alone. 
3.2.6 Preparation of 20nm P80-PS 
An estimated adsorption plateau could not be measured for 20nm nanoparticles (at these 
particle concentrations) due to the accuracy limits of the ζ potential instrument used. 
Therefore, the polysorbate 80 concentration required to coat 20nm PS was calculated 
from the adsorption plateau concentration of polysorbate 80 and relative surface area of 
200nm PS. Hence: 
200
20
20020 5 S
SCC ××=   
Where: 
C20= estimated polysorbate 80 concentration required for coating of 20nm PS (µg/ml) 
C200= polysorbate 80 concentration required for coating of 200nm PS (134µg/ml) 
S20= Relative Surface Area of 20nm particles (3.69x10-2m2/ml) 
S200= Relative Surface Area of 200nm particles (1.16x10-2m2/ml) 
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Particles were prepared as described previously (3.2.5 Preparation of 100nm and 200nm 
P80-PS). Particle concentration was 0.02% w/v and polysorbate 80 concentration was 
2140µg/ml. It was thought, based on the adsorption plateaus of the 200nm P80-PS 
particles, that this concentration would achieve maximum adsorption of the surfactant 
on the particles. This concentration of polysorbate was equivalent to 5 times that needed 
to achieve ζ potential adsorption plateau for 200nm particles. 
 
The particle size was also measured for coated, uncoated particles and for 2140µg/ml 
polysorbate 80 solution alone. 
3.2.7 Preparation of P80-FCS-PS 
Serum proteins from FCS were adsorbed onto the P80-PS in order to investigate the 
potential of these proteins to enhance selectivity of uptake into olfactory cells.  
 
For formulation, P80-PS were prepared as detailed above (Section 3.2.5 Preparation of 
100nm and 200nm P80-PS). The coated particle suspension was pipetted into the 
required concentration of FCS in a 1:1 ratio and allowed to rest for 30 minutes for 
adsorption to take place. All vessels containing FCS were pre-coated with excess FCS 
and washed thoroughly. This prevented the adsorption of FCS to the vessel walls during 
formulation steps (Section 3.2.8 Preventing FCS Adsorption to Vessels during 
Formulation). 
 
The particle size and ζ potential of the suspensions were measured as before (3.2.3 
Nanoparticle Physicochemical Characterisation). In addition, the protein content of the 
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supernatant (after centrifugation of the particles) was measured using a Bradford’s 
assay. The procedure is described below. 
 
First, the formulated samples were centrifuged at 18,000 rpm for 90 minutes which was 
sufficient to sediment all the particles. The concentration of the FCS in the supernatent 
was determined by Bradford’s protein assay. The Bradford’s Protein Assay was 
performed by adding 0.75ml of supernatant to 0.75ml of Bradford’s reagent. This was 
allowed to rest at room temperature for 15minutes. Samples were prepared in triplicate 
and assayed for absorbance by UV spectroscopy at 590nm and 450nm. The procedure 
was repeated without particles in order to produce a calibration plot.  
 
In addition, initial data suggested that polysorbate 80 interfered with the results from the 
Bradford’s Assay. Therefore, a control experiment was also preformed to determine the 
effect of polysorbate 80 on Bradford Assay. This was done by performing the Bradford 
Assay on solutions containing varying concentrations of polysorbate 80. 
3.2.8 Preventing FCS Adsorption to Vessels during Formulation 
Loss of FCS from the formulation due to adsorption to container walls could be 
misinterpreted as adsorption to particles. Therefore, it was necessary to determine extent 
of FCS adsorption onto the formulation vessels (glass vials and Eppendorf tubes).  
 
There were three parts to the experiment; first, three vessels were filled with 1.5ml 
92g/ml FCS in SNS; second, three vessels 1.5ml 92g/ml FCS that had been pre-
incubated with 10%v/v FCS at 37ºC overnight. Pre-coated vessels were thoroughly 
washed to remove all excess FCS prior to use; third, three vessels were filled with 1.5ml 
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FCS-free samples. The same performed on glass vials to investigate the adsorption onto 
glass as well as plastic. The vials, however, could not be centrifuged. 
 
The effect of centrifugation was also investigated for these samples since it was 
necessary to investigate whether FCS sedimented from the solution. A summary of the 
samples is listed in Table 3.1. 
 
Table 3.1 Summary of samples used during the investigation of FCS 
adsorption to formulation container vessels 
Sample Description 
Sample A FCS (glass vial) 
Sample B FCS (eppendorf) 
Sample C FCS (eppendorf) + centrifuge 
Sample D  FCS (FCS pre-treated eppendorf) 
Sample E FCS + centrifuge (FCS pre-treated eppendorf) 
Sample F SNS (glass vial) 
Sample G SNS (eppendorf) 
Sample H SNS (eppendorf) + centrifuge 
Sample I SNS (FCS pre-treated eppendorf) 
Sample J SNS + centrifuge (FCS pre-treated eppendorf) 
 
Thereafter, Bradford’s assay was performed on solutions taken from each vessel to 
determine loss of FCS from the solutions (3.2.7 Preparation of P80-FCS-PS). 
3.3 RESULTS 
In this section the results are presented in order of the chapter objectives. Hence, (i) 
aqueous phase ionic strength and pH conditions were altered to investigate the 
experimental conditions that were required to improve the adsorption of chitosan onto 
PS nanoparticles; (ii) the minimum concentration of bulk phase polysorbate 80 was 
determined to enable maximum adsorption of polysorbate 80 to the PS surface; (iii) 
attempts were made to establish the existence of FCS serum protein adsorption to P80-
PS nanoparticle. 
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3.3.1 Formulation Development of C-PS Nanoparticles 
3.3.1.1 Varying pH conditions for Adsorption 
It was observed that the pH of each suspension was different after overnight stirring. 
This was attributed to the lack of pH buffering ions in the colloids. Therefore, overnight 
control of formulation pH was difficult with water alone. The results shown in Table 3.2 
therefore report both intended experimental pH conditions and the actual pH after 
overnight stirring. 
 
Table 3.2 shows the relationship between pH, ζ potential and particle diameter of 
100nm PS and 100nm C-PS. For uncoated samples ζ potential reduced as pH increased. 
Particle diameter did not change with pH. The 100nm PS sample showed a negligible ζ 
potential at pH3.15 of 0.0±4.8mV whereas the sample at pH6.66 had a ζ potential of  
-63.8mV. The low ζ potential at pH3.15 was thought to be an artefact of the alternating 
current that was applied across the charge stabilised colloid in order to measure its ζ 
potential. Currents applied across (electrically stabilised) colloids may destabilise them 
by neutralising the charges on the colloidal substrate by either donating electrons or 
removing electrons from the charged surface groups into the bulk phase. 
 
The ζ potential measurement artefact was characterised by a gradual increase in ζ 
potential from -7.8mV to +5.2mV during the 5 consecutive measurements of the same 
sample. Therefore, the first measurement, -7.8mV, was thought to be the most reliable 
reading for this sample and this was used in further discussion. A similar artefact was 
observed for the 100nm PS sample at pH4.01 as well. 
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A different trend was observed for C-PS. Here, as formulation pH was increased from 
pH4.56 to 5.02. ζ potential of the particles remained relatively constant in the range 
+39.1mV to +41.5mV. Repeated sample readings demonstrated that these ζ potential 
measurements were not markedly different. Concomitantly, particle size dramatically 
increased from 113nm to 182nm over the pH range 3.80 to 5.02. ζ potential 
measurements were not possible for particles at pH2.96 since the particles had 
aggregated and the suspension had visibly destabilised. 
 
Table 3.2 The relationship between formulation pH, ζ potential and particle size during adsorption 
of chitosan to 100nm PS. 
Chitosan 
present? 
pH of sample 
after overnight 
stirring 
Intended 
formulation pH 
Diameter (nm) 
mean(±PdI) 
ζ potential (mV) 
mean(±s.d.) 
100nm PS 3.15 3.0 117±0.029 0.0±4.8b 
(-7.8mV) 
100nm PS 4.01 4.0 106±0.047  -3.0±35.1b 
(-44.0mV) 
100nm PS 4.56 4.0 104±0.049  
100nm PS 5.91 4.0 106±0.030  -63.6±1.9 
100nm PS 6.66 5.0 106±0.044  -63.8±1.2 
100nm C-PS 2.96 3.0 Visibly 
aggregated 
Not possiblea 
100nm C-PS 3.80 4.0 113±0.076  
100nm C-PS 4.56 4.0 117±0.109  +39.1±0.7 
100nm C-PS 4.89 5.0 153±0.056  +39.8±1.1 
100nm C-PS 5.02 4.0 182±0.044  +41.5±1.2 
For DLS the mean(±PdI) of thirty (3 second) readings were calculated. For ζ potential the 
mean(±s.d.) of 5 readings were calculated. a Due to colloidal instability. b Colloid destabilised during 
consecutive measurements of ζ potential (first measurement of 5 quoted in parenthesis). 
 
3.3.1.2 Evaluating the Effect of Adjusting Aqueous Phase Ionic Strength 
Table 3.3 shows the physicochemical characteristics of 20nm, 100nm and 200nm C-PS 
before (pH4.5) and after (pH6.0) supplementation with salts and glucose. Full 
physicochemical characterisation was not always performed due to time constraints. 
However, the following three observations were made; first, pH affected particle size 
and ζ potential as observed previously (Table 3.2). Hence, when pH was increased from 
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4.22 to 6.50 for 100nm C-PS, particle size increased from 105nm to 267nm and ζ 
potential values reduced from +41.6mV to +15.9mV. 
 
Second, it was shown that supplementing the 100nm C-PS (and not changing pH) did 
not alter its size or ζ potential (Table 3.3). The particle diameter and ζ potential values 
for one sample were 106nm and +42.4±1.4mV before supplementation and 105nm and 
+41.6±1.2mV after supplementation. In addition, the narrow intra-sample spread of ζ 
potential data (given by the standard deviations [n=5]) showed that these ζ potential 
measurements had similar ζ potentials. 
 
Finally, adsorption of chitosan was not detectable by particle sizing for 100nm C-PS. 
The mean particle size of three different samples was 108±6nm and 111±5nm for 
uncoated and coated samples, respectively (mean±standard deviation). 
 
The particle sizing method showed a larger increase between uncoated and coated 20nm 
particles than for 100nm particles. The mean particle diameter of three different samples 
was 31±3nm and 48±7nm, for uncoated and coated samples, respectively (mean±s.d.). 
Hence, the thickness of the adsorbed chitosan layer for 20nm particles was ([48-
31]/[111-108])=5.7 times larger than that for the 100nm particles. ζ potential 
measurements for 20nm particle may have given more detail of the adsorption 
behaviour of chitosan onto 20nm PS. However, the ζ potential measuring instrument 
could not detect sufficient scattering of light to undertake a reliable reading for these 
samples. 
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Table 3.3 Physicochemical characteristics of 20nm, 100nm and 200nm C-PS particles before and after addition of supplement. 
  Before Supplement  After Supplement   
Sample pH Particle Diameter 
(nm±PdI) 
Ζeta potential 
(mV) 
mean(±s.d.) 
pH Particle Diameter 
(nm±PdI) 
Ζeta potential 
(mV) 
mean(±s.d.) 
20nm C-PS a 4.53 48±0.060 - 5.95 141±0.155 - 
20nm C-PS a 4.31 54±0.500 - 5.92 161±0.010 - 
20nm C-PS a 4.41 41±0.031 - 6.46 138±0.358 - 
20nm PS a 4.55 29±0.034 -   - 
20nm PS a 4.52 30±0.027 -   - 
20nm PS a 4.54 35±0.071 -   - 
100nm C-PSb 4.33 106±0.077 +42.4±1.4 4.22b 105±0.035 +41.6±1.2 
100nm C-PS 4.47 116±0.090  5.92 163±0.080 +30.1±2.0 
100nm C-PS 4.41 112±0.084 +40.4±0.8 6.50 267±0.150 +15.9±0.7 
100nm PS 4.40 114±0.050 -7.0±1.6 4.21 119±0.015 +8.0±2.1 
100nm PS 4.55 104±0.039 -43.7±1.5    
100nm PS 4.54 105±0.030 -42.1±2.9 6.53 111±0.030  
200nm C-PS 4.53 197±0.019 +44.7±0.6 5.95 276±0.058 +23.2±1.6 
200nm C-PS 4.46 200±0.055 +40.6±0.4 6.49 196±0.021 +13.6±1.6 
200nm PS 4.68 191±0.022 -61.1±1.1    
200nm PS 4.60 202±0.034 -63.7±6.6 6.51 171±0.023  
For DLS the mean(±s.d.) of thirty (3 second) readings were plotted. For ζ potential the mean(±s.d.) of 5 readings were calculated. Measurement of ζ potential 20nm 
was not possible due to the detection limit of measuring instrument. a 20nm C-PS particles were statistically larger than the uncoated versions (P<0.05 unpaired t-
test). b pH was not adjusted to 6.0 after supplementation for this sample.
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3.3.2 100nm and 200nm P80-PS 
The adsorption of polysorbate 80 to PS nanoparticles was investigated by adding 100nm 
and 200nm diameter nanoparticles to polysorbate 80 in SNS. Figure 3.1 and Figure 3.2 
show that the particle size did not change noticeably for either 100nm or 200nm PS 
particles as polysorbate 80 was increased. As more surfactant was added the ζ potential 
of the 100nm particles reduced from -38mV to -20mV (Figure 3.1). Initially, small 
additions of surfactant screened the particle surface charge and therefore caused large 
reductions in ζ potential. As more surfactant was added the ζ potential reached a plateau 
at -20mV. At this stage it is possible that no further polysorbate 80 could adsorb since it 
had become saturated on the particle surface. This, however, was not confirmed as the 
adsorption isotherm was not determined. Figure 3.2 showed that 200nm particles 
demonstrated the same adsorption behaviour between -41mV and -25mV. 
 
The adsorption plateau was estimated from the least polysorbate 80 concentration 
required to reach the ζ potential plateau. Adsorption plateau was estimated as 9.8mg/m2 
(3.84x10-4mol/g) and 23.1mg/m2 (5.11x10-4mol/g) for 100nm and 200nm particles 
respectively by using the following equations: 
)/(
)/](80[)/( 22 mlmrfaceAreaParticleSu
mlmgePolysorbat
mmgdsorptionEstimatedA =  
or 
)/]([
)/](80[)/(
mlgnncentratioParticleCo
mlmolePolysorbatgmoldsorptionEstimatedA =  
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The adsorption plateau value for 200nm P80-PS was used to calculate the P80 
concentration required to coat 20nm PS with polysorbate 80 (3.2.6 Preparation of 20nm 
P80-PS). 
 
These values for estimated adsorption are relatively high compared to the literature 
(3.4.2.3 Estimated Adsorption of Polysorbate 80 to FluoSpheres™). Also, up to ~2.4 
times more polysorbate 80 adsorbed to 200nm particles than 100nm particles. 
According to the manufacturer, the charge densities of the different particles were not 
the same; 100nm particles had a 1.71x10-2carboxylate groups/Å2 whereas 200nm 
particles had 5.90x10-2carboxylate groups/Å2. Hence, the difference between the values 
may have been due to the different surface charges of the core particles.  
 
Also, micelles may influence the particle size distribution hence the presence of 
micelles in the polysorbate 80 solution was investigated. No micelles were detected by 
DLS in polysorbate 80 solution alone (2140µg/ml). 
 
The CMC (Critical Micellar Concentration) for polysorbate 80 in HBSS buffer (pH7.4) 
at 25°C has been measured at 65.5µg/ml (50µM) (Nerurkar et al 1997). In fact, the 
diameter of polysorbate 80 micelles has been measured in 50mM phosphate buffer 
(pH~7) as ~20nm (Simoes et al 2005). 
 
The concentration of polysorbate 80 in this sample was 321µg/ml. In theory, micelles 
should have been detected at these levels but it was likely that they did not scatter 
enough light for the DLS detection under the current experimental conditions. However, 
micelles were indirectly detected when 20nm PS nanoparticles were coated with 
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polysorbate 80 as discussed later (3.4.2.1 Thickness of Adsorption Layer). Indeed, 
micelles have been measured by this equipment in the laboratory before. It is likely that 
the polysorbate 80 micelles would be detected by increasing the laser strength. It was 
therefore concluded that these particle size measurements were not considerably 
affected by the presence of micelles. 
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Figure 3.1 ζ potential and particle size measurements of 100nm P80-PS. Measurements were performed in SNS buffer (pH7.4) as described in Section 3.2.5 
Preparation of 100nm and 200nm P80-PS. For DLS the mean(±s.d.) of thirty (3 second) readings were plotted. For ζ potential the mean(±s.d.) of 5 readings were 
plotted. 
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Figure 3.2 ζ potential and particle size measurements of 200nm P80-PS. Measurements were performed in SNS buffer (pH7.4) as described in Section 3.2.5 
Preparation of 100nm and 200nm P80-PS. For DLS the mean(±s.d.) of thirty (3 second) readings were plotted. For ζ potential the mean(±s.d.) of 5 readings were 
plotted. 
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3.3.3 20nm P80-PS 
Ζeta potential measurements were not possible in the case of 20nm particles due to their 
small size and the limitations of the instrument used. 
 
Particle diameter was measured at 31nm and 33nm for coated and uncoated particles, 
respectively. Analysis of the particle size distribution for each sample (Figure 3.3) 
showed that there was little difference between them.  
 
 
Figure 3.3 Radius mass distributions of 20nm FluoSpheres (red line) and 20nm FluoSpheres with 
Polysorbate 80 (brown line). 
 
The mean particle size in the sample has reduced after adding polysorbate 80 (Figure 
3.3). The dispersity of the coated particles has also increased. These facts are consistent 
with the detection of micelles in the colloid which are smaller than the PS nanoparticles. 
However, micelles were not detected in solution alone. 
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3.3.4 P80-FCS-PS 
3.3.4.1 Zeta potential and Particle Size 
Figure 3.4 shows the effect of adding FCS to 100nm P80-PS on the ζ potential and 
particle size measurements. ζ potential and the particle size did not change as higher 
concentrations of FCS were applied to the bulk phase. Average ζ potentials remained 
constant in the region of -15mV. Average particle diameter was ~110nm. Neither 
measurement showed any trend. If FCS had adsorbed onto the particle surface then it 
was not detectable by either of these methods. 
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Figure 3.4 Ζeta potential and particle size measurements of 100nm P80-FCS-PS. Measurements were performed in SNS buffer as described in Section 3.2.5 
Preparation of 100nm and 200nm P80-PS. For DLS the mean(±s.d.) of thirty (3 second) readings were plotted. For ζ potential the mean(±s.d.) of 5 readings were 
plotted. 
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3.3.4.2 Bradford’s Protein Assay 
The particle size and ζ potential data was inconclusive therefore further clarification of 
FCS serum protein adsorption to PS was necessary (3.3.4.1 Zeta potential and Particle 
Size). An alternative method to determine FCS adsorption was used whereby the P80-
FCS-PS nanoparticles were prepared and centrifuged. It was expected that some FCS 
proteins would not adsorb to the P80-PS. The excess protein that remained in the 
supernatant after particle sedimentation was quantified using the Bradford Assay. 
 
Figure 3.5 shows findings from the Bradford Assay for the 100nm P80-PS and control 
solutions of polysorbate 80; both series contained increasing concentrations of FCS. 
The Bradford’s reagent absorbed more UV light as more FCS was added to the P80-PS 
suspensions (or polysorbate 80 solutions). This indicated that the Bradford’s Assay 
could detect increasing amounts of protein at these concentrations. 
 
When examining the two curves, however, it appeared that the test samples (with 
particles [Figure 3.5 solid line curve]) contained protein levels that were 
indistinguishable from the control samples due to high data variability. Therefore, it 
could not be said that serum proteins from FCS had adsorbed onto the particles. Hence, 
construction of an adsorption isotherm was abandoned. 
 
Also, it was observed that FCS-free samples (blank samples) showed absorbance of 
0.12±0.003 and 0.08±0.01 for polysorbate 80 solution and P80-FCS-PS, respectively. 
Hence, it was suspected that polysorbate 80 was interacting with the Bradford’s Assay. 
Therefore, a calibration plot was constructed to evaluate the effect of polysorbate 80 on 
the Bradford’s Assay. Figure 3.6 shows Bradford’s reagent absorbed more UV light as 
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the concentration of P80 increased. Hence, polysorbate 80 did react with Bradford’s 
reagent at these concentrations. 
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Figure 3.5 Absorbance values from centrifuged particle suspensions using Bradford’s Reagent. Solid line: 100nm P80-FCS-PS with varying amounts of FCS. 
Broken line: solutions of polysorbate 80 with varying amounts of FCS. 
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Figure 3.6 The effect of polysorbate 80 on Bradford’s Assay 
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3.3.4.3 FCS Adsorption to Glass- and Plastic- ware 
Background levels of absorbance were found for samples that contained no initial FCS 
(Samples F-J Figure 3.7). All samples that contained FCS showed higher absorbance. 
Therefore, protein was detected in the samples that contained FCS. 
 
Samples D and E contained the greatest amount of residual FCS in the solution 
compared to samples A, B and C. This showed that saturation of the adsorption sites on 
the inner walls of the Eppendorf tubes with FCS pre-treatment prevented further 
adsorption of FCS from the sample. 
 
Also, there was little difference between Samples D and E which showed that FCS was 
not sedimented after centrifugation from solution. 
 
Hence, containers were pre-incubated with FCS for future studies of FCS adsorption 
onto P80-PS nanoparticles. 
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Figure 3.7 Qualitative assessment of FCS adsorption to surfaces of glass vials and Eppendorf tubes that were used during formulation of Polysorbate 80-coated FCS 
Surface Carrier Nanoparticles. 
Samples 
 
Sample A = FCS (glass vial) 
Sample B = FCS (eppendorf) 
Sample C = FCS (eppendorf) + centrifuge 
Sample D = FCS (FCS pre-treated eppendorf) 
Sample E = FCS + centrifuge (FCS pre-treated eppendorf) 
Sample F = SNS (glass vial) 
Sample G = SNS (eppendorf) 
Sample H = SNS (eppendorf) + centrifuge 
Sample I = SNS (FCS pre-treated eppendorf) 
Sample J = SNS + centrifuge (FCS pre-treated eppendorf) 
 
  163 
3.4 DISCUSSION 
The aim of this Chapter was to develop colloidal nanoparticle systems that could be 
used to investigate the effect of nanoparticle diameter and surface character in nasal 
transport studies (Chapter 4). A naturally occurring polysaccharide (chitosan) and a 
non-ionic surfactant (polysorbate 80) were chosen for surface coating (Chapter 1). An 
attempt was also made to adsorb serum proteins onto the P80-PS formulations from 
FCS. The adsorbed serum proteins may interact with the olfactory epithelium to induce 
receptor-mediated uptake (Chapter 1). 
 
The aim of this Chapter was met by: (i) changing the aqueous phase ionic strength and 
pH conditions to investigate the experimental conditions that were required to improve 
the adsorption of chitosan onto PS nanoparticles; (ii) determine the minimum 
concentration of bulk phase polysorbate 80 required to enable maximum adsorption of 
polysorbate 80 to the PS surface; and (iii) determine the existence of FCS serum protein 
adsorption to P80-PS nanoparticle. 
3.4.1 Interactions between FluoSphere™ Surfaces and Chitosan  
The application of chitosan onto the PS surface was based on the degree of ionisation of 
the of the amine groups on the macromolecule which is governed by the acidity of the  
–NH3+ group (pKa ~6.3) (Darder et al 2003). 
 
The solubility of chitosan is a major obstacle since surface modification of the PS is 
best achieved when chitosan is in solution. Variable factors that influence chitosan 
solubility in aqueous conditions are ionic concentration of the bulk phase (ionic 
strength) and pH.  
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Previously, there have been attempts by others to fix the positive charge on the chitosan 
by methylating the glucosamine residues. The methylated product, trimethylchitosan, is 
aqueous soluble to pH 9 (Kotze et al 1998). Trimethylchitosan does not show toxicity in 
short term studies (<8 hours) but it is toxic to cells in the longer term (Mao et al 2007). 
Therefore, chitosan was not modified in the current work. 
 
Without methylation, chitosan is not soluble above pH6.5 or in high ionic strength 
solutions (Li et al 2006; An & Dultz 2007). Temperature, degree of N-group acetylation 
and distribution of acetyl groups along the chain are also known as solubility factors 
(Rinaudo 2006). The pH and ionic strength of the aqueous phase were variables and the 
other factors were controlled factors in the work presented here. 
3.4.1.1 Effect of pH on Chitosan Adsorption 
Chitosan is soluble at acidic pH due to protonation of the glucosamine residues. For a 
highly deacetylated chitosan (~90%) at least 50% of N-groups need to be protonated to 
dissolve it in aqueous conditions (Rinaudo et al 1999). Therefore, solubility increases as 
pH reduces. 
 
In contrast, carboxylated PS nanoparticles have a pKa of ~2.5 (Norris & Sinko 1997) 
therefore the carboxylate groups protonate at low pH. When a certain number of 
carboxyl groups are deionised the attractive hydrophobic-hydrophobic interactions 
overcome the negative-negative charge repulsion forces between particles. The 
polystyrene particles will thus agglomerate below pH 2.5. 
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Consequently a suitable pH was required for the chitosan-coating of carboxylated PS 
nanoparticles. An appropriate pH condition was one that allowed both a stable particle 
suspension and suitable chitosan protonation for adsorption. 
 
One of the objectives of this Chapter was to find the optimal pH conditions for 
adsorption of chitosan from the bulk phase onto the PS surface. Uncoated particles 
showed little difference in particle size over the pH range 3.15-6.70 since the PS was 
suitably charged to enable electrostatic stabilisation of the particles at this pH. This was 
reflected in the ζ potential measurements over this range which was -7.8mV to -63.8mV 
(Table 3.2). 
 
In contrast, the ζ potential of the chitosan-coated system was positively charged owing 
to the charged glucosamine units that were not interacting with the surface carboxylate 
groups (An & Dultz 2007). The charge (~+40mV) was enough to form a stable 
suspension by electrostatic repulsion. 
 
In addition, for these particles, a range of chitosan coating thicknesses were observed 
from 3.5nm (pH3.80) to 38nm (pH5.02). The particle size observations can be related to 
either of two hypotheses. First, the widely accepted ‘loop-train-tail’ theory of 
polycationic adsorption to anionic surfaces (Breen 1999); and second, an alternative 
hypothesis which suggests that the adsorption layer of chitosan could grow as a result of 
better chitosan segment-segment interactions at low protonation (Darder et al 2003; An 
& Dultz 2007). 
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According to the first explanation, as pH increased, chitosan segment-segment 
interactions were more favourable as increasing numbers of glucosamine groups 
became deprotonated on the chitosan molecule. In addition, segment-water interactions 
also became less favourable as the charge neutralised along the polyelectrolyte. 
Concurrently, the number of strong electrostatic anchor points decreased and some 
segments were replaced by adsorbing ions from the bulk solution. In total, this lead to 
longer loops, a more flexible chitosan backbone, shorter trains and shorter tails; 
therefore the coating layer may have become more compact and more extended from 
the surface (Figure 3.8). 
 
Indeed, direct measurements of fluorescently labelled chitosan adsorption onto DOPC 
(1,2-Dioleoyl-sn-glycero-3-phosphocholine) liposomes showed that more chitosan was 
adsorbed onto the liposomes at pH6.0 compared to pH3.4 (Quemeneur et al 2007). 
 
 
Figure 3.8 Schematic describing the influence of pH on adsorption of chitosan to PS according to the 
loop-train-tail hypothesis. 
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In addition, the distance between glucosamine monomer units within chitosan was 
computationally calculated as 9.839Å. The theoretical length of a single linear chitosan 
molecule of 143kDa is 6047.0Å (604.7nm). Therefore, if one chitosan molecule forms 
one loop (with negligible trains and no tails) then it would have only two anchor points 
and a maximum layer thickness of 302.4nm. 
 
Since single carboxylate and charged glucosamine units interact in 1:1 ratio (both 
monovalent charges), it can be said that the number of anchor points (Anch) (charged 
glucosamine units interacting with carboxylate groups) and chitosan layer thickness can 
be related by the following equation: 
 
Anch
nm
nmnessLayerThick 7.604)( =  
 
Thus, a 38nm coat would require 16 anchor points and a 3.5nm coat would require 173 
anchor points; hence there would be (173/16=) 10.9 times more anchor points at pH5.02 
than pH3.80. 
 
In theory, however, there are 6.1610 )80.302.5( =−  times more charged glucosamine units at 
pH5.02 compared to pH3.80. Therefore, the number of anchor points was less than the 
theoretical maximum (i.e. coated layer should have been thinner). The difference could 
be attributed to: i) presence of tails which were not accounted for in the calculation; ii) 
steric hindrance of anchorage (from other chitosan molecules) (An & Dultz 2007); or, 
iii) >1 electrostatic interactions per anchorage (long trains) (Quemeneur et al 2007). In 
addition, it has been shown previously that not all surface groups are electrostatically 
coupled by charged glucosamine units. Quemeneur et al. found up to 40% of charged 
groups on the chitosan molecule were involved in electrostatic surface interaction to 
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DOPC liposomes (Quemeneur et al 2008). This could also account for low anchorage. 
There was, nevertheless, an increase similar to what was expected. 
 
The second hypothesis that could explain the existence of larger particles at lower pH is 
one where chitosan forms double or triple layers around the particles (Darder et al 2003; 
An & Dultz 2007). The authors of these studies did not offer and explanation for the 
mechanism of chitosan layer formation around negatively charged particles. However, 
(in my interpretation) the chitosan became less protonated as the pH was changed from 
4.5 to 6.0. The reduced chitosan protonation (as well as the addition of electrolytes into 
the suspension to create the physiological buffer conditions) meant that the numbers of 
positive charges on the chitosan had reduced or the positive charged –NH3+ units were 
shielded. This favoured chitosan segment-segment (hydrophobic-hydrophobic) 
interactions (Philippova et al 2001). Therefore, the chitosan from solution could 
aggregate around the particle to form double and possibly triple layers. This 
explanation, however, remains questionable as discussed later (3.4.1.4 Chitosan 
Adsorption and Surface Curvature). 
3.4.1.2 Effect of Excess Chitosan in Suspension 
Excess chitosan was not removed from the bulk solution since it is required for the 
stability of the particle suspension (Brooking et al 2001). The requirement for excess 
polycation in solution to provide stabilisation can be explained thus; the increased 
competition for particle surface adsorption sites when chitosan is in excess could lead to 
the formation of longer loops and tails and therefore to a greater steric stabilisation 
component (Bauer et al 1998). To confirm this for the C-PS system, physicochemical 
analysis of a series of samples with increasing concentrations of chitosan would be 
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necessary. This work, however, was not undertaken since it was deemed to be beyond 
the scope of this project. 
3.4.1.3 Chitosan Adsorption and pH Control 
Since thickness of the chitosan coating was dependent on the pH of the aqueous phase. 
Small pH increments had marked affect on coating layer thickness (Table 3.2 and 
3.4.1.1 Effect of pH on Chitosan Adsorption). Therefore, tight control of the aqueous 
phase pH with use of pH buffer was required. 
 
A citrate buffer was chosen for this purpose. It was more suitable than SNS (phosphate) 
buffer which was previously employed in Chapter 2. Phosphate buffer (pKa 7.2) is not 
optimal for use at pH4.5 since the ability of a buffer to stabilise pH is optimal within 1 
pH scale of its pKa. Citrate buffer (pKa 4.76, 6.40) was therefore chosen for future 
experiments with chitosan (Table 3.4). 
 
Table 3.4 pKa values for different buffers at 25ºC. Buffers are most effective when required buffer 
pH is ±1pH scale of one of the pKa values. 
Buffer pKa (at 25ºC) 
Citrate 3.13 (pKa 1) 
4.76 (pKa 2) 
6.40 (pKa 3) 
Phosphate 2.15 (pKa 1) 
7.20 (pKa 2) 
12.33 (pKa 3) 
 
The key advantage of citrate buffer is that they it can stabilise pH at both 4.5 and 6.0 
since it has three pKa values resulting from different protonable carboxylate groups. 
Therefore, the same buffer can be used for the absorption of chitosan at pH4.5 as well as 
undertaking transport studies at the more physiologically acceptable pH6.0. 
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3.4.1.4 Chitosan Adsorption and Surface Curvature 
DLS showed that coating layer thickness was measurable for 20nm and 100nm 
particles, whereas, it was undetectable for 200nm particles ([pH4.5] chitosan 98% 
ionised). As the particles became smaller the size of the coating layer became thicker. 
 
It is widely accepted that chitosan adsorbs with a flatter conformation at higher 
protonation due to: (i) greater opportunity to form electrostatic coupling with a 
negatively charged surface; and (ii) the increased rigidity of the chitosan backbone from 
intra-molecular charge repulsion reduces the ability of chitosan to form loops (3.4.1.1 
Effect of pH on Chitosan Adsorption and (Claesson & Ninham 1992; Breen 1999; 
Mazeau et al 2000; Quemeneur et al 2008) ). 
 
The particle curvature was increased when the core PS particle diameter was changed 
from 200nm to 100nm. However, this increase in curvature was not sufficient to 
increase the thickness of the adsorption layer to a great extent. Some loops may have 
formed due to electrostatic anchorage of the chitosan molecule to the PS surface (Figure 
3.9) though this was probably minimal due to the rigidity of the chitosan molecule as 
discussed above. 
 
When particle diameter was reduced further to 20nm, the curvature of the particle was 
increased sufficiently for the chitosan adsorption behaviour to change. Hence, for 20nm 
diameter PS nanoparticles particles the long tails may interact with other particles to 
form compact floc structures that were limited in size by the length of the polycation ( 
(Breen 1999)and Figure 3.9). These small flocculates could explain why there was such 
a large increase in particle size with the 20nm particles. 
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Figure 3.9 Theoretical representation of adsorption of chitosan to varying sizes of PS nanoparticles. 
Smaller particles had larger curvature but less charge density. Arrows indicate relative coating 
layer thickness. 
 
In addition, according to the manufacturer of the PS particles, the charge density of the 
particles increased from 0.0171carboxylate groups/Å2 for 20nm particles, to 
0.0363carboxylate groups/Å2 for 100nm particles, and 0.0590carboxylate groups/Å2 for 
200nm particles. This provided greater opportunity for adsorption onto the larger 
particles and therefore increasing anchorage for the larger particles. This could also 
have contributed to increasing chitosan anchorage and therefore reducing the chitosan 
layer thickness on the larger particles. 
 
Regarding surface charge density of the PS and formation of chitosan layers around the 
particle - it would be expected that more chitosan would aggregate in layers around the 
larger, highly charged 200nm particles than the lesser charged 20nm particles. However, 
this was not observed so the observation that 20nm particles formed the largest coating 
layer seems incompatible with the chitosan layering hypothesis (3.4.1.1 Effect of pH on 
Chitosan Adsorption).  
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Hence, it was likely that tail and loop lengths increased as the particle diameter reduced 
to 20nm which was interpreted as either: i) a thicker particle coating layer; or ii) (for 
20nm particles) the formation of small flocculates with a discrete size determined by the 
MW of the chitosan (Table 3.3 and Figure 3.9).  
3.4.1.5 Chitosan Adsorption and Aqueous Phase Ionic Strength 
Once particles were chitosan-coated the suspensions were supplemented with the 
remaining salts and glucose to form a physiologically acceptable buffer which was 
necessary for olfactory tissue survival in the nasal transport studies (Chapter 4).  
 
It was inferred from Table 3.3 that the bulk solution pH had a stronger influence on 
adsorbed layer thickness than addition of salts and glucose. The three 100nm C-PS 
samples helped to make the distinction. One sample (Table 3.3(c)) was kept at pH4.5 
and supplemented. This sample showed that chitosan layer thickness did not increase 
after the supplementing. On the other hand, the other two 100nm C-PS samples showed 
a size increase when pH was increased to 6.0 and supplements were added. 
 
This related well with current understanding; for example, Philippova et al. (2001) 
found that 250g/ml chitosan solution did not aggregate in acetate buffer (0.3M 
CH3COOH/0.2M CH3COONa) pH4.58. If aggregation of chitosan molecules was 
observed in this study then it could be said that nanoparticles with adsorbed chitosan 
would also aggregate. At pH4.58 the chitosan was 98% ionised and the ionic strength of 
this buffer was 200mM (Philippova et al 2001). The ionic strength used in Phillipova’s 
study was higher than that of the citrate buffer used in this work after supplementation 
(122mM). Therefore, ionic shielding of charges on the chitosan was not expected to 
cause aggregation of the particles after supplementation in the current work. 
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Hence, it was important to control the aqueous environment during the adsorption 
process itself in order to control the adsorption process for reproducibility. Ionic 
strength and low pH are important factors (Henriksen et al 1997). Henriksen et al. 
(1997) found that high cationic charge on the chitosan (low pH) and low ionic shielding 
of the cationic and surface charges produced many anchorage points per chitosan 
molecule for chitosan adsorption to liposomes. Indeed, an ionic strength as low as 
10mM was seen to increase the diameter of the chitosan-coated liposomes. This 
indicated that that a much lower ionic strength condition would be necessary for 
chitosan adsorption. Hence, a low concentration of citrate buffer 0.5mM and low pH 
conditions (pH4.5) were used to control the initial adsorption step. 
 
3.4.1.6 Other factors Influencing Chitosan Adsorption to Surfaces  
A biphasic adsorption of chitosan to the PS surface could also be possible. Such an 
adsorption behaviour has been demonstrated on clay mineral montmorillonite at 25°C 
(An & Dultz 2007). For this material, there was an initial fast electrostatic adsorption 
within 30 minutes followed by a slower adsorption which was thought to be driven by a 
rearrangement of chitosan segments by Brownian motion at the surface of the clay 
material. The slow rearrangement continued until optimal conformation of the chitosan 
molecules were achieved with respect to intra- and inter- molecular forces between 
chitosan molecules and the particles surface and chitosan molecules between 
themselves. An & Dultz (2007) thought that this rearrangement uncovered previously 
uncoupled adsorption sites. Hence, the longer range attractive force between bulk phase 
chitosan and uncovered surface charge compared to adsorption sites sterically hindered 
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by uncharged chitosan molecule segments may then drive the adsorption of more 
chitosan. 
 
For montmorillonite the secondary phase did not stabilise until approximately 80 hours 
after initial adsorption (An & Dultz 2007). Most measurements in the current work were 
taken after 1 hour of the initial adsorption; therefore, incomplete chitosan rearrangement 
could have contributed to some variation in the data presented here. 
3.4.2 Interactions between FluoSphere™ Surfaces and Polysorbate 80  
Polysorbate 80 has been primarily used in drug delivery as a surfactant coating for 
nanoparticles across the blood-brain endothelium (Chapter 1). It is regarded as safe as a 
formulation excipient and, unlike chitosan, adsorbs to surfaces with minimal 
manipulation of the bulk phase (Kreuter 2001).  
 
Little is known, however, about the interaction between polysorbate 80 and polystyrene 
in aqueous conditions. For example, no adsorption isotherm information is available. 
Nevertheless, since the surfactant is non-ionic, it was anticipated that the adsorption 
process would be driven by hydrophobic interactions between the PS surface and the 
oleic acid residue of the polysorbate 80. Therefore (unlike with chitosan) electrostatic 
shielding of the polysorbate 80 by salts and pH conditions of the aqueous phase were 
less important variables to control. 
 
The main formulation problem was to limit the excess amount of polysorbate 80 in the 
bulk solution after adsorption to the polystyrene. Excess surfactant could have 
interfered with nanoparticle transport, or lack thereof, through the olfactory epithelium 
during transport studies. For example, the polysorbate 80 may interact with the 
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phospholipid membrane (possibly by membrane solubilisation) and allow the 
nanoparticles to pass into cells by a route that may not be possible with less excess 
surfactant. With little excess surfactant these effects are less likely to occur and thus a 
greater certainty of interpretation can be placed on other mechanisms of nanoparticle 
transport into the epithelium. The following section discusses the extent of polysorbate 
80 adsorption onto PS and the factors that influence the adsorption behaviour. 
 
3.4.2.1 Thickness of Adsorption Layer 
The adsorption behaviour of polysorbate 80 onto PS was characterised by particle size 
analysis (light scattering) and ζ potential measurements. 
 
Particle size was unable to clearly indicate the presence of the adsorbed layer. It is likely 
that the surfactant layer was very thin since it has a relatively small molecular weight 
(MW 1310). Nevertheless, the adsorption layer thickness of polysorbate 80 to 
polystyrene particles has been measured previously as 2.9nm by PCS (Muller et al 
1992). This value, however, was larger than theoretical predictions of coating layer 
thickness as discussed below. 
 
For instance, it is widely held through investigations of a variety of PEG-containing 
surfactants on polystyrene nanoparticles, that coating layer thickness increases with 
PEG chain length (Stuart et al 1984; Li et al 1994; Wijmans et al 1994). In fact, a 
previous study has correlated the thickness of the adsorbed layer to the chain length of 
PEG units in each copolymer molecule (Illum et al 1987). It can be estimated from such 
analysis that polysorbate 80, a 20 PEG unit copolymer with an average PEG chain 
length of 7 PEG units, should have an adsorbed layer thickness of ~0.875nm. 
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It was also found that the hydrodynamic layer thickness was related to twice the radius 
of gyration for each copolymer (Stolnik et al 1997). The radius of gyration is defined as 
a length representing the distance between the point about which rotation of a body 
occurs (the axis of rotation) and the point at which the body mass is distributed at its 
maximum effect. Information about the radius of gyration, however, is not available for 
polysorbate 80. But a relationship exists between PEG chain length and radius of 
gyration. Therefore, a value for radius of gyration can be estimated from the 
homopolymers containing the same amount chain length of PEG monomer units (Li et 
al 1994). Hence, twice radius of gyration for a PEG homopolymer with chain length of 
7 units is ~1nm which is in good agreement with Illum et al (1987).  
 
Finally, a mathematical model based on the DLVO theory has estimated that Triton X-
100 (a 10-mer PEG copolymer; MW647) would produce adsorption layer of 0.8nm 
(Romero-Cano et al 1998). 
 
Nevertheless, the diameter of the 20nm PS nanoparticles appeared to reduce by ~2nm 
after addition of polysorbate 80 to the colloid (Figure 3.3). The dispersity of the 20nm 
P80-PS nanoparticles also increased compared to 20nm PS. These facts are consistent 
with the detection of polysorbate 80 micelles in the colloidal mixture. Indeed, it would 
be expected that micelles did appear in the mixture since the CMC (Critical Micellar 
Concentration) for polysorbate 80 in HBSS buffer (pH7.4) at 25°C has been measured 
at 65.5µg/ml (50µM) (Nerurkar et al 1997). Also, the diameter of polysorbate 80 
micelles has been measured in 50mM phosphate buffer (pH~7) as ~20nm (Simoes et al 
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2005) which is consistent with the findings made here since these micelles are smaller 
than the [nominal] 20nm PS nanoparticles. 
 
Hence, it was not possible to determine the thickness (or even existence) of the 
polysorbate 80 layer on the 20nm P80-PS nanoparticles using DLS. It was also difficult 
to make this distinction for 100nm and 200nm P80-PS (Figure 3.1 and Figure 3.2). 
Therefore, a firm conclusion regarding polysorbate adsorption layer thickness could not 
be made. 
3.4.2.2 The Influence of Adsorption on ζ Potential 
There was decrease in ζ potential from -38mV (uncoated) to -20mV (fully coated) for 
100nm particles and similarly from -41mV and -25mV for 200nm particles (Figure 
3.1and Figure 3.2). Values for ζ potential reduced as more copolymer was applied to the 
particle surface as a consequence of shear plane movement away from the particle 
surface. Thus, the coating layer protected part of the diffuse layer against displacement 
by shear as more surfactant was applied. For small surfactants, however, the distance 
that the shear plane can move away from the surface is limited by the size of the 
surfactant molecule. Therefore, since polysorbate 80 has a small chain length, a residual 
negative ζ potential remained after maximum adsorption was reached for polysorbate 80 
to PS particles (adsorption plateau Figure 3.1 and Figure 3.2). 
 
Furthermore, the differences in ζ potential for uncoated particles were probably due to 
the differences in their inherent surface charge densities. According to the manufacturer, 
the charge densities for the different particles were 1.71x10-2carboxylate groups/Å2 for 
100nm particles and 5.90x10-2carboxylate groups/Å2 for 200nm particles. Therefore, the 
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larger particles had a greater initial surface charge which was measured as a larger ζ 
potential. 
 
3.4.2.3 Estimated Adsorption of Polysorbate 80 to FluoSpheres™ 
The estimated adsorption values were 3.84x10-4mol/g and 5.11x10-4mol/g for 100nm 
and 200nm particles, respectively. These estimates were unrealistically high in relation 
to adsorption of other low molecular weight non-ionic surfactants to polystyrene 
surfaces. For example, Triton X-100 (a 10-mer PEG copolymer) and hepta-ethylene 
glycol mono-n-dodecyl ether (a 7-mer PEG copolymer) had specific adsorption values 
of 1.0x10-5mol/g and 1.3x10-5mol/g, respectively, for ~150nm PS particles. These 
values are up to 50 times lower than those estimated by ζ potential here (Zhao & Brown 
1996). 
 
The high values found here were probably due to the indirect method of obtaining 
maximal adsorption values through ζ potential measurements. It was assumed in the 
calculations for estimated adsorption that all polymer molecules in solution had 
adsorbed to the particle surface. However, some polymer may have remained in solution 
since the adsorption process is governed by thermodynamic equilibria. Therefore, the 
values obtained through ζ potential measurements were likely to be high. 
 
3.4.3 Adsorption of FCS to 100nm P80-PS 
FCS is a complex mixture of plasma proteins and other biological molecules. FCS 
contains components such as ApoE which, if adsorbed to particle surfaces, can promote 
interaction of the particle with cells (Kreuter 2001). The presence of polysorbate 80 on 
the particles modifies the adsorption pattern of serum proteins so that the particle 
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surface becomes enriched with Apo E (Muller et al 1992; Goppert & Muller 2005). This 
serum protein adsorption modifying behaviour of polysorbate 80 was consistent with 
PBCA, PMMA and solid lipid nanoparticle colloidal substrates; therefore, it was 
thought that PS nanoparticles would also demonstrate the same effect. ζ potential, 
particle sizing and the Bradford Protein Assay were used to detect the presence of 
adsorbed protein to the particle surface. 
 
Figure 3.4 shows there was no trend in ζ potential or the particle size when FCS was 
added to 100nm P80-PS (Figure 3.1). Neither parameter showed any trends. If FCS had 
adsorbed onto the particle surface then it was not detectable by either of these methods. 
It was unclear why the ζ potential did not change as expected since changes in ζ 
potential have been demonstrated with serum adsorption to other PEG-containing 
surfactant coated PS systems (Illum et al 1987). An increase of sampling numbers could 
have made the findings more conclusive. 
 
Alternatively, FCS proteins may not have adsorbed whatsoever. This is, however, 
unlikely since a variety of plasma proteins have previously been identified to adsorb 
onto both uncoated polystyrene particles and polystyrene particles coated with PEG 
containing surfactants (Luck et al 1997; Stolnik et al 2001). 
 
Further clarification was necessary since the particle size and ζ potential data was 
inconclusive. An attempt was made to detect the protein directly with use of Bradford’s 
protein assay (Zor & Seliger 1996). This method has previously been shown to detect 
levels of 0.2g/ml Bovine Serum Albumin. The lowest concentration of FCS used to 
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coat particles here was 4.6g/ml. Therefore, this assay was deemed suitable to evaluate 
FCS adsorption to the particles as described here. 
 
Figure 3.5 shows that more protein was detected as more FCS was added to the particle 
suspensions. On average there always appeared to be more FCS remaining in 
supernatants of the control solutions that contained no particles. But it was difficult to 
detect whether FCS was adsorbed onto the particles due to the variability of the data. 
Since the use of Bradford’s Assay at these levels has previously been reported (Zor & 
Seliger 1996) it may have been that this was a limitation of the accuracy of the 
spectrophotometer. 
 
However, it was more likely that the proportion of serum protein that adsorbed from the 
FCS to the nanoparticle surface may have been below the detectable range of the 
Bradford’s Assay. In fact, Apo E is only thought to constitute 0.005%w/v (46µg/ml) of 
total FCS content (Goppert & Muller 2005). On this basis, the concentration of Apo E at 
the lowest dilution was 0.92ng/ml. Therefore, the loss of Apo E from FCS may not have 
been detected by Bradford’s assay at the lowest FCS dilution used for formulation. 
 
In addition, the polysorbate 80 had also reacted with the Bradford’s Assay. Figure 3.5 
demonstrates this since there was a difference in absorbance values between samples 
that contained no FCS. The relationship was confirmed when absorbance correlated 
with increasing concentrations of polysorbate 80 in solution (Figure 3.6). This was not 
expected since the manufacturer’s literature for Bradford’s Reagent states that 
concentrations of polysorbate 80 below 663µg/ml should not interfere with the results 
obtained by Bradford’s reagent (Sigma-Aldrich 2005). The concentration of polysorbate 
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80 used during the FCS adsorption study was below this threshold (107µg/ml). The 
interaction of polysorbate 80 and Bradford’s reagent at these low levels could, therefore, 
have resulted from the cumulative effects of buffer components and surfactant. Future 
studies could use an alternative method, such as 2D electrophoresis, as used previously 
(Blunk et al 1993; Luck et al 1998). However, there was not enough time remaining to 
undertake these studies. 
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3.5 CONCLUSIONS 
PS particle of varying sizes were coated with either chitosan (143kDa, 89% 
deacetylated) or polysorbate 80 (1310MW). Chitosan has mucoadhesive properties and 
polysorbate 80 has previously been shown to improve particle delivery to the brain. 
Both are deemed as biologically safe materials for use in this respect. 
 
For chitosan adsorption to PS, the pH and ionic strength can markedly affect the final 
diameter of the coated particle. Therefore, controlling these factors during adsorption 
was important. A low ionic strength citrate buffer (0.5mM) allowed control of pH at 4.5 
and at 6.0 which corresponded to the adsorption and supplementing steps during 
formulation, respectively. 
 
In general, the thickness of the chitosan coating layer increased with increasing pH. 
This was attributed to the deprotonation of glucosamine units on the chitosan at higher 
pH and the subsequent decoupling of glucosamine-carboxylate electrostatic bonds 
between the chitosan and the particle surface. An alternative hypothesis was also 
considered that suggested a layered chitosan structure around the core PS particle. This 
arrangement, however, was deemed less likely to occur since the 200nm diameter 
particles had a greater surface charge and a thinner chitosan adsorption layer compared 
to 200nm particles. 
 
Also, the surface curvature of the particle may have been an important factor for 
chitosan adsorption behaviour since the coating layer thickness increased with smaller 
particles. This could have resulted from the inability of the chitosan molecules to form 
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loops and trains due to the high rigidity of the chitosan backbone particularly when 
highly charged at low pH. This could even have lead to multiple particle anchorage onto 
a single chitosan molecule which could have been detected as flocculates with a size 
defined by the length of the chitosan molecule. 
 
The inherent particle surface charge density, however, was less for smaller sized 
particles and so the thicker coat could merely have been a result of less opportunity for 
chitosan-particle interactions. Therefore the effect of particle size on chitosan 
adsorption behaviour remains unclear. 
 
In the P80-PS colloidal system ζ potential values became smaller as more polysorbate 
80 was added to the particles. This was a consequence of shear plane movement away 
from the particle surface as more non-ionic surfactant was adsorbed.  
 
The adsorption of polysorbate 80 to PS was estimated by ζ potential for 100nm and 
200nm particles as 9.8mg/m2 and 23.1mg/m2, respectively. But these values were up to 
x50 higher than what was expected from the literature which was probably due to the 
indirect nature of ζ potential as a measure of adsorption. 
 
Unlike with chitosan, however, particle size changes were not reliably detected for the 
P80-PS colloid. This was probably a result of the small size of the surfactant in 
comparison to the chitosan molecule. A greater sample number may have improved the 
variability of the measurements. 
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Finally, FCS was used to overcoat the P80-PS. The presence of FCS was hypothesised 
to improve selective uptake of particles into olfactory neurones due to the presence of 
binding ligands such as Apo E. The FCS adsorption to P80-PS could not be confirmed 
using a variety of methods (including ζ potential, particle sizing and [Bradford’s] 
protein assay). The literature, however, was consistent in stating that serum proteins do 
adsorb onto PEG-containing surfactant-coated PS nanoparticles. Therefore, it was 
thought that a low degree of FCS serum proteins were adsorbed to the P80-PS particles. 
Future confirmation could come from the use of 2D gel electrophoresis. 
 
The PS, C-PS, P80-PS and FCS-P80-PS nanoparticle colloidal systems were applied to 
olfactory epithelia in vitro and in vivo as described in Chapter 4. 
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4. DIRECT NOSE-TO-BRAIN NANOPARTICLE TRANSPORT STUDIES  
4.1 INTRODUCTION 
 
A number of studies have demonstrated the ability of small molecular weight drugs, 
peptides and nanoparticles to appear in the olfactory system after intranasal 
administration (Chapter 1). The aim of this chapter is to investigate the fundamental 
mechanism involved in the transport of nanoparticles into the olfactory system in both 
the in vitro porcine (Chapter 2) and in vivo murine animal models. The possible toxic 
effects of the nanoparticles on the olfactory epithelia were also investigated. A number 
of colloidal formulations, which differed in nanoparticle diameter and surface 
characteristics, were developed for application to these models (Chapter 3). 
 
Two types of biological models were used to undertake this investigation. First, an in 
vitro approach was adapted using porcine olfactory epithelium mounted onto the 
vertical Franz diffusion cell. This in vitro model allows a detailed investigation of: (i) 
the time-related movement of nanoparticles across the olfactory epithelium; and (ii) 
interaction between the test formulation and mounted tissue. In addition, it permits strict 
control of physiological conditions such as pH, temperature and oxygenation. These 
conditions may affect the viability of the olfactory epithelium and/or stability of the 
colloids applied to the system.  
 
The second adapted approach used a mouse in vivo model. In this investigation 
nanoparticle test formulations were placed directly into the nasal cavity of mice. The 
olfactory system was later histologically examined to determine the location of the 
applied nanoparticles. Advantages of using in vivo models compared to the vertical 
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Franz diffusion chamber were that: (i) transport of particles beyond the olfactory 
epithelium could be evaluated; (ii) the model handled the formulation in a more realistic 
way (e.g. formulation can clear away from the nasal cavity or formulation may not be 
accessible to different regions of the nasal cavity); (iii) the movement of particles in the 
olfactory system could be evaluated over longer periods; and (iv) the procedure was 
simpler (e.g. the animal is alive during the experiments therefore it is not necessary to 
measure the viability of the tissue). 
4.2  TRANSPORT STUDY USING THE FRANZ DIFFUSION CELL 
 
The aim of this study was to use fluorescence microscopy and fluorescence 
spectroscopy to compare the ability of nanoparticles, of different sizes and surface 
characteristics, to transport through excised olfactory epithelia in the nasal cavity using 
the in vitro vertical Franz diffusion cell model. For this investigation the procedures for 
measuring tissue viability (Rm, PD, Isc and Alamar Blue™ tests) and dissection method 
to extract the olfactory epithelium from pigs are described in Chapter 2. 
4.2.1 Materials and Methods 
4.2.1.1 Materials 
Bright Cryo-M-Bed cryomountant was obtained from Bright Instrument Co. Ltd. 
Huntingdon, UK. Glycerol jelly mounting medium was prepared (by dissolving 10g 
gelatine [Sigma, Gillingham, UK] in 60ml water and 70ml glycerol [Sigma, Gillingham, 
UK]) and stored at 2-8°C. All other materials were sourced and prepared as described in 
Chapters 2 and 3. 
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4.2.1.2 Transport Study Protocol 
Domestic pigs (circa 6 months old) were slaughtered by exsanguination, the olfactory 
epithelium dissected, transported on ice in cold buffer (either SNS (pH7.4) or 0.5mM 
citrate (pH6.0) buffer depending on the test formulation requirements) and loaded onto 
the diffusion chamber apparatus within approximately one hour post mortem. 
 
After a 30 minute electrophysiological equilibration period (during which Rm, PD and 
Isc measurements were taken) a suitable volume of the nanoparticle-containing test 
formulation was placed into the donor chamber to create a suspension containing 
4.55x1010particles/ml. 
 
Thereafter, 200µl aliquots were withdrawn from the receiver side every 10 minutes (for 
90 minutes) into a 96 well microtitre plate. The receiver chamber sample volume was 
replaced with the appropriate pre-warmed and pre-oxygenated buffer. The aliquots were 
later quantified for nanoparticles using fluorescence. 
 
Finally, Rm, PD and Isc measurements were taken for another 30 minute before 
dismounting the tissue. Three 3mm diameter circular pieces of epithelium were cut out 
from the dismounted tissue using a cork borer. Thereafter, the Alamar Blue™ viability 
test was immediately performed on these circular pieces of tissue. 
 
For test formulations, two different types of FluoSpheres™ were used for the three 
different colloidal systems in this study. PS and C-PS nanoparticles contained a yellow-
green fluorescent dye with excitation and emission (Ex/Em) maxima of 505nm and 
515nm (505/515), respectively. P80-PS nanoparticles encapsulated a red fluorescent dye 
Ex/Em 580/605. The change of core particles was made to improve the visualisation of 
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the nanoparticles in the tissue samples. Red fluorescent nanoparticles were easier to 
distinguish from the natural autofluorescent background signal in fluorescent images 
since, unlike the yellow-green nanoparticles, they did not fluoresce in the same spectral 
region. According to the manufacturer’s batch specifications the differences between 
size and surface characteristics of the red and yellow-green nanoparticles were 
considered negligible. Therefore, the different core particle composition was considered 
not to have influenced the ability of the nanoparticles to transport through the tissue in 
any measurable way. 
 
Finally, in order to investigate the effects of chitosan or polysorbate 80 in the absence of 
nanoparticles, control samples of chitosan solution (125µg/ml) in 0.5mM citrate buffer 
(pH6.0) or polysorbate 80 solution (137.5µg/ml) in SNS buffer (pH7.4) were 
investigated in the same way as described above. 
 
The concentration of each of these control solutions was approximately the highest 
theoretical concentration of chitosan or polysorbate 80 to which the olfactory epithelia 
was exposed during the nanoparticle transport studies. For example, 20nm P80-PS was 
formulated with 2140µg/ml polysorbate 80. After dilution of the 20nm P80-PS 
formulation for the transport study the actual concentration of polysorbate 80 in the 
donor side of diffusion chamber was 6.4µg/ml (Table 4.1). Hence, the highest 
concentration of either chitosan or polysorbate 80 found in the nanoparticle transport 
studies was equivalent to that found in the 200nm C-PS or 200nm P80-PS samples since 
they required the least dilution (Table 4.1). 
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Table 4.1 Concentration of formulated particles and resultant concentrations of chitosan 
or polysorbate 80 in donor chambers during transport studies 
Nominal 
Particle 
Diameter 
(nm) 
Formulated 
Concentration 
(particles/ml) 
Donor Chamber 
Chitosan 
Content 
Donor Chamber 
Polysorbate 80 
Content 
Control 
solutions 
 125µg/ml 
(0.87µM)* 
137.5µg/ml 
(105µM)† 
20 1.51x1013 0.75µg/ml 
(0.005µM) 
6.4µg/ml 
(4.9µM) 
100 2.91x1011 39.1µg/ml 
(0.27µM) 
8.4µg/ml 
(6.4µM) 
200 9.59x1010 119µg/ml 
(0.83µM)* 
127.4µg/ml 
(97mM)† 
*
, †
 concentration of control solutions was approximately equal to the highest 
concentration of either chitosan or polysorbate 80 in the other samples 
4.2.1.3 Test Formulations 
20nm, 100nm or 200nm PS nanoparticles (surface modified with either chitosan 
(pH6.0) or polysorbate 80 (pH7.4) (Chapter 3)) were used in the transport studies. 
Uncoated versions were also investigated inorder to compare the effect of the surface 
coatings. SNS buffer and 0.5mM pH6.0 citrate buffer were used as control solutions, 
with and without 300mM sodium azide, to compare the effects of each of these 
solutions on the tissue. In addition, 100nm C-PS nanoparticles were also formulated at 
pH4.5 in order to investigate the relationship between pH and mucoadhesion in relation 
to the C-PS system. 
 
Procurement of pigs was halted nationally by the British Government during part of this 
study due to an outbreak of foot-and-mouth disease in animals. Therefore,  
P80-FCS-PS nanoparticles could not be investigated using the diffusion chamber model. 
4.2.1.4 Spectrofluorometry 
The 200µL aliquots, taken during the transport study from the receiver chamber, were 
analysed for nanoparticles using a spectrofluorometer. Yellow-green or red fluorescent 
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nanoparticles were detected at Ex/Em 485/530 (FL600FA, Labtech Int. Ltd., Ringmer, 
UK) or 530/590 (FluoroSkan Ascent, Thermo, Stone, UK), respectively. The 
concentration of particles (particles/ml) in each aliquot was calculated by using a 
standard curve. 
 
To construct a standard curve the concentration of particles per ml was calculated by 
using the following equation (Bangs 1984) : 
Number of nanoparticles/ml = 3
12106
piρϕ
×C
 
Where: 
C = concentration of suspended nanoparticles (g/ml) 
φ= diameter of nanoparticles (m) 
ρ = density of polymer (g/ml) [1.05g/ml for polystyrene] 
 
Serial dilutions were made and the fluorescence value (RFU) for each triplicate standard 
was measured. The mean and standard deviation for each concentration was calculated. 
The limit of detection was derived (as shown in Figure 4.1). Samples that had a signal 
less than this value were assumed to contain no particles. 
 
The limit of detection was used to exclude samples that gave readings which were 
indistinguishable from blank values (buffer alone) to a confidence level of 99.85% (i.e. 
within 3 standard deviations of the mean blank value assuming that the error about the 
blank samples is random and normally distributed) (Miller 1993). 
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Limit of detection was determined by adding the 3 standard deviations to the mean 
blank value and then deriving the corresponding particles/ml using the standard curve 
(Figure 4.1). 
 
 
Figure 4.1 Determination of the Limit of Detection 
 
4.2.1.5 Histological Sample Preparation 
Two small pieces (approx. 4mm2) of olfactory epithelium were cut from the dismounted 
tissue from the Franz diffusion cell after termination of the experiment using a scalpel 
knife. One sample was immediately placed into 3% glutaraldehyde in 0.1M cacodylate 
buffer for at least 48 hours and subsequently processed for light microscopy as 
previously described (2.2.7 Preparation of Tissue Samples for Microscopy). 
 
The second sample was frozen by submerging it into isopentane which was supercooled 
using liquid nitrogen. This is a standard histological technique called ‘snap freezing’ 
(Bancroft & Stevens 1999). Isopentane is used for this purpose since it is hydrophobic 
and quickly permeates the biological tissue to freeze it. Liquid nitrogen could also be 
used but its boiling point is lower and it is less hydrophobic. Therefore, without 
cryoprotection techniques (4.3.1.5 Histological and Imaging Procedures), the inner core 
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Fluorescence (RFU) 
 
Standard 
deviation x 3 
 
0 
Limit of Detection 
 
x 
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of the tissue may not freeze instantaneously with the outer parts and hence this may lead 
to distortions in the morphology of the tissue. These samples were then stored at -80°C 
until required for cryo-sectioning. 
 
For cryosectioning, snap-frozen samples were held in perpendicular alignment in 
relation to a cork disc. The embedding compound, Cryo-M-bed™, was applied onto the 
top and quickly frozen by dripping supercooled isopentane over the whole assembly. 
This froze the tissue sample in the correct orientation with respect to the cork disk. 
 
The embedded sample was then sliced into 10m sections using a cryostat (B3889, 
Bright Instrument Co. Ltd. Huntingdon, UK). These slices were placed on poly-L-lysine 
pre-coated microscope slides and allowed to melt and air dry. Air drying allowed the 
sample to fix onto the microscope slide. 
 
A coverslip was then mounted using a standard histological glycerol-based mounting 
medium (Bancroft & Stevens 1999). The medium had low refractive index (1.42) which 
had the advantage of allowing better visibility of unstained structures in the tissue 
sample. It was also aqueous-based and therefore, unlike organic solvent-based 
alternatives, did not leach away the fluorescent dye from within the particles. After 
applying the coverslip with glycerol jelly the slide was left on a warm (40ºC) hotplate 
for about 30 minutes; this allowed the medium soak into the section. It was then 
removed to a cool place to set. Care was taken to avoid bubbles trapped under the 
coverslip.  
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Imaging of histological sections was performed using a Labophot 2 fluorescent 
microscope (Nikon UK Ltd, Kingston Upon Thames, UK) mounted with a high-
resolution DXM1200 camera (Nikon UK Ltd, Kingston Upon Thames, UK) and 
bandpass filter cubes for DAPI, FITC and TRITC (Nikon UK Ltd, Kingston Upon 
Thames, UK). Images were acquired using Nikon ACT software (Nikon UK Ltd, 
Kingston Upon Thames, UK). 
4.2.1.6 Statistical Analysis 
Results are presented as means±standard error. A one-way analysis of variance 
(ANOVA) with a post hoc test was used to compare either 0.5mM citrate (pH6.0) or 
SNS (pH7.4) buffered samples to samples exposed to test formulations. A Bonferroni 
post hoc test was performed on groups with equal variances and a Games-Howell post-
hoc test was performed on groups with unequal variances. A value of p<0.05 was 
considered statistically significant. 
 
4.2.2 Results 
This section describes the findings of the vertical Franz diffusion cell study. 
Fluorescence microscopy and spectroscopy were used to view excised porcine olfactory 
epithelia after application of test formulations. In addition, histology, electrophysiology 
and a fluorescence-based cellular metabolism assay (Alamar Blue™) were used to 
investigate the effect of the different nanoparticle formulations on the morphology and 
viability of the olfactory epithelia samples, respectively. 
 
In relation to the study objectives and to demonstrate the differences (or lack thereof) in 
the results the data are grouped by surface modifications (PS, C-PS, P80-PS) or particle 
diameter (20nm, 100nm, 200nm). 
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4.2.2.1 The Influence of Particle Surface Modifications on Particle Transport 
No transport was detected to the receiver chamber for any of the nine nanoparticle 
formulations. However, losses of nanoparticles were detected from the donor chamber 
after the transport study compared to the initial concentrations; this was calculated as a 
percentage loss (Table 4.2). Only a negligible (0.9±3.0%) number of particles were lost 
from the donor chamber for PS nanoparticles. A slightly greater loss was seen for the 
P80-PS nanoparticles (4.2±6.3%) compared to PS but this difference was not significant 
(p>0.05 ANOVA). In pH6.0, C-PS showed significantly higher losses from the donor 
side compared uncoated particles (10.6±3.2%; p≤0.05 ANOVA). This loss was even 
greater when were applied in pH4.5 buffer (39.9±4.6%; p≤0.01 ANOVA). At pH4.5 
chitosan has a higher degree of charged glucosamine units. This showed that a lowering 
of the pH in the bulk phase changed the degree of interaction of the adsorbed chitosan 
layer (on the PS nanoparticle) with the olfactory mucosa. 
 
Table 4.2 Percentage loss of particles from donor chamber during transport study 
with surface modified and unmodified PS 
Test Formulation % (Mean±Standard Error) 
Uncoated Particles pH7.4 (n=12) 0.9±3.0 
Polysorbate 80-coated particles pH7.4 (n=9) 4.2±6.3 
Chitosan-coated Particles pH6.0 (n=11) 10.6±3.2a 
Chitosan-coated Particles pH4.5 (n=4) 39.9±4.6b 
Statistically significant compared to uncoated particles (ANOVA with Bonfferoni 
post hoc test a p<0.05, bp<0.01) 
 
The loss of nanoparticles from the donor chamber, however, did not result in the 
appearance of nanoparticles in the receiver chamber as mentioned above. Therefore, a 
histological evaluation of the olfactory tissue was conducted with the aim to assess 
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whether the nanoparticles that were lost from the donor chamber were associated with 
the tissue or had penetrated into the tissue. 
 
Figure 4.2(a,b) shows fluorescent microscopy images of PS (green), P80-PS (red) and 
associated with porcine olfactory epithelium prepared after transport studies. Images 
were slightly overexposed in order to view the location of the particles in relation to the 
autofluorescence signal from the olfactory tissue. The images seem to correlate with the 
quantitative losses of particles from the donor chambers since, in general, more 
fluorescence was seen interacting with the olfactory mucosa when a greater number of 
particles were lost from the donor chamber (Table 4.2 and Figure 4.2). 
 
Uncoated particles showed little association with the olfactory tissue (Figure 4.2). The 
location of the PS at the apical edge of the mucosa suggested that they were trapped in 
the overlying mucus and did not penetrate into the cells. 
 
A greater number of 100nm P80-PS nanoparticles were observed in the olfactory 
mucosa after a transport study than 200nm PS. It was not possible to conclude whether 
the particles had penetrated into the cells. The location of these particles could show 
that they were trapped in the overlaying mucus layer. 
 
For 200nm C-PS in pH6.0 buffer, the bright field image shows that the particles can 
become highly associated with the luminal surface of the olfactory mucosa (Figure 
4.2c). This high level of association was, however, not uniform throughout the whole 
epithelial surface. Again, it was difficult to assess if particles had penetrated into the 
cells. Unfortunately, direct comparisons between 100nm diameter particles with 
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different surface modifications were not possible since many of the transport study 
epithelia were lost during the protocol development stage for producing the 
fluorescence microscopy images. 
 
In future, staining of cell membranes and/or nuclei could clarify the exact position of 
the nanoparticles in relation to the epithelial cell and overlying mucus. 
 
  
 
Figure 4.2 Images of porcine olfactory epithelium 
after transport study with PS, P80-PS, C-PS, 
surface-modified nanoparticles. * shows the 
luminal space. 
 
 
(a,b) Fluorescence microscope images of (a) 200nm 
PS (green) (scalebar 50µm) (b) 100nm P80-PS 
(red) (scalebar 50µm) (c) Bright field image of 
200nm C-PS (visible as orange) (Scalebar, 10µm).  
 
Investigations were carried out using Rm, PD, Isc and Alamar Blue™ tests to evaluate 
whether nanoparticles applied to the olfactory epithelium affected the viability of the 
epithelium itself. Quantitative data from these tests were collected and statistically 
analysed for changes compared to the control samples which were exposed to either 
50µm 
* 
* 
a 
c 
50µm 
* 
b 
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SNS (pH7.4) or 0.5mM citrate (pH6.0) buffers without nanoparticles. Bright field 
microscopy was also used to evaluate the condition of the olfactory epithelium after use 
in the vertical Franz diffusion cell (Figure 4.3). In addition, similar information was 
gathered to evaluate the effect of polysorbate 80 (105µM) and chitosan (0.87µM) 
solutions on olfactory epithelium compared to the SNS or citrate buffered control 
samples. 
 
In the analysis below, only the surface effect of 100nm diameter nanoparticles are 
presented since they were the smallest nanoparticles that could be observed by 
fluorescence microscopy. Also, these particles were the smallest that were shown to 
directly interact with the olfactory epithelial cell and in vivo studies had shown that 
fewer 200nm nanoparticles were absorbed into the olfactory epithelium than 100nm 
particles (4.3.2.2 The Influence of Particle Surface Modifications on Particle Transport). 
Thus, 100nm nanoparticle had more potential to affect the viability of the epithelium 
than the 200nm nanoparticles; hence, data for 20nm and 200nm nanoparticles are not 
presented here. 
 
Table 4.3 shows that Rm, PD and Alamar Blue™ measurements of olfactory epithelia 
exposed to SNS containing 300mM sodium azide were statistically different to samples 
that were exposed to only SNS buffer without sodium azide (p<0.05 ANOVA). Isc 
measurements of the same epithelia were not found to be statistically different, due to 
the variability within the samples. Nevertheless, the mean values were markedly 
different for the different groups of olfactory epithelia that were exposed to varying 
conditions; -107±42µA/cm2 for SNS with sodium azide compared to +13±1µA/cm2 
SNS without sodium azide, +14±4µA/cm2 for polysorbate 80 in SNS, +1±7µA/cm2 for 
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100nm PS, and +5±1µA/cm2 for 100nm P80-PS. Overall sodium azide was considered 
to have significantly reduced the metabolism of the cells in the SNS buffered olfactory 
epithelium (2.4.2 Tissue Viability: The Effect of pH Buffers and Sodium Azide). 
 
Rm, PD and Isc values for polysorbate 80 (105µM) in SNS were not significantly 
different compared to the SNS buffer control. Alamar Blue™ data, however, were 
significantly lower (p<0.05 ANOVA). It is difficult to conclude from these 
contradicting results whether polysorbate 80 had any effect on the olfactory epithelium 
in these studies. However, when the images of olfactory epithelium that had been 
exposed to polysorbate 80 were compared to those that were exposed to only SNS 
buffer, it can be concluded that some morphological changes resulted from the 
application of the surfactant on the mucosa (Figure 4.3b). It can be concluded that 
105µM polysorbate 80 in SNS did change the metabolic activity and morphology of the 
cells which was detected as a significant fall in Alamar Blue™ values and visible 
changes to the epithelium, respectively. 
 
Changes to epithelial viability were not observed by any of the four viability scores for 
100nm PS. This was expected since (carboxylated) PS particles should not be toxic to 
cells at these concentrations (Xia et al 2006). Surface modification of the 100nm PS 
with polysorbate 80 did not significantly reduce the viability of the samples (except for 
Isc values) compared to the SNS buffered controls (Table 4.3) (p<0.05 ANOVA). 
However, the bright field image of 100nm P80-PS exposed olfactory epithelia (Figure 
4.3c) showed little damage compared to the samples buffering in SNS alone (Figure 
4.3a). Therefore, overall the P80-PS nanoparticles did not affect the viability of the 
olfactory epithelia. 
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For citrate buffer, only Isc measurements for 0.5mM citrate buffer containing 300mM 
sodium azide (pH6.0) were statistically different to corresponding SNS values (p<0.05 
ANOVA). Rm, PD and Alamar Blue™ measurements of the citrate buffered epithelia 
were not found to be statistically different. In fact, when the citrate buffer exposed 
epithelial were observed under light microscopy (Figure 4.3d), the apical cells in the 
epithelial appeared to be damaged compared to the SNS buffered olfactory epithelia 
(Figure 4.3a). For example, cilia appeared to be shorter and the olfactory knob (boxed) 
appeared disfigured compared to their usual distinctive shape (Figure 4.3d). Therefore, 
sodium azide was not considered to have significantly reduced the metabolism of the 
cells in the olfactory epithelium because the major reduction in metabolic activity was 
thought to have been a consequence of the 0.5mM citrate buffer itself (2.4.2 Tissue 
Viability: The Effect of pH Buffers and Sodium Azide). 
 
Damage to the olfactory epithelium was made worse by the addition of 0.87µM 
chitosan solution (Figure 4.3e) to the citrate buffer. Under bright field, not only had the 
cells lost their cilia but chitosan had physically damaged cell integrity as well (Figure 
4.3e). 
 
Finally, 100nm C-PS even further deteriorated the condition of the olfactory epithelia 
compared to those samples exposed to chitosan solution in citrate buffer (Figure 4.3f). 
The 100nm C-PS exposed epithelia had damaged cell integrity to the point that the 
epithelium was no longer recognisable as pseudostratified columnar. Again, there was 
no significant difference in Rm, PD, Isc and Alamar Blue™ values between 100nm C-PS 
and 0.5mM citrate buffer exposed olfactory epithelia.  
  200 
 
Table 4.3 The effect of nanoparticle surface modification on Rm, PD, Isc and Alamar Blue™ 
viability measurements using porcine olfactory epithelia during vertical Franz diffusion cell 
transport studies 
Test Formulation Rm (	cm2) PD (mV) Isc(µA/cm2) Alamar 
Blue™ (RFU) 
SNS Buffer pH7.4 59±7 -0.8±0.1 +13±1 10530±390 
SNS Buffer pH7.4+azide 8±2a +0.7±0.2b -107±42 3260±280a 
Polysorbate 80 in SNS 69±8 -0.9±0.3 +14±4 6910±870a 
100nm PS 79±5 -0.0±0.5 +1±7 10490±880 
100nm P80-PS 44±11 -0.2±0.1 +5±1b 8200±750 
 
Test Formulation Rm (	cm2) PD (mV) Isc(µA/cm2) Alamar 
Blue™ (RFU) 
Citrate Buffer pH6.0 79±23 -0.1±0.0 +1±0 5760±280 
Citrate Buffer pH6.0+azide 11±2 +1.5±0.5 -134±43c 3080±440 
Chitosan Solution 68±28 +1.0±0.9 -9±7 6200±660 
100nm C-PS 45±14 -0.2±0.2 +9±8 6850±880 
Mean±Standard error (n=3). a Significantly different (p<0.05) compared to SNS buffer (pH7.4) 
(ANOVA Bonferroni post hoc test, n=3), b Significantly different (p<0.05) compared to SNS buffer 
(pH7.4) (ANOVA Games-Howell post hoc test, n=3), c Significantly different (p<0.05) compared to 
0.5mM citrate buffer (pH6.0) (ANOVA Bonferroni post hoc test, n=3).  
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Figure 4.3 The effect of nanoparticle surface modification on epithelial morphology using porcine 
olfactory epithelia during vertical Franz diffusion cell transport studies 
  
 
 
 
 
(a) SNS Buffer pH7.4 (b) Polysorbate 80 (105µM) in SNS buffer (c) 100nm P80-PS (d) 0.5mM 
citrate buffer pH6.0, olfactory knob boxed (e) Chitosan.HCl solution (0.87µM) (f) 100nm C-PS. 
* shows the luminal space. 
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f 
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4.2.2.2 The Influence of Particle Diameter on Particle Transport 
No transport of 20nm, 100nm or 200nm C-PS nanoparticles to the receiver chamber 
was detected for any of the nanoparticle test formulations. 
 
In the analysis below only the C-PS system is presented since chitosan modification 
showed the greatest toxicity to the porcine olfactory epithelia (Figure 4.3). These 
particles also demonstrated the clearest size-related damage to olfactory epithelium. 
 
For each of the three formulations a mean loss of 8-12% of nanoparticles from the 
donor chamber was detected after the transport study compared to initial concentration 
(Table 4.4). However, no significant differences were observed between the groups of 
different sized nanoparticles (p>0.05 ANOVA). This possibly showed that particle 
surface modification with either chitosan or polysorbate 80 had a greater effect on the 
interaction of the nanoparticles with the olfactory mucosa than particle diameter in these 
samples, because statistical differences in percentage donor chamber particle losses 
were shown by surface modifying the nanoparticles (Table 4.2). 
 
Alternatively, it was more difficult to evaluate the exact losses of particles from the 
donor chamber as the particle size was reduced. This may have lead to the greater 
degree of standard error that was observed with the smaller particles (Table 4.4), which 
consequently resulted in a lack of significance between the groups. Hence, 
proportionally more particles may have been lost from the donor chamber as particle 
size reduced but it was not detectable due to the accuracy limits of the fluorimeter that 
was employed. 
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Table 4.4 Percentage loss of 20nm, 100nm and 200nm C-PS nanoparticles from donor 
chamber during transport studies 
Test Formulation % (Mean±Standard Error) Total Donor Chamber 
Chitosan Content 
20nm C-PS (n=3) 12±9 0.005µM 
100nm C-PS (n=4) 12±7 0.27µM 
200nm C-PS (n=4) 8±3 0.83µM 
No statistically differences were observed between the groups (p>0.05 ANOVA) 
 
A morphological examination of the olfactory epithelia after exposure to the different 
sized C-PS, however, revealed that the 20nm diameter nanoparticles may have caused 
considerable more damage than either the 100nm or 200nm C-PS (Figure 4.4). The 
relationship between olfactory tissue damage and particle diameter showed that more 
damage was observed with smaller particles. For example, 200nm C-PS changed the 
appearance of the pseudostratified columnar cells to become less regular in shape and 
removed completely the appearance of cilia. 100nm C-PS damaged cell integrity of the 
tissue further so that the nuclei remained as the only subcellular features that could be 
distinguished by light microscopy. 20nm C-PS deteriorated the epithelial cells further so 
that even the nuclei very not visible.  
 
Particle diameter was implicated as the main factor causing this damage, though, 
another uncontrolled variable in this experiment was the donor chamber chitosan 
concentration. Some chitosan remained in solution during the transport studies because 
an excess of chitosan was used during the surface modification process. The exact 
concentration of excess chitosan that was free in solution was not determined; but, 
knowledge of the initial chitosan concentration during formulation (1.74µM) was used 
to calculate the total chitosan in the donor chamber for each C-PS formulation (Table 
4.4). By this analysis excess chitosan was unlikely to have been the cause of the 
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epithelial damage since the larger particle formulations contained greater concentrations 
of total chitosan in the system but showed least epithelial damage (Figure 4.4). 
 
Figure 4.4 Condition of porcine olfactory epithelium after Franz diffusion cell transport studies with 
20nm, 100nm, 200nm C-PS. * shows the luminal space. 
 
 
 
 
(a) Chitosan solution in citrate buffer (0.87µM) (b) 200nm C-PS (c) 100nm C-PS (d) 20nm C-PS 
 
Rm, PD or Isc and Alamar Blue™ measurements for olfactory epithelia that were 
exposed to 20nm, 100nm or 200nm C-PS again showed no significant difference 
compared to the citrate buffered epithelia (p>0.05 ANOVA) (Table 4.5). This was in 
line with the morphological observation above and earlier results that showed that the 
0.5mM citrate buffer pH6.0 reduced the viability of the porcine olfactory epithelia 
during the vertical Franz diffusion chamber studies. 
* 
* 
* 
* 
a c 
b d 
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Table 4.5 The effect of 20nm, 100nm and 200nm diameter C-PS nanoparticles on Rm, PD, Isc and 
Alamar Blue™ viability measurements using porcine olfactory epithelia during vertical Franz 
diffusion cell transport studies 
 Rm (cm2) PD (mV) Isc(µA/cm2) Alamar 
Blue™ (RFU) 
Citrate Buffer pH6.0 79±23 -0.1±0.0 +1±0 5760±280 
20nm chitosan-coated 37±7 +0.2±0.4 -11±15 4960±410 
100nm chitosan-coated 45±14 -0.2±0.2 +9±8 6850±880 
200nm chitosan-coated 65±16 +0.3±0.4 -3±6 8090±1380 
No statistically differences were observed between particle exposed epithelia and citrate buffered 
groups (p>0.05 ANOVA). Mean±Standard error (n=3). 
 
4.3 TRANSPORT STUDY USING THE IN VIVO MOUSE MODEL 
 
The objective for this study was to use fluorescence microscopy and stereological 
techniques to compare the abilities of nanoparticles, of different sizes and different 
surface characteristics, to transport through the olfactory or non-olfactory epithelia in 
the nasal cavity of the in vivo mouse model. 
 
The different formulations used in this study were 100nm or 200nm PS nanoparticles 
which were surface modified with either chitosan or polysorbate 80/FCS. Uncoated 
100nm particles were also used in the experiment in order to compare the effect of the 
surface coatings. 
4.3.1 Materials and Methods 
4.3.1.1 Materials 
Histological samples were mounted onto microscope slide using Prolong Gold DAPI 
(Invitrogen A/S, Taastrup, Denmark). All other materials were sourced and prepared as 
described in Chapter 3. 
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4.3.1.2 Animals 
Male inbred mice (C57BL/6JBom) (Taconic, Lille Skensved, Denmark) approximately 
10 weeks old were used (body weight of 23-25g). The mice, in groups of 3-5, were 
housed in microisolators (filter top cages, Tecniplast, Italy) under pathogen-free 
conditions with a 12-hour light / 12-hour dark schedule and fed autoclaved standard 
chow (Altromin #1324, Lage, Germany) and water ad libitum throughout the 
experiment. The Danish Experimental Animal Inspectorate approved the experimental 
protocol and all the animal experiments were performed according to the ethical 
standards required by the local Guidelines. 
 
The animals were inbred and provided with a standardised environment and diet to 
reduce data variability (Gizurarson 1990). In addition, the anatomy of the scrolled 
turbinates and morphology of the different nasal epithelia in the mouse are similar to 
most other mammals including pigs and humans.  
 
4.3.1.3 Intranasal Administration 
Prior to dosing, animals were anesthetised with isoflurane in air (3.75% v/v Forene™, 
Abbott Laboratories, UK) and maintained to effect. Mice were handled in a supine 
position to allow better contact of the formulation with the nasal epithelia during dosing 
(Gizurarson 1990). 15µl of the test formulation containing 4.55x1010particles/ml was 
instilled by pipette into each naris. Mice were then placed on their sides until they woke 
up approximately 1-2 minutes later. The procedure was repeated every ~24 hours with 
freshly prepared samples for two further days. Animals were deeply anaesthetized 
(isoflurane) and killed on day 4 by cardiac perfusion fixation with 4% formalin in PBS. 
Then the head was removed and placed in the same fixative for 48 hours. Thereafter, 
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they were stored (for no longer than 6 weeks) in PBS buffer with 0.02% sodium azide 
until ready for cryosectioning.  
4.3.1.4 Test formulations 
In total, 6 groups of two animals were dosed intranasally with 30µl of test formulation 
as follows: (Group 1) 0.5mM Citrate buffer pH6.0, (Group 2) 100nm C-PS, (Group 3) 
200nm C-PS, (Group 4) 100nm P80-FCS-PS, (Group 5) 200nm P80-FCS-PS, or (Group 
6) 100nm PS. The formulations were made as previously described (Chapter 3) and 
diluted to 4.55x1010particles/ml using citrate buffer (Groups 1-3) or SNS buffer (Groups 
4-6) before intranasal instillation. 
 
Not all formulations that were developed in Chapter 3 were used here due to limitations 
of time and availability of animals. P80-FCS-PS formulations were preferred to P80-PS 
formulations since it was considered that FCS adsorbed to P80-PS could improve 
uptake of nanoparticles into the epithelial cells. 20nm nanoparticle formulations were 
not investigated here since it was not clear from the in vitro work whether these 
particles could be seen by fluorescence microscopy. The citrate buffer was chosen as a 
non-particulate control since damage to the epithelia due to the buffer alone could be 
evaluated. It was expected that the citrate buffer had a greater potential to show such 
damage compared to SNS buffer due to the conclusions drawn from the Franz diffusion 
chamber experiments (Chapter 2). In addition, SNS buffer has not shown to cause 
mucosal damage previously in rats (Jansson 2004) therefore a control experiment with 
SNS buffer alone was deemed less important than the citrate buffer. 
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4.3.1.5 Histological and Imaging Procedures 
First the skin was removed from the skull taking care not to break the nose. Excess 
water was blotted off and then the sample was weighed and placed overnight into a 
beaker under slow stirring with EDTA in PBS buffer 0.25M pH 7.4. The skulls were 
subsequently blotted, weighed and returned into the decalcifying buffer each day until 
decalcification endpoint was reached. The decalcification was reached when skulls no 
longer lost weight but started to regain it. This marked the end of decalcification and 
start of water absorption into the tissue. Skulls were briefly washed and placed in 
sucrose solution for cryoprotection. 
 
The skulls were cryoprotected by placing them in 30%w/v sucrose for 48 hours. They 
were then mounted onto metal discs with a layer of cryomountant (TissueTek, Sakura 
Finetek). Then more cryomountant was used to cover the entire skull. The whole 
assembly was subsequently frozen directly with liquid nitrogen. 
 
Cryosections were cut to 5µm thickness at -20°C. At the first appearance of olfactory 
bulbs three sections for every 250µm were cut and placed on microscope slides until the 
olfactory bulbs were no longer visible. Sections were placed on microscope slides and 
allowed to fix by warming and drying at room temperature. Sections were then 
coverslip-mounted with Prolong Gold DAPI which incorporated a nuclear stain. Finally, 
the location of the particles along the entire olfactory system was determined using 
fluorescence microscopy as described below. 
 
Imaging was performed in an inverted Axiovert 200M fluorescent microscope (Zeiss, 
Germany) mounted with a high-resolution CoolSnap HQ CCD camera (Photometrics, 
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USA) and bandpass filter cubes for GFP, Cy3 and DAPI (Chroma Technology, USA). 
Images were acquired using MetaMorph software (Molecular Devices, USA). 
 
4.3.1.6 Estimating Tissue Particle Numbers 
Fluorescence microscopy was used to count fluorescently labelled red particles in the 
histological sections. An autofluorescent signal from the epithelium was used to locate 
and identify the tissue during particles counting. 
 
The method for estimating the number of particles in the tissue for each type of nasal 
epithelium was adapted from the stereological estimation method described by 
Nyengaard (Nyengaard 1999). Briefly, an unbiased sampling frame was used together 
with random tessellation in order to eliminate duplicate counting of particles. The 
random tessellation was controlled by a computer-aided stereology tool (CAST 
software; Visiopharm, Hørsholm, Denmark). Particles were counted manually therefore 
only particles that were associated with the olfactory or non-olfactory epithelium were 
included in the count. However, at the low magnification used (x4) to view the whole 
sample, it was not possible to conclude if the apically located nanoparticles were 
positioned extracellularly or intracellularly. But nanoparticles associated with mucus 
that was detached from the epithelium lining were not included (e.g. Figure 4.6b). The 
square sampling frame (30,000µm2) was moved randomly by the software programme 
with a step length of 500µmx500µm in (x,y) coordinates. The total sampling area per 
histological section was 12% of the total sample surface. A total of 7-8 sections per 
animal were analysed in this way. The number of particles per unit area was calculated 
by dividing the number of particles in either olfactory or non-olfactory epithelium by 
the area of the sample. 
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Histological sections were analysed for particle numbers in an upright fluorescent 
microscope (Olympus BX51, Tokyo, Japan) with a GFP/dsRed filter (Chroma 
Technology, USA), a mounted digital camera (Olympus DP-70) and a motorized stage 
(Prior Scientific) in conjunction with CAST software (Visiopharm, Copenhagen, 
Denmark). 
 
The appearance of olfactory epithelium was confirmed, by comparing samples with 
images from a histological reference (Geneser 1990) and using local knowledge within 
the stereological laboratory, to ensure that the correct regional distinctions between the 
non-olfactory and olfactory epithelia were made. 
 
Statistical analysis of the data was not possible due to low sample numbers (only two 
mice were used per test formulation). 
 
4.3.2 Results 
In this section Figure 4.5 to Figure 4.6 show fluorescent microscope images of the 
murine nasal epithelia taken from the mice which were intranasally administered one of 
the six test formulations. The histological images are grouped, in relation to the chapter 
objectives, to demonstrate the differences (or lack of) between: (i) condition of buffer-
control and nanoparticle-exposed epithelia; (ii) transport of 100nm and 200nm diameter 
particles; and (iii) transport of surface modified nanoparticles (C-PS and P80-FCS-PS)  
across olfactory or non-olfactory epithelia. 
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4.3.2.1 Condition of Epithelia after Exposure to Citrate Buffer 
Autofluorescence (green) from the epithelia samples was detected by fluorescence 
microscopy to show the morphology of (a) olfactory and (b) non-olfactory nasal 
epithelia; in addition, nuclei were labelled with DAPI (blue) (Figure 4.5). In Figure 
4.5(a) the apical surface of the olfactory epithelium was in tact and the borders of 
individual cells can be distinguished. The pseudostratified columnar cells were tall and 
nuclei were densely packed. An example of non-olfactory epithelium morphology is 
shown in Figure 4.5(b). The epithelium in this example was ciliated cuboidal. However, 
epithelial cells in the non-olfactory region in general were a mixture of ciliated cuboidal 
or ciliated pseudostratified columnar. Columnar cells in the non-olfactory region were 
shorter than pseudostratified columnar cells in the olfactory region. Also, nuclei (blue) 
were less densely packed in non-olfactory compared to olfactory epithelial cells. The 
mixture of epithelial morphologies in the non-olfactory regions meant that this tissue 
could not be described as respiratory epithelium; respiratory epithelium has 
pseudostratified columnar morphology (Adams 1972, Matulionis & Parks 1973 and 
1.2.4 The Structure of Nasal Epithelia). The quality of both epithelia was comparable to 
those using light microscopy of fresh porcine olfactory epithelia (2.3.1 Morphological 
Features of Porcine Nasal Epithelia). 
 
In some samples nuclei appeared in the mucus (Figure 4.6b). It was therefore concluded 
that cell debris was found in mucus lying on top of the epithelial cells in these samples. 
This is considered normal since mucus has been shown previously to contain cell debris 
by Khanvilkar et al. (2001). The content of cell debris in mucus varies from region-to-
region (Sims & Horne 1997). 
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Figure 4.5 Fluorescent microscope images of murine nasal epithelia after treatment with citrate buffer. 
  
The images show the morphological differences between olfactory and non-olfactory epithelia: (a) 
Olfactory epithelium; (b) Non-olfactory epithelium. An autofluorescent signal (green) was used to 
visualise the cells. Nuclei were labelled with DAPI (blue). * marks luminal space. Magnification x40 
 
4.3.2.2 The Influence of Particle Surface Modifications on Particle Transport 
Stereological data showed that the overall particle numbers of 100nm PS associated 
with the mouse olfactory epithelium was 50-375particles/mm2. 100nm PS nanoparticles 
were taken up into the mouse olfactory epithelium was seen by fluorescence microscopy 
(Figure 4.6a). Polysorbate 80-FCS modification of 100nm PS nanoparticles did not 
appear to change the ability of the nanoparticles to transport into the olfactory 
epithelium (100-300particles/mm2) compared to bare 100nm PS particles. This was 
qualitatively confirmed by fluorescence microscopy (Figure 4.6a and Figure 4.7a).  
 
Chitosan surface modification of 100nm PS (100nm C-PS), however, appeared to 
reduce the transport of the particles into the cells (0-60particles/mm2) and increase 
association of the particles to the mucus as seen by fluorescence microscopy (Figure 
4.6b) compared to both 100nm PS (50-375particles/mm2) and 100nm P80-FCS-PS 
(100-300particles/mm2) systems. This suggested that surface modification of the 
nanoparticles with chitosan reduced their association with the olfactory epithelia 
b a 
* 
* 
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compared to 100nm PS. However, surface modification of 100nm PS with P80/FCS did 
not affect epithelial distribution compared to bare 100nm PS. 
 
Figure 4.6 Fluorescent microscope images of murine nasal epithelia after treatment with (a) 100nm PS 
or (b) 100nm C-PS  
  
(a) 100nm PS penetrated to basement membrane of olfactory epithelium (sample contained a hole in the 
tissue due to a cryosectioning artefact (dashed boxed)). (b) More 100nm C-PS particles (red) associated 
with the mucus (arrow) and fewer 100nm C-PS particles were seen in cells. Cells were nuclear labelled 
with DAPI (blue). Autofluorescence (green) from olfactory epithelium. Magnification x40. * marks 
luminal space. 
 
a b 
* 
* 
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4.3.2.3 The Influence of Particle Diameter on Particle Transport 
100nm and 200nm diameter P80-FCS-PS and C-PS nanoparticles were used to 
investigate the effect of particle size on particle transport into the olfactory epithelium. 
A similar comparison could not be performed for PS nanoparticles since 200nm PS was 
not studied in the mouse model. The transported nanoparticles were observed within 
epithelial cells and not between cells. An example of the transcellular transport of 
100nm and 200nm P80-FCS-PS is shown in Figure 4.7(a,b).  
 
Figure 4.7 Fluorescent microscope images of murine nasal epithelia after application of with 100nm or 
200nm P80-FCS-PS 
  
A greater number of (a) 100nm particles (red) were observed in the cells of the olfactory epithelia 
compared to (b) 200nm particles (red). Cells were nuclear labelled with DAPI (blue). Magnification 
x40.* marks luminal space. 
 
Figure 4.7(a,b) shows a larger number of P80-FCS-PS 100nm nanoparticles were taken 
into the cells compared to P80-FCS-PS 200nm nanoparticles as visualised by 
fluorescence microscopy. This qualitative assessment was strengthened by stereological 
findings; hence, a greater quantity of 100nm P80-FCS-PS was associated with the 
murine olfactory epithelia (100-300 particles/mm2) than 200nm diameter P80-FCS-PS 
a b 
* 
* 
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(~40 particles/mm2) nanoparticles. The difference between 100nm and 200nm C-PS 
was less distinct (40-60 particles/mm2 and 90-130 particles/mm2, respectively). In 
addition, nanoparticles were not found in the olfactory bulbs of any animals (data not 
presented). 
 
4.3.2.4 Affect of Olfactory and Non-Olfactory Nasal Epithelia on Particle Transport 
Stereological results from the mouse model showed that particle association increased 
with non-olfactory epithelium compared to olfactory epithelium. A greater number of 
100nm PS, 100nm C-PS and 100nm P80-FCS-PS nanoparticles were found in the non-
olfactory mucosa (215 particles/mm2, 211 particles/mm2 and 44 particles/mm2, 
respectively) compared to olfactory mucosa (101 particles/mm2, 137 particles/mm2 and 
11 particles/mm2, respectively). 
 
In addition, 100nm P80-FCS-PS surface modification strategy did not result in clear 
preferential uptake of these nanoparticles compared to 100nm PS into either non-
olfactory (211 particles/mm2 and 215 particles/mm2, respectively) or olfactory tissues 
(137 particles/mm2 and 100 particles/mm2, respectively). 
 
4.4 DISCUSSION 
 
The objective of this study was to investigate the abilities of nanoparticles with different 
surface characteristics and different sizes to transport into the porcine or murine 
olfactory epithelia using excised tissue mounted in the in vitro vertical Franz diffusion 
cell and the in vivo mouse models, respectively. Both models were also used to assess 
the extent of epithelial damage by the different nanoparticles. In addition, the in vivo 
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model was used to investigate the transport of the test nanoparticles into the non-
olfactory epithelium and the olfactory epithelia.  
 
A number of different techniques were used to assess the affect of surface coating (PS, 
C-PS and P80-FCS-PS nanoparticles) and particle diameter (100nm and 200nm) on the 
transport of these particles into the nasal epithelium. The techniques used were: (i) 
histological imaging of epithelial samples, (ii) stereological and spectroscopic 
assessment of nanoparticle transport, and (iii) biochemical and bioelectrical assessment 
of epithelial viability. The results are discussed below. 
4.4.1 The Influence of Particle Surface Modifications on Particle Transport 
Intranasal uptake of PS nanoparticles is commonly found in the literature, however, 
there have been no specific studies investigating nose-to-brain transport of polystyrene 
particles. Brooking et al. showed transmucosal transport of 100nm PS particles into the 
systemic circulation after i.n. administration in rats (Brooking et al 2001). The 
bioavailability was 2% after 3 hours as a proportion of the administered dose. This was 
attributed to passage of nanoparticles through non-olfactory epithelium via M cells to 
NALT for antigen sampling. However, the researchers found negligible 100nm PS in 
whole brain homogenate 3 hours after administration of the dose. At first it would 
appear that the 100nm PS did not pass into brain after i.n. instillation. However, better 
microdissection of certain brain areas (such as the olfactory bulb) may have shown a 
higher degree of uptake in specific areas. An investigation of brain uptake was not the 
main objective for their experiment therefore a microdissection of the brain was not 
done. It was found in the current study that 100nm and 200nm PS did not reach the 
brain in detectable concentrations. Hence, the data presented here agreed with the 
findings of Brooking et al. (2001).  
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For C-PS it was observed, from the bright field image (Figure 4.2), donor chamber 
losses of nanoparticles from the in vitro system (Table 4.2) and fluorescence 
microscopy in the mouse model (Figure 4.7), that more nanoparticles remained in the 
extracellular mucus compared to PS, P80-PS or P80-FCS-PS. This prevented C-PS 
progress into the underlying epithelial cells. Indeed, a similar observation was made by 
Campos et al. who found by confocal microscopy that 465nm diameter chitosan-coated 
poly-ε-caprolactone particles favoured retention in the superficial layers of the New 
Zealand rabbit nasal epithelium after i.n. instillation (de Campos et al 2004).  
 
A well documented explanation for the retention of chitosan in mucus relates to the 
electrostatic interaction between the chitosan-coated nanoparticles and mucus 
(Kawashima et al 2000). It has been shown that the 100nm and 200nm C-PS have a 
positive charge in citrate buffer since they have a ζ potential of approximately +40mV 
(Chapter 3). It is also known that acidic residues (e.g. sialic acid pKa 2.6 (Leung & 
Robinson 1992) ) on mucus gel layer glycoproteins impart a negative charge to the 
mucosal surface (Mygind 1979). When the attractive forces were brought together by 
the application of C-PS to the mucus the C-PS nanoparticles adhered to the mucus 
which impeded their progress through it. 
 
Indeed, in the diffusion chamber experiment 10.6±3.2% of the C-PS particles in the 
donor chamber adhered to the mucus at pH6.0 compared to 39.9±4.6% at pH4.5 during 
the transport study experiments (Table 4.2). Therefore, more particles adhered to the 
mucus when the olfactory epithelium was buffered at a lower pH. This result 
demonstrated that adhesion between mucus and C-PS was predominantly due to 
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electrostatic interactions and implies that other forces such as hydrogen bonding had a 
lesser affect. 
 
Surface coating the PS nanoparticles with polysorbate 80 (P80-PS and P80-FCS-PS) did 
not statistically improve transport of surface modified particles into the nasal epithelial 
cells compared to bare PS nanoparticles. Donor chamber loss of the P80-PS particles 
(4.2±6.3%) was not a significantly greater than PS particles (0.9±3.0%) (Table 4.2). 
However, it is unclear whether more particles did penetrate the mucus in the in vitro 
model since fluorescence microscopy images of the dismounted olfactory epithelium 
found some areas of tissue did absorb P80-PS particles (Figure 4.2). 
 
It was expected that a surface modification with PEG would increase transport of the 
nanoparticles through the olfactory mucus by increasing the hydrophilicity and reducing 
the negative charge of the particle compared to PS (Vila et al 2004; Lai et al 2007). 
 
For example, Lai et al. (2007) found that conjugating 2kDa homopolymer PEG to the 
surface of 100nm and 200nm PS nanoparticles increased the diffusion coefficient of the 
particles through the cervicovaginal mucus by 20 and 381 times, respectively. However, 
differences in the experimental design described by Lai et al. (2007) and the current 
work may account for the disparity between the results from these studies. For example, 
in the diffusion chamber experiment the polysorbate 80 was adsorbed to the PS by 
hydrophobic-hydrophobic interactions whereas Lai et al. (2007) covalently bonded the 
PEG to the PS nanoparticles. Hence, it was less likely that the PEG molecule would 
disassociate from the PS surface in their study than in the diffusion chamber study. In 
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future, dissociation of the polysorbate 80 from the PS nanoparticles in the biological 
environment may be observed by fluorescently labelling the polysorbate 80. 
 
In addition, there are 2.3 times more PEG monomer units in 2kDa PEG homopolymer 
than in polysorbate 80. Hence, surface modification of 100nm PS with 2kDa PEG 
homopolymer reduced ζ potential from -41mV to -4mV (Lai et al 2007); however, 
surface modification of 100nm PS with polysorbate 80 reduced ζ potential from -38mV 
to -20mV (Chapter 3). The greater negative charge on the P80-PS compared to 2kDa 
PEG-ylated PS would mean that the P80-PS would be repelled by negatively charged 
mucus to a greater extent than 2kDa PEG-ylated PS. 
 
Nevertheless, the effect of nanoparticle PEG-ylation on mucosal penetration is 
controversial since there is also evidence in the literature that nanoparticles made from 
PEG-PLA (PEG 5kDa, PLA 45kDa) can reduce the mucosal penetration in cells 
(Behrens et al 2002). To assay the uptake of fluorescently labelled 196nm PEG-PLA 
nanoparticles, Behrens et al. (2002) lysed cells after 120 minute incubation of 
nanoparticles with (mucus producing) MTX cells or (non mucus producing) Caco-2 
cells. A four-fold reduction of internalised nanoparticles was found for MTX cells. It 
was thought that PEG-chains on the nanoparticle surface inhibited interaction of the 
nanoparticles with cell surfaces. 
 
Therefore, the effect of PEG surface modification is not fully understood. A number of 
variables may affect the ability of PEG-ylated nanoparticles to penetrate mucus and 
further uptake into epithelial cells; these may include PEG molecular weight, 
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nanoparticle core composition and/or effect of nanoparticle surface adsorbed proteins 
from the biological system. 
 
In the mouse model, fluorescence microscopy images (Figure 4.6a and Figure 4.7a) 
showed that surface modification of PS with polysorbate 80 and FCS did not change the 
distribution of nanoparticles in the olfactory mucosa. Similarly, stereological data 
estimated that 50-375 100nm PS particles/mm2 and 100-300 100nm P80-FCS-PS 
particles/mm2 were associated with olfactory epithelium.  
 
It was expected that polysorbate 80 would enrich the adsorption of certain serum 
proteins to the polysorbate 80 modified nanoparticles surface (e.g. ApoE, albumin) and 
reduce the adsorption of other FCS serum proteins (e.g. IgG) (Goppert & Muller 2005). 
Polysorbate 80 has been proven to promote the adsorption of ApoE (from human 
plasma) onto 230nm diameter solid lipid nanoparticles nanoparticles (Goppert & Muller 
2005). Hence, the proportion of ApoE increased from 0.005%(w/v) in human plasma to 
5.4%(w/v) adsorbed to solid lipid nanoparticles; the proportion of ApoE adsorbed to 
nanoparticles was increased further (15%w/v) when the core particle was made of poly-
butyl-methacrylate. 
 
Neuronal guidance during regeneration of neurones in the mouse olfactory epithelium is 
mediated by the presence of ApoE (Nathan et al 2007). However, the exact mechanism 
for this is not yet fully understood. It was speculated that the enrichment of Apo E to the 
PS nanoparticle surface would promote the uptake of P80-FCS-PS nanoparticle across 
the epithelial cells in the olfactory epithelium. Indeed, the improved uptake of serum 
exposed polysorbate 80-coated polybutylcyanoacrylate nanoparticles has been proven in 
  221 
brain endothelial cells in vitro (Ramge et al 2002). The uptake of particles was mediated 
by the involvement of ApoE receptors in brain endothelial cells. This was proven in 
vivo through use of Apo E receptor knockout mice (Kreuter et al 2002). However, a 
number of reasons could explain the lack of improved uptake for the P80-FCS-PS 
nanoparticles compared to the PS nanoparticles in mice. 
 
First, it has been shown that the pattern of serum protein adsorption can be determined 
by the nature of the core particle (as described above) (Goppert & Muller 2005). 
Therefore, the serum protein adsorption to polysorbate 80-coated PS nanoparticles may 
be different to polysorbate 80-coated polybutylcyanoacrylate nanoparticles. The PS core 
particle may reduce the concentration of ApoE adsorbed to the nanoparticle surface and 
therefore reduce the ability of the nanoparticles to be taken into cells by a receptor-
mediated endocytic pathway. In fact, adsorption of FCS serum proteins to the P80-PS 
nanoparticles could not be proven by ζ potential measurements, particle sizing or 
Bradford’s protein assay (Chapter 3). Second, the existence of ApoE receptors on the 
apical cell layer of the olfactory epithelium in mice has not been proven in the literature. 
Finally, extra time may be required for the adsorption of FCS serum proteins to P80-PS. 
Adsorption of the correct type or concentration of serum proteins may require longer 
than 30 minutes as used in the current work P80-FCS-PS formulation (Chapter 3). 
 
Future experiments could use antibodies or lectin histochemistry to identify real 
receptor targets in the olfactory epithelium. This could be combined with better 
characterisation of ligand adsorption (e.g. 2D electrophoresis) which would prove the 
existence of appropriate ligands on the nanoparticle surface before application of these 
particles onto the olfactory epithelium. 
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4.4.2 The Influence of Particle Diameter on Particle Transport 
Nanoparticle diameter may have affected the ability of P80-FCS-PS particles to 
penetrate the mucus overlying the nasal epithelial cells in the mouse model. Stereology 
showed that fewer 200nm P80-FCS-PS particles (~40 particles/mm2) were associated 
with the olfactory and non-olfactory as compared to 100nm P80-FCS-PS particles (100-
300 particles/mm2) (Figure 4.7). It may be that, for this system, the larger 200nm 
particle could not penetrate the mucus to the same extent as the smaller 100nm particles 
and therefore had a more restricted access to the cell surface. For example, in one study, 
a greater number of 176nm diameter PEG-PLA nanoparticles were observed after i.n. 
instillation of the respective colloids (by confocal microscopy) in rat nasal epithelial 
cells than 1.5µm diameter particles (Vila et al 2004). 
 
Similarly, the appearance of 125I-labelled Tetanus Toxoid in the blood of rats after i.n. 
instillation of 200nm diameter PEG-PLA nanoparticles was significantly greater than 
that found for PEG-PLA 10µm diameter particles. The relationship was size dependent 
since more radioactivity was found in the blood as the particle size was reduced to 5µm 
and 1µm diameter, respectively (Vila et al 2005). 
 
However, there does not appear to be a consensus within the literature about the ability 
of sub-micron diameter particles to penetrate the mucosal barrier. For example, it has 
been found that PS particles up to 500nm can penetrate cervical mucus (Lai et al 2007). 
This study, however, did not conclude that smaller particles penetrated the mucus faster. 
In fact, 200nm diameter particles penetrated the mucus just as quickly as 500nm 
diameter nanoparticles; 100nm particles progressed even slower. The authors proposed 
an explanation derived from size-exclusion chromatography that smaller particles can 
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access a greater number of pores in the heterogeneous mucosal pore structure. 
Therefore, the more tortuous route taken by smaller particles impedes their progress 
through the mucus. 
 
This, however, does not fit well with observations made by others who show that 
smaller polystyrene particles permeate gastric mucin faster than larger ones (Norris & 
Sinko 1997) i.e. smaller particles have more freedom to move through the 
heterogeneously distributed porous structure. 
 
In addition, particles did not transport to the olfactory bulbs. This may have been related 
to the diameter of the nanoparticle since the olfactory axons taper to a narrower width as 
they pass through the basement membrane. The average width of the olfactory axons in 
2 month old rabbits was 200nm but many of these axons had diameters of less than 
100nm (De Lorenzo 1960). Therefore, in my opinion, for reproducible transcellular 
transport of nanoparticle through the olfactory axons, nanoparticles should have a 
diameter of <100nm. Indeed, all studies to date that have demonstrated successful 
translocation of particles from the olfactory epithelium to olfactory bulbs have had 
diameters of less than 100nm (Chapter 1). 
 
Also, through observations of toxicity to the porcine olfactory epithelium (Figure 4.4), 
the results presented here indirectly indicated that 20nm C-PS penetrated the mucus 
further in a basolateral direction than 100nm or 200nm C-PS. Hence, greater penetration 
of 20nm C-PS particles may have caused the greatest toxicity to the porcine olfactory 
epithelia, followed by 100nm C-PS, and least damage was caused by 200nm C-PS 
(Figure 4.4). Indeed, there is growing opinion in the literature that nanoparticles can 
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inherently cause greater damage to cells as their size reduces (4.4.3 Toxicological 
Aspects of Nanoparticle Exposure to Olfactory Epithelium). Therefore, the observed 
damage to the epithelia after their exposure to 20nm C-PS may be a result of either a 
more efficient mucosal penetration or a greater damaging capacity (or a combination of 
both). 
 
4.4.3 Toxicological Aspects of Nanoparticle Exposure to Olfactory Epithelium 
In general, a number of broad observations were made regarding the toxicological 
effects of the test formulations on the nasal epithelia: (i) chitosan solution and C-PS 
damaged porcine olfactory epithelium more than the other test formulations; (ii) a sized-
dependent toxicity was observed for C-PS; and (iii) more chitosan-related toxicity was 
observed to the olfactory epithelia in the vertical Franz diffusion cell model than the in 
vivo mouse model. 
 
Chitosan is widely accepted as a safe biological material (Schipper et al 1996). For 
example, Howard et al. (2006) intranasally administered 30µl of chitosan/siRNA 
nanoparticles (1mg/ml, 230nm diameter) for 5 consecutive days to EGFP (Enhanced 
Green Fluorescence Protein) transgenic mice. On day 6 the mice were killed and 
bronchioles were inspected by fluorescence microscopy for EGFP knockdown. EGFP 
was present in control animals (mismatched siRNA-chitosan nanoparticles) but the 
matched siRNA-chitosan nanoparticles showed EGFP knockdown (Howard et al 2006). 
This showed that the chitosan nanoparticles were not toxic to the cells in vivo since 
EGFP knockdown can only be produced in live cells. However, the researchers also 
found that siRNA-chitosan nanoparticles formed with large excesses of chitosan may be 
harmful (using MTT assay) to EGFP-H1299 (human lung cancer cell line).  
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It is clear, from the results presented here that application of the different test 
formulations changed the level of olfactory tissue damage (Figure 4.3). In general, the 
in vitro experiments showed that chitosan solution and C-PS particles were more 
damaging than equivalent P80-PS or PS particles. The reasons for the damaging effects 
of these particles on olfactory epithelium could be explained in terms of: (i) the chitosan 
salt form (chitosan.HCl) and the molecular weight (143kDa); and (ii) variation between 
results from different toxicity/viability assay; and (iii) the type of cell line or epithelium 
which were used in the experiments. 
 
To expand, properties of chitosan such as molecular weight, degree of deactylation and 
salt form has been shown to modify the dose-dependent toxicity of the material towards 
cells in vitro. The chitosan solution (0.125mg/ml) used here had a large molecular 
weight (143kDa) and high degree of deactylation (89%). Increasing MW and DA% 
have been shown affect the viability of cells. Indeed, chitosans of molecular weight 
>100kDa are more toxic to Caco-2 cells than those with molecular weights <100kDa as 
determined by MTT assay (Carreno-Gomez & Duncan 1997). Also, Huang et al. found 
by MTT assay that the cytotoxic effect of chitosan solution to A549 (carcinomic human 
alveolar basal epithelial cells) was increased ~1.7-fold by increasing the %DA of 
chitosan from 46% to 88% (Huang et al 2004). Furthermore, chitosan.HCl could be 
regarded as the most cytotoxic salt form since it had the lowest IC50 values of 
0.27±0.08mg/ml in caco-2 monolayers (compared to chitosan aspartate, chitosan 
glutamate and chitosan lactate) (Opanasopit et al 2007), and similarly, 0.21±0.04mg/ml 
in B16F10 cells (compared to chitosan hydroglutamate, chitosan hydrolactate and 
glycol chitosan) (Carreno-Gomez & Duncan 1997)as measured by MTT assay.  
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Also, Huang et al. found that 188nm diameter chitosan nanoparticles (MW 213kDa, 
DA% 88) were toxic to A549 in concentrations higher than 0.741mg/ml using MTT 
assay and neutral red (a dye that is endocytosed by viable cells) (Huang et al 2004). 
Since the chitosan was not surface loaded the concentration dependent cytotoxic effect 
is difficult to compare with the data presented here. Nevertheless, the specific nature of 
chitosan could explain the toxicity observed for chitosan solution to olfactory epithelia 
in the present study compared to the absence of such elsewhere. 
 
In contrast, Rm or LDH assay scores showed no change after application of 290nm 
diameter chitosan.HCl (MW 100-130kDa, 80% deacetylation) nanoparticles to Caco-2 
cell monolayer compared to monolayers without addition of chitosan nanoparticles 
(Behrens et al 2002). According to these workers, this ruled out the possibility that the 
chitosan nanoparticles caused cytotoxicity to the Caco-2 cells. 
 
Dodane et al. did not find significant toxicity to Caco-2 cells up to 5mg/ml 
chitosan.HCl (MW 100-130kDa, 80% deacetylation) as assayed by Trypan Blue 
(Dodane et al 1999). Also, the study showed no damaging effects to Caco-2 cells of 
1mg/ml chitosan by Transmission Electron Microscopy, although, changes in 
enlargement of endoplasmic reticulum and the appearance of large vacuoles were seen 
in the cells. These findings show that the assay method influences the interpretation of 
the toxicity threshold. Nevertheless the consensus suggests that no toxicity should have 
been observed in the current work since these thresholds are all above the concentration 
of chitosan used in the current work. 
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In the current work Alamar Blue™ assay and bioelectrical measurements (Rm, PD and 
Isc) showed that 20nm, 100nm and 200nm C-PS did not significantly affect the viability 
of porcine olfactory epithelium compared to the 0.5mM citrate buffer control (pH6.0). 
This was probably because the citrate buffer reduced the viability of the epithelium 
before the application of the C-PS nanoparticles to the mucosal surface. However, 
histology did show that the mucosae were damaged after the exposure (Table 4.5). The 
amount of visible damage was increased with the application of smaller nanoparticles to 
the surface of the olfactory epithelia (Figure 4.4) when compared to the larger particles. 
This demonstrated that the Alamar Blue™ and bioelectrical viability measures used 
here may not have been able to sufficiently determine the effects of the test formulations 
on epithelial viability compared to standard histological evaluation.  
 
Hence, Alamar Blue™ measured the viability of the whole tissue whereas the Rm, PD 
and Isc data predominantly measured the function of the epithelial cell layer. Therefore, 
damage to the epithelial cells may not have been detected using Alamar Blue™. 
 
On the other hand, Rm, PD and Isc data are based on the integrity of the epithelial tight 
junctions, and the ability of the epithelial cells to generate a potential difference across 
the mucosa by actively transporting ions into the donor chamber against the ion 
concentration gradient. Therefore, in theory, this technique should produce a more 
accurate account of the viability of the epithelial cells compared to Alamar Blue™. 
However, the variability between different epithelia (i.e. the lack of precision of the 
results) was high using the electrophysiological technique. This meant that statistical 
differences between the grouped data were not found - which otherwise may have been. 
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Hence, histology, Alamar Blue™ and the Rm, PD and Isc data were determining 
different aspects of viability of the epithelia. This difference could account for the 
inconsistency between the data from these techniques. Furthermore, the damage 
observed to the olfactory epithelial cells found here and the lack of toxicity of similar 
chitosan containing nanoparticle system elsewhere could be explained in a similar way. 
For instance, Huang et al. (2004) and Behrens et al. (2002) did not show the detailed 
histological effects of the chitosan nanoparticles in their studies therefore toxicity may 
have been observed by these researchers if this analysis was undertaken. 
 
To my knowledge the toxicity of chitosan-coated nanoparticle systems to olfactory 
epithelium has not been reported to date. However, it has already been shown that 
physiological differences exist between olfactory and respiratory epithelia in pigs; 
hence, it was found that the metabolic rate of respiratory epithelia was greater than that 
of olfactory epithelia from the same animals (2.3.4 Comparison of Olfactory and 
Respiratory Tissue Metabolism). It is therefore reasonable to extrapolate that other 
physiological differences may also exist that may influence the susceptibility of 
olfactory epithelium to toxicity compared to non-olfactory epithelium. Indeed, a number 
of different cell types were used in the experiments described in the previous discussion 
on chitosan toxicity. The inherent variation in cellular physiology may have influenced 
the variation in toxicity that was observed in these experiments. Therefore, the chitosan-
related toxicity to olfactory epithelium observed by bright field microscopy in Figure 
4.4 may be influenced by the physiological nature of the olfactory epithelium compared 
to non-olfactory epithelium or in vitro cell lines. 
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In addition, there is growing evidence that the toxicity of nanoparticles to cells can 
increase as their diameters reduce (Oberdorster et al 2005). In the current work, it was 
observed in the diffusion chamber experiments that C-PS toxicity was sized-dependent 
(Figure 4.4). For example, in the previous discussion, the size of the chitosan 
nanoparticles used by Huang et al. (2004) and Behrens et al. (2002) (188nm and 
290nm, respectively) were larger than the most toxic particle found in the current study 
(20nm and 100nm C-PS particles). Hence, this could also explain the differences 
between the lack of toxicity observed to cells with the larger particle used in these 
studies and the toxicity to olfactory epithelial cells found here after exposure to 20nm, 
100nm and 200nm C-PS. 
 
Two explanations can be given for the size-related toxic effects of nanoparticles to cells. 
Toxicity is thought to be related to either the high relative surface area (which is the 
surface area of an object proportional to its volume) associated with nanoparticles 
(Brown et al 2001) and/or the capability of small nanoparticles (<60nm) to access cell 
organelles (such as mitochondria) that larger particles may not (Xia et al 2006). The 
current observation of C-PS induced epithelial damage to the porcine olfactory epithelia 
is more easily explained by the latter explanation since the particle numbers were kept 
constant for all nanoparticle formulations (4.55x1010particles/ml). Therefore, relative 
surface area increased with increasing nanoparticle diameter for these test formulations. 
 
However, there are problems with a similar interpretation for the current data. First, no 
direct evidence of C-PS nanoparticles was seen in the porcine olfactory epithelium by 
fluorescence microscopy. This was mainly due to a lack of fluorescence microscopy 
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analysis which was a result of sample wastage during the method development phase to 
produce the images. 
 
Second, the histological observations between the in vitro vertical Franz diffusion cell 
and the in vivo mouse model did not correlate well since uptake of 100nm and 200nm 
C-PS did not show morphological changes to the mouse olfactory epithelia (Figure 4.6). 
An explanation for this could be that pH6.0 was probably better controlled in vitro than 
in vivo (4.4.4 Comparison of In vitro and In vivo Biological Models) hence the C-PS 
nanoparticles would not have formed as many aggregates in the in vitro system which 
would result in better mucus penetration and more cellular uptake and therefore more 
cell damage. 
 
However, this is speculation based on indirect evidence therefore the effect of 
nanoparticle C-PS surface modification and diameter on olfactory epithelial damage 
remains unclear. 
 
To improve the accuracy of epithelial viability/cytotoxicity determinations after 
exposure to nanoparticles future in vitro studies could evaluate cellular events that are 
relevant in the drug delivery context. A combination intracellular calcium levels, ROS 
activity and lipid peroxidation indicators and improved histological analysis could give 
a more detailed and precise account of the cellular injury during nanoparticle uptake 
(Xia et al 2006). 
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4.4.4  Comparison of In vitro and In vivo Biological Models 
The biological model may have affected the distribution of the nanoparticles in the nasal 
cavity. For example, results from the in vivo model showed that 100nm PS and 100nm 
P80-FCS-PS nanoparticles were found mainly inside the olfactory epithelium. In the 
vertical Franz diffusion, however, it was difficult to conclude whether PS or P80-PS 
were transported into cells or rested in the overlying mucus since these particles did not 
penetrate basolaterally far enough through the mucosa to make a clear distinction. 
 
The difference between PS and P80-PS mucosal penetration could be attributed to the 
contact time that was allowed for particles with nasal epithelium in the different 
experiments. In the diffusion chamber experiments the particles were exposed to the 
olfactory tissue for 120 minutes. Contact time for the nanoparticles with the nasal 
epithelium in the mouse model was four days (although it was noted that some 
nanoparticles drained away from the nasal cavity after the mice recovered from 
anaesthesia 2 minutes post-dosing). 
 
Also, bright field images of the porcine olfactory epithelia exposed to 0.5mM pH6.0 
citrate buffer did not agree with the mouse model data. The quality of mouse olfactory 
and non-olfactory epithelia after exposure to 0.5mM citrate buffer pH 6.0 was 
comparable to those using light microscopy of fresh porcine olfactory epithelia (Figure 
2.16 and Figure 4.5). These samples were therefore considered to be undamaged by the 
0.5mM pH6.0 citrate buffer alone. However, the morphology of the 0.5mM pH6.0 
citrate buffered olfactory tissue from the diffusion chamber experiment was damaged 
compared to the light microscopy of fresh porcine olfactory epithelia (Figure 2.17). The 
difference between the results can be explained by: (i) the inability of the citrate buffer 
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to maintain a pH gradient in the diffusion chamber model (Chapter 2); and (i) the 
difference in epithelium:buffer ratio in the two models. 
 
To explain the first point, the viability of the olfactory epithelia in the diffusion chamber 
model was reduced in the pH6.0 citrate buffer. This may be explained in terms of a 
reduced mucosal pH gradient in vitro due to the lack of HCO3- ions in the citrate buffer 
(2.3.2 Effect of Different Buffers and Sodium Azide on Olfactory Epithelium and 
Figure 4.8). The exposure of surface epithelial cells in vitro to pH6.0 conditions could 
explain the damage observed to the cells in these epithelia. However, it is assumed that 
the mucosal pH gradient is maintained in vivo by blood born HCO3- ions. This could 
explain why reduced epithelial damage was observed in vivo compared to in vitro. 
 
Also, pH6.0 conditions were more likely to have been maintained in the diffusion 
chamber since less tissue (1.0 cm2 [in vitro], 2.5cm2 [in vivo (Gizurarson 1990)]) was 
exposed to more 0.5mM citrate buffer (3.7ml [in vitro], 30µl [in vivo]) in this model. 
This difference may also have contributed to the increased damage to the epithelia in the 
diffusion chamber model. 
 
C-PS nanoparticles were found in the mucous layer in both in vivo and in vitro models. 
However, more damage was observed to the epithelial cells in the diffusion chamber 
model than the mouse model when C-PS nanoparticles were applied. This may also be 
explained by the mucosal pH gradient (Figure 4.8). Hence, in the mouse model, pH of 
the mucus may change from pH6.0 at the gel layer surface to pH7.4 at the epithelial cell 
surface. Aggregation and physical entrapment of C-PS may occur in the gel layer as the 
colloid becomes unstable at higher pH towards to the epithelial cell surface (Figure 4.8). 
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In the diffusion chamber model the C-PS colloid is charge stabilised in the gel layer. 
Electrostatic interactions between the cationic particles and anionic gel layer may 
dominate. Hence, the mechanism of C-PS retention in mucus in each biological model 
may have been different. 
 
  
 
The C-PS related epithelial damage observed by bright field microscopy could also be 
due to the diminished mucosal pH gradient in vitro (Figure 4.8). Hence, the C-PS 
colloid would remain stable in the sol layer and induce nanoparticle size-related damage 
to the epithelium as explained earlier (4.4.3 Toxicological Aspects of Nanoparticle 
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Exposure to Olfactory Epithelium). In the mouse model trapped C-PS aggregates in the 
mucous layer would prevent particles from reaching the epithelial cell surface. 
However, it was noted that C-PS nanoparticles were presumed to have reached the 
epithelial cells in vitro but no direct evidence of C-PS was observed in the olfactory 
tissues from the diffusion chamber transport studies by microscopy. 
 
4.4.5 Particle Transport into Olfactory and Non-olfactory Epithelia 
Stereological results showed there were 2.1-fold, 4.0-fold and 1.5-fold increases in the 
number of 100nm PS, 100nm C-PS and 100nm P80-FCS-PS nanoparticles 
(respectively) in the non-olfactory mucosa compared to olfactory mucosa (n=2). A well 
documented explanation for this is that nanoparticles are transported to a greater extent 
into M cells (for the function of presenting antigens to the NALT) of the non-olfactory 
epithelium compared to columnar epithelial cells (Ghirardelli et al 1999; Brooking et al 
2001). NALT regions are not thought to exist in the olfactory epithelium. Therefore, the 
general increase of nanoparticle association with non-olfactory epithelium can be 
explained by transport into these regions. However, direct evidence for the existence of 
NALT and its association with nanoparticles was not investigated by microscopy in this 
study therefore a clear conclusion for this explanation can not be made. 
 
100nm P80-FCS-PS surface modification strategy did not result in clear preferential 
uptake of these nanoparticles compared to 100nm PS into either non-olfactory or 
olfactory tissues. P80-FCS-PS nanoparticles were formulated with speculation that 
selective adsorption of certain serum proteins to P80-PS would result in preferential 
transport into the olfactory epithelium. Rationale for the study design and explanations 
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for the lack of positive outcome have been given previously (4.4.1 The Influence of 
Particle Surface Modifications on Particle Transport). 
 
Future progress for olfactory selective nanoparticle formulations is likely to be made 
through surface modification of nanoparticles with targeting ligands that are known to 
react selectively with olfactory epithelium. Biorecognitive molecules such as lectins 
could provide the answer (Plendl & Sinowatz 1998). In fact, one successful study using 
Ulex europeus agglutinin I has already demonstrated the olfactory selectivity of lectin-
conjugated nanoparticles in nasal mucosa (Gao et al 2007).  
4.4.6 Implications of Study Outcomes 
The outcome of this study has shown that more PS and P80-FCS-PS nanoparticles were 
found in nasal epithelial cells compared to C-PS. Hence, these formulations would be 
useful in different circumstances. 
 
For example, C-PS nanoparticles would be useful to allow passage of surface-carried 
drug paracellularly through the nasal epithelia after release from the particle surface. If 
the release occurs over the respiratory epithelium this might result in systemic transport. 
However, release over olfactory epithelium could allow a direct N-B transport. If C-PS 
was used in this way then it would be necessary to deliver the formulation to the 
required epithelial locations in the nasal cavity by using drug delivery devices designed 
for selective deposition. Also, C-PS particles larger than 200nm may reduce mucosal 
penetration of the particles further and therefore avoid the damaging effects of the 
nanoparticles to the epithelial cells. Of course, for clinical success, the core polystyrene 
would eventually need to be exchanged for a biodegradeable polymer. 
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On the other hand, PS and P80-FCS-PS showed similar transport of particle numbers 
into nasal epithelial cells. Clearly, non-biodegradable polymers are not clinically useful 
for this type of drug delivery. As a result of this study, however, it is speculated that 
surface modification of biocompatible polymers with P80/FCS could produce 
equivalent uptake into the nasal cells to that seen here for P80-FCS-PS. Furthermore, if 
this strategy is successful for delivery of biodegradable nanoparticles into olfactory 
axons then nanoparticles containing molecules that are sensitive to the extracellular 
environment could eventually be delivered direct from nose-to-brain. 
 
Indeed, the design of colloidal carriers intended to address specific delivery 
requirements by chitosan-coating nanoparticles for paracellular drug uptake and PEG-
coating nanoparticles for transcellular uptake has also been suggested before across 
rabbit corneal epithelial cells (De Campos et al 2003). 
4.5 CONCLUSIONS 
An in vitro vertical Franz diffusion cell model using porcine olfactory epithelium and an 
in vivo mouse model were used to investigate the nasal transport of 20nm, 100nm 
and/or 200nm diameter nanoparticles with different surface modifications (PS, C-PS, 
P80-PS and/or P80-FCS-PS). The damaging effects of these nanoparticles to the 
olfactory epithelium were also reported. The in vivo transport of these particles were 
investigated through the non-olfactory and olfactory epithelia, however, particular 
emphasis was placed on the latter in accordance with the overall thesis aims. 
 
First, modification of surface character changed the distribution of nanoparticles within 
the epithelia. C-PS caused particles to adhere to the extracellular mucus. It was thought 
that chitosan could be useful for deposition of drug in the extracellular mucus matrix in 
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order for a transport of drug via a fast paracellular route after release from the particle. 
In contrast, PS and P80-FCS-PS were taken into the nasal epithelial cells. In my 
opinion, encapsulating drugs that are sensitive to the extracellular environment into 
biodegradeable polymers and then overcoating with the polysorbate 80 (with or without 
adsorbed serum proteins) may be useful strategy for transport of drugs that are sensitive 
to the extracellular environment. 
 
Second, a greater number of 100nm PS and 100nm P80-FCS-PS appeared in both types 
of epithelia compared to 200nm diameter equivalents. Therefore, the size of the 
nanoparticles was important. It was speculated that the successful translocation of the 
smaller particles was related to their ability to penetrate mucus more effectively than the 
larger ones. In the mouse model, the distinction between uptake of 100nm and 200nm 
C-PS particles was less pronounced than that for 100nm and 200nm P80-FCS-PS which 
suggested that surface character played a greater role in particle transport into the nasal 
epithelium compared to particle size (at these diameters) in these systems. 
 
In addition, nanoparticles were not observed in the mice olfactory bulbs. The 
nanoparticles used here were possibly too large for transcellular transport after the 
olfactory axons narrowed in the basement membrane region in the mouse model. This 
agreed with in vitro data which showed that no particles were detectable in the receiver 
chamber in any of the diffusion chamber transport experiments. Therefore, it is 
speculated that an optimal nanoparticle size for transcellular nanoparticle transport 
direct from nose-to-brain would be <100nm diameter. 
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Also, C-PS nanoparticles caused the greatest amount of damage to the porcine olfactory 
epithelium compared to PS, P80-PS and P80-FCS-PS systems. The damage was likely 
to be a combination of: (i) the (hydrochloride) salt form and molecular weight 
(>100kDa) of the chitosan; (ii) the relative surface area and/or physical diameter of the 
nanoparticles; and (iii) depletion of the mucosal pH gradient in the in vitro model using 
pH6.0 citrate buffer. 
 
However, C-PS size-related damage was not found in the mouse model. It was 
hypothesised that, unlike the in vitro model, the mouse model may have been able to 
maintain a pH gradient across the mucous layer by neutralising the acidity from the 
citrate buffer using blood born HCO3- ions. This would protect the epithelial cells by 
causing C-PS to aggregate in the mucus thereby preventing them from accessing the 
epithelial cells. 
 
Nevertheless, if similar chitosan-coated nanoparticle systems are to be used in direct  
N-B drug delivery in the future then a particle diameter of >200nm is speculated to be 
appropriate for this system. This may enable paracellular drug delivery of small 
molecular weight drugs, which are insensitive to cellular efflux and degradation, to be 
achieved with less damage to the underlying epithelium than that found here. 
 
Third, PS, C-PS and P80-FCS-PS nanoparticles were found in greater concentrations in 
the non-olfactory epithelium compared to the olfactory epithelium in the mouse model. 
This may be due to the transport of nanoparticles into NALT regions of the non-
olfactory epithelium for antigen sampling since NALT has not been found to exist in the 
olfactory epithelium to date. However, this was not confirmed by co-localising NALT 
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and nanoparticles by fluorescence microscopy; therefore, the reason for increased 
association nanoparticles to non-olfactory regions remained unclear. 
 
In conclusion, nanoparticles may be useful for drug delivery through the olfactory 
system. However, altering the surface character and size of the nanoparticles may lead 
to improved efficacy at the expense of toxicity to the biological system. Therefore, the 
future challenge is to design nanoparticle systems that deliver the drug payload through 
the appropriate pathway to the brain in a safe and efficacious manner. 
 
To improve drug delivery to the olfactory region, promising approaches that could be 
used in the future relate to targeting of the olfactory epithelium through conjugation of 
olfactory-selective biorecognitive ligands. Such a strategy would reduce the reliance of 
drug delivery devices to target the olfactory epithelium through selective deposition of 
the nanoparticles in the olfactory region. 
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5. SUMMARY 
5.1 FINAL CONCLUSIONS 
 
The primary aims of the project are listed below. 
(i) Design biological drug delivery models to investigate the physiological mechanisms 
that may allow the transport of nanoparticles directly from nose-to-brain. 
(ii) Formulate a number of novel non-biodegradable nanoparticulate systems and 
compare their relative abilities to transport into the olfactory system. 
(iii) Monitor the affect of nanoparticle exposure to the viability and morphology of 
olfactory epithelia. 
 
In vitro vertical Franz diffusion chamber and in vivo mouse models were adapted to 
investigate the transport of nanoparticles via the olfactory system. A tissue extraction 
protocol was established by identifying the location of the olfactory epithelium in the 
porcine nasal cavity. The olfactory region was found at the caudal portion of the nasal 
cavity and extracted from the epithelium lining the dorsal nasal turbinate. 
 
To ensure the scientific validity of the diffusion chamber studies it was necessary to 
prove that the experimental procedures themselves (without the addition of 
nanoparticles) had no effect on the mounted tissue. Therefore, viability and cellular 
morphology of the dissected olfactory epithelia were assessed prior to application of 
nanoparticles to tissues. The results showed that the diffusion chamber experiment did 
not visibly damage or have an affect on the metabolic activity of the olfactory tissue. 
However, the nature of the buffering system had significant effects on the viability of 
the diffusion chamber mounted olfactory epithelia. The citrate buffered samples (pH6.0) 
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were presumed to have reduced the viability of the olfactory epithelium by depleting the 
mucosal pH gradient in the epithelium but this did not kill the epithelial cells 
completely. 
 
Other conclusions drawn from this work showed that; (i) metabolic activity of the 
olfactory epithelium was statistically reduced compared to respiratory epithelium, and 
(ii) normalising Alamar Blue™ data by the thickness of the epithelium did not reduce 
the variability of the Alamar Blue™ viability data. Overall, the diffusion chamber 
method validation concluded that both SNS buffered and citrate buffered porcine 
olfactory epithelia were suitable for nanoparticle transport studies in the vertical Franz 
diffusion cell. 
 
The development of colloidal nanoparticle formulations was undertaken by surface 
modification of fluorescently labelled nanoparticles with chitosan, polysorbate 80 or 
polysorbate 80+FCS. 20nm, 100nm and 200nm diameter PS nanoparticles were surface 
modified with these materials. The dominant adsorption forces for chitosan and 
polysorbate 80 were different in each case. Chitosan adsorbed onto the carboxylated 
nanoparticle surface by electrostatic interactions which required careful manipulation of 
electrostatic charges on the surface of the nanoparticles and the chitosan molecules 
during formulation. Adsorption of polysorbate 80 was presumed to be driven by 
hydrophobic-hydrophobic interactions between the oleic acid moiety on polysorbate 80 
and the surface of the PS nanoparticle. Adsorption of FCS serum proteins onto P80-PS 
nanoparticles was not detected by ζ potential, particle size or Bradford’s protein assay. 
Nevertheless, the literature has consistently shown that serum protein adsorption does 
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occur on various polysorbate 80-coated nanoparticles. Therefore, it was presumed that 
serum adsorption had occurred.  
 
The PS, C-PS, P80-PS and P80-FCS-PS nanoparticles formulations were either applied 
to the mucosal surface of the diffusion chamber mounted olfactory epithelia or 
administered intranasally in the in vivo mouse model. 
 
The following observations were made: first, surface modification changed the 
distribution of nanoparticles within the epithelia. C-PS particles adhered to the 
extracellular mucus whereas PS and P80-FCS-PS were taken into the nasal epithelial 
cells. Stereological data showed that there was no difference between the uptake of PS 
and P80-FCS-PS nanoparticles in the mouse model. It was unclear whether this was due 
to a lack of adsorption of serum proteins to the nanoparticle surface. 2D electrophoresis 
may be used in the future to clarify FCS adsorption behaviour to P80-PS nanoparticles. 
 
Second, the size of the nanoparticles was important. A greater number of 100nm PS and 
100nm P80-FCS-PS appeared in mouse nasal epithelial cells compared to 200nm 
diameter equivalents. 
 
Nanoparticles were not observed in the mice olfactory bulbs. This agreed with in vitro 
data which showed that no particles were detectable in the receiver chamber in any of 
the diffusion chamber transport experiments. 
 
C-PS nanoparticles caused the greatest amount of damage to the porcine olfactory 
epithelium compared to PS, P80-PS and P80-FCS-PS systems. This may have been due 
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to the physicochemical character of the chitosan, the size of the C-PS nanoparticles 
and/or (iii) depletion of the mucosal pH gradient in the in vitro model using pH6.0 
citrate buffer. However, similar cellular damage in the mouse model were not observed. 
It was hypothesised that, unlike the in vitro model, the mouse model may have been 
able to maintain a protective pH gradient across the mucous layer by neutralising the 
acidity from the citrate buffer using blood born HCO3- ions. 
 
Third, nanoparticles were found in greater concentrations in the non-olfactory 
epithelium compared to the olfactory epithelium in the mouse model possibly due to the 
absorption of nanoparticles into non-olfactory NALT regions. However, this was not 
confirmed by co-localisation studies of NALT and nanoparticles by fluorescence 
microscopy. 
5.2 SIGNIFICANCE AND FUTURE POSSIBILITIES 
 
The outcome of this study has shown that more PS and P80-FCS-PS nanoparticle were 
found in nasal epithelial cells compared to C-PS. Hence, these formulations would be 
useful in different circumstances. 
 
For example, C-PS nanoparticles would be useful to allow passage of surface-carried 
small molecular weight drugs paracellularly through the nasal epithelia after release 
from the particle surface. Drugs that are less sensitive to cellular efflux and degradation 
would be suitable candidates for this type of drug delivery. If the drug release occurs 
over the respiratory epithelium this might result in systemic transport. In contrast, 
release over olfactory epithelium could allow a direct N-B transport. However, since 
chitosan has no biorecognitive targeting ability, it would be necessary to deliver C-PS to 
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the required epithelial locations in the nasal cavity by using drug delivery devices 
designed for selective deposition. C-PS particles larger than 200nm may reduce 
mucosal penetration of the particles further and therefore avoid the damaging effects of 
the nanoparticles to the epithelial cells. Of course, for clinical success, the core 
polystyrene would eventually need to be exchanged for a biodegradeable polymer. 
 
In contrast, PS and P80-FCS-PS showed similar uptake of particle numbers into nasal 
epithelial cells. Again, non-biodegradable polymers are not clinically useful for this 
type of drug delivery. As a result of this study, however, it is speculated that surface 
modification of biodegradeable polymers with P80/FCS could produce equivalent 
uptake into the nasal cells to that seen here for P80-FCS-PS. Furthermore, if this 
strategy is successful for delivery of biodegradable nanoparticles (<100nm diameter) 
into olfactory axons then nanoparticles containing molecules that are sensitive to the 
extracellular environment could eventually be delivered direct from nose-to-brain. 
 
To improve drug targeting to the olfactory region, promising approaches that could be 
used in the future relate to selective targeting of olfactory epithelium through 
conjugation of olfactory selective biorecognitive ligands (e.g. lectins). Such a strategy 
would reduce the reliance of drug delivery devices to target the olfactory epithelium. 
 
Also, olfactory epithelium had a reduced metabolic activity compared to respiratory 
epithelium. From a direct N-B drug delivery perspective, and depending on the drug to 
be delivered, this may be either detrimental (by allowing slower uptake of drug into the 
olfactory epithelial cells) or beneficial (by allowing slower drug degradation in the 
olfactory mucosa or slower efflux of drug from apical cells). However, the relationship 
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between epithelial metabolic activity and drug transport would need to be investigated 
in greater detail to establish this opinion. 
 
Overall, nanoparticles may be useful for drug delivery through the olfactory system. 
However, altering the surface character and size of the nanoparticles may lead to 
improved efficacy at the expense of toxicity to the biological system. Therefore, the 
future challenge is to design nanoparticle systems that deliver the drug payload through 
the appropriate pathway to the brain in an efficacious and safe manner. 
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APPENDIX 
 
The following buffers were required during sample preparation, for measuring DNA 
content of tissues, as described in Section 2.2.5.3 Hoechst DNA Quantification. 
 
Papain Buffer 
Dibasic sodium phosphate (0.1M), cysteine HCl (0.005M) and EDTA (0.005M) were 
diluted with water and adjusted to pH6.5 2.0M HCl. 
 
Preparation of Papain Solution 
Papain was dissolved in papain buffer (1.06mg/ml) to produce papain solution. 
 
Preparation of Hoechst Concentrate Solution 
Saline sodium citrate buffer was diluted (1 in 20) with water. This was used to dissolve 
bisbenzamide (1mg/ml). 100l aliquots of this concentrated solution were frozen  
(-20°C) until required.  
 
Preparation of Hoechst Buffer 
EDTA (0.01M), NaCl (0.1 M) and Trizma Base (0.01M) were diluted with water and 
adjusted to pH7 with 2.0M HCl. 
 
Preparation of Hoechst working solution 
Bisbenzimide (1.5µg/ml) was diluted in Hoechst buffer with 0.4 M NaCl. 
